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ABSTRACT OF DISSERTATION

ROLE OF CALCIUM AND NITRIC OXIDE SYNTHASE (NOS) IN BRAIN
MITOCHONDRIAL DYSFUNCTION
Mitochondria are essential for promoting cell survival and growth through
aerobic metabolism and energy production. Mitochondrial function is typically
analyzed using mitochondria freshly isolated from tissues and cells because they
yield tightly coupled mitochondria, whereas those from frozen tissue can consist
of broken mitochondria and membrane fragments. A method, utilizing a wellcharacterized cryoprotectant such as dimethyl sulfoxide (DMSO), is described.
Such mitochondria show preserved structure and function that presents us with a
possible strategy to considerably expand the time-frame and the range of
biochemical, molecular and metabolic studies that can be performed without the
constraints of mitochondrial longevity ex vivo.
Mitochondrial dysfunction is implicated in Alzheimer’s disease (AD) mainly
through oxidative stress and altered metabolism. Mitochondria are isolated from
post-mortem brain samples from selective regions of AD and control patients
and, utilizing the cryopreservation strategy, analyzed for respiration and oxidative
damage. While we did not observe increases in free radicals, we did observe
decreased respiration and increases in oxidative damage markers in AD patients,
suggesting a role for oxidative stress in mitochondrial dysfunction.
While in the mitochondria, calcium (Ca2+) increases free radical generation
by processes not completely understood. A new isoform of nitric oxide synthase
(mtNOS) has been isolated and localized to mitochondria; though its existence
and physiological role is debated. Nitric oxide synthase (NOS), when activated by
Ca2+, produces nitric oxide (NO•) that can interact with ROS producing various
reactive nitrogen species (RNS). These highly reactive radical species can
damage DNA, proteins and lipids, ultimately resulting in cell death via apoptosis
or necrosis.

The current research is aimed at understanding the role of Ca2+ and NOS
in oxidative stress leading to mitochondrial dysfunction. We observed a
significant reduction in mitochondrial respiration with increasing doses of calcium.
We also observed NOS enzyme activity and detected NOS protein in the purified
mitochondrial fraction. Lastly, we were also able to show that Ca2+ increased the
levels of free radicals and changes in oxidative damage markers. These results
suggest the presence of NOS in mitochondria that could play a role in Ca2+
induced mitochondrial dysfunction and potentially leading to cell death as
relevant to aging and neurodegenerative diseases.
KEYWORDS: Brain Mitochondria, Cryopreservation, Alzheimer’s disease (AD),
Calcium, Nitric Oxide Synthase and Oxidative Stress
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Chapter One

Mitochondria, Calcium, Nitric Oxide Synthase,
Oxidative Stress, Cell Death and Aging

Mitochondria act as a biological switch in determining a cell’s fate, in that
they provide the necessary energy for the cell and in cases of noxious stimuli
cause cell death by necrosis and/or apoptosis. The physiological function of
mitochondria is to produce adenosine triphosphate (ATP), energy currency of the
cell, through Kreb’s cycle and electron transport chain (ETC). This ATP is utilized
for various biological reactions inside the cell. Mitochondria are also involved in
calcium (Ca2+) homeostasis. However, as a consequence of ATP production,
mitochondria also produce reactive oxygen species (ROS) as a by-product,
mainly in the form of superoxide. The mitochondria are also equipped by antioxidant molecules and enzymes, and repair mechanisms. However, during
pathophysiological

conditions

such

as

aging,

neurodegeneration

and

neurotrauma, the balance between ROS and anti-oxidants is tipped causing
oxidative stress and Ca2+ dysregulation. This leads to mitochondrial dysfunction,
triggering a signaling cascade resulting ultimately in death of the cell (Pedersen
1999; Duchen 2000; Kroemer and Reed 2000; Newmeyer and Ferguson-Miller
2003; Smaili et al. 2003; Wallace 2005).

Mitochondria
Margulis, in one of the early theories of mitochondrial evolution in 1970,
proposed that mitochondria originated from α-Proteobacteria that formed an
endosymbiotic relationship with nucleocytoplasm of Archeon about 1.5 – 2.0
billion years ago (Gray et al. 1999; Lang et al. 1999; Gray et al. 2001; Searcy
2003; Dyall et al. 2004). However, studies of protists (unicellular eukaryotes)
indicate that mitochondria originated at the same time as the eukaryotic nucleus
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and not as a separate and subsequent event. In either case, genes necessary for
amino acid biosynthesis, nucleoside biosynthesis, anaerobic glycolysis, cofactor
biosynthesis, fatty acid and phospholipid metabolism, energy and intermediary
metabolism, cell envelope synthesis, and cell division as well as most
informational genes (genes directing replication, transcription, and translation)
were typically transferred to host nuclear de-oxy ribo nucleic acid (DNA), thereby
rendering a simple mitochondrial DNA (Gray et al. 1999; Wallace 2005).
Kolliker, in 1850, was among the first to describe characteristically
arranged granules in the sarcoplasm of striated muscle, separated them from cell
structure and noted they possess a membrane. They were termed “sarcosomes”
by Retziius and “bioplasts” by Altman in 1890 and “mitochondria” (Greek; mitos
meaning a thread and chondros meaning grain) by Benda in 1898. They were
also known by various other terms such as blepharoblasts, chondriokonts,
chondriomites, chondrioplasts, chondriosomes, chondriospheres, fila, interstitial
bodies, mitogel, parabasal bodies, plasmasomes, spheroplasts, and vermicules,
among others. Kingsbury and Warburg in 1912 studied mitochondria and
demonstrated that they were involved with respiration, while Lewis and Lewis in
1914 found mitochondria to undergo changes in their size, shape and location. In
the

1920s

and

1930s,

Szent-Gyorgyi

(awarded

the

Nobel

Prize

in

Physiology/Medicine in 1937) discovered the catalytic effect of the four-carbon
dicarboxylic acids on respiration and Krebs (Nobel Prize in Physiology/Medicine
in 1953) postulated the citric acid cycle as the primary cellular mechanism for the
oxidation of carbohydrates, thus bringing mitochondria into the limelight as
“powerhouses of the cell”.
Lohmann in 1931 discovered ATP, but its true significance in cellular
energy requirements came about with the demonstration of Warburg in 1937–
1938 of the formation of ATP coupled to enzymatic oxidation of glyceraldehyde
phophate (and won the Nobel Prize in Physiology/Medicine in 1931) and the
work of Meyerhof (Nobel Prize in Physiology/Medicine in 1922) on the formation
of ATP from phosphopyruvate. During the same period, Kalckar demonstrated
that oxidative phosphorylation was coupled to respiration. In 1940, Claude
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investigated the structure, behavior, and chemical composition of mitochondria
and microsomes isolated by differential centrifugation of liver homogenates (and
won the Nobel Prize in Physiology and Medicine in 1974). During the period from
1943–1947, Leloir and Munoz, Lehninger and Kennedy, and Schneider and
Potter conducted studies on oxidation of fatty acids in the liver, and established
that mitochondria are indeed the sites of fatty acid oxidation, citric acid cycle and
synthesis of ATP by oxidative phosphorylation (Nisoli et al. 2004).
Biogenesis of mitochondria has its roots in three theories: a) de novo
synthesis of mitochondria from precursors present in the cytoplasm; b) formation
from other membranous structures in the cell and c) growth and division of preexisting mitochondria. Biogenesis of mitochondria can be initiated during mitosis
or various external and internal stimuli such as inhibitors of oxidative
phosphorylation,

Ca2+

fluxes,

thyroid

hormone

and

low

temperature.

Mitochondria are also capable of undergoing frequent fusion and fission cycles,
modulated by the mitofusins (Mfn) and dynamin-related proteins (Drp)
respectively, thus displaying plasticity in their size, shape, number (or mass
volume) and distribution. This ensures adequate availability of mitochondria to
meet the energy requirements and limits the number of defective or damaged
mitochondria. Mitochondrial biogenesis is brought about by transcriptional
regulation. Peroxisome proliferator-activated receptor-γ coactivator 1α (PGC-1α)
and PGC-1β induce the expression of nuclear respiratory factors (NRF-1 and
NRF-2), which in turn upregulate the expression of genes coding for both nuclear
subunits of the respiratory chain and proteins involved in mitochondrial DNA
transcription and replication. There is growing evidence of involvement of Ca2+
and nitric oxide acting as cellular sensors of energy expenditure and activating
the mitochondrial biogenesis pathways (Nisoli et al. 2004; Nisoli et al. 2005).
The first high resolution images and structure of mitochondria were
described by Sjostrand and Palade in 1952 and 1953 respectively. Mitochondria
consist of an outer (OMM) and inner membranes (IMM) separated by the intermembrane space (IMS). The inner membrane is impermeable to most molecules
and consists of numerous invaginations called cristae, coined by Palade (who
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later won the Nobel Prize in Physiology/Medicine in 1974), that house
components of the ETC (Complexes I, II, III, IV) and ATP Synthase (Complex V).
The inner membrane also encloses the matrix containing mitochondrial DNA
(mtDNA), ribonucleic acid (RNA), ribosomes and several enzymes. In
mammalian cells, each organelle contains several identical copies of mtDNA,
whose structure and gene organization is highly conserved among mammals,
each containing 37 genes that code for 2 ribosomal RNAs (rRNA), 22 transfer
RNAs (tRNA) and 13 polypeptides (Taanman 1999; Szewczyk and Wojtczak
2002; Gibson 2005).
Another unique feature of mtDNA is its maternal inheritance in mammals.
mtDNA is transferred through germline alone, when the sperm mitochondria are
transferred to the oocytes during fertilization. All the mtDNA-coded polypeptides
are subunits of the enzyme complexes of the ETC. The rest of the proteins are
transcribed in the nucleus and imported into the mitochondria by an elaborate
machinery of translocases located on the membranes of the mitochondria (Dyall
et al. 2004; Wallace 2005). The outer membrane contains TOM (translocase of
the outer membrane) complex for translocation and SAM (sorting and assembly
machinery) complex for assembly of outer membrane proteins. The inner
membrane contains TIM23 (translocase of the inner membrane) that mediates
the import of mitochondrial matrix proteins with a typical N-terminal targeting
sequence (positively charged on one side and hydrophobic on the other side and
gets cleaved upon import), and the TIM22 complex mediates the import of inner
membrane proteins (Koehler 2004).
One of the reasons for oxidative damage in mitochondria is increased
susceptibility of mtDNA, owing to its proximity to ROS generation sites, absence
of introns and lack of protective histones. This invariably leads to a very high
mutation rate among mtDNA leading to a mixed intracellular population of
mtDNAs, termed as heteroplasmy. Furthermore, in post-mitotic tissues, mtDNAs
harboring deleterious mutations have been found to be preferentially, clonally
amplified within cells. As the percentage of mutant mtDNAs increases, the
mitochondrial energetic output declines, ROS production is elevated, and the

4

propensity for apoptosis increases. As cells are progressively lost through
apoptosis, tissue function declines causing aging and/or movement disorders,
dementias, cardio-vascular diseases and diabetes (Wallace 2005).
Mitochondria

generate

upto

95%

of

cellular

ATP

via

oxidative

phosphorylation carried out by the ETC. The ETC located on the IM of
mitochondria comprises of Complexes I through IV and mobile electron carriers,
coenzyme Q and cytochrome c. They are arranged in a series such that the
electrons, donated by reducing equivalents from Kreb’s cycle like nicotanamide
adenine dinucleotide (NADH) or flavin adenine dinucleotides (FADH2), flow down
a voltage gradient, ultimately reducing oxygen to water at the level of Complex
IV. In 1961, Mitchell proposed a mechanism for the coupling of electron transfer
to ATP synthesis, based on an indirect interaction between oxidizing and
phosphorylating enzymes. He suggested that the flow of electrons through the
enzymes of the respiratory chain causes positively charged hydrogen ions, or
protons, from the mitochondrial matrix being pumped by Complexes I, III and IV
to the IMS of mitochondria. As a result, an electrochemical proton gradient is
created across the membrane. The gradient consists of two components: a
difference in hydrogen ion concentration (pH gradient) and a difference in
membrane potential (∆ψ) of around 150mV; forming the 'protonmotive force'. The
synthesis of ATP is driven by a reverse flow of protons down the gradient through
ATP synthase (Complex V) resulting in generation of ATP from ADP (adenosine
diphosphate) and inorganic phosphate (Pi). Mitchell's proposal has been called
the 'chemiosmotic theory', which won him a Nobel Prize in Chemistry in 1978,
giving rise to the field of ‘bioenergetics’ (Pedersen 1999; Nicholls and Ward
2000; Nicholls and Ferguson 2002; Newmeyer and Ferguson-Miller 2003;
Wallace 2005).
Each of the components of the ETC undergoes a cycle of oxidation and
reduction reactions resulting in energy changes. NADH donates electrons to
NADH-ubiquinone oxidoreductase (Complex I), which transfers them to
coenzyme Q (ubiquinone), accompanied by pumping of protons from matrix into
the IMS. Complex I can be inhibited by rotenone and piericidin A. On the other
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hand, FADH2 bypasses complex I and donates electrons to Succinateubiquinone oxidoreductase (Complex II) instead, that can then transfer them to
ubiquinone. Complex II can be inhibited by malonate and nitroproprionic acid (3NP) (Nicholls and Ferguson 2002).
Coenzyme Q transfers electrons to cytochrome b component of
Ubiquinone-cytochrome c oxidoreductase (Complex III or cytochrome c
reductase or simply bc1 complex), which then reduces cytochrome c1
component. This leads to further pumping of protons into the IMS. Complex III
can be inhibited by Antimycin A, myxothiazol and stigmatellin (Nicholls and
Ferguson 2002).
The electrons are carried from cytochrome c1 of Complex III to
cytochrome c oxidase (Complex IV or cytochrome a,a3) by Cytochrome c located
in the IMS, causing pumping of more protons into the IMS. Only cytochrome c
oxidase is capable of overcoming the large kinetic barrier of simultaneous
addition of four electrons to a molecule of oxygen that is then reduced to water
(H2O). Cyanide can inhibit Complex IV (Nicholls and Ferguson 2002).
F0-F1-ATPase or ATP synthase (Complex V) synthesizes ATP from ADP
and Pi. This is achieved through reversing the ATPase in favor of synthase by
consuming the energy of the proton gradient when protons flow back into the
matrix from the IMS. This pioneering work on ATP synthase earned Boyer and
Walker the Nobel Prize in Chemistry in 1997.ATP can then be transported out of
the mitochondria by the ADP/ATP antiporter, adenine nucleotide translocase
(ANT). Thus, flow of electrons down the voltage gradient is coupled to the proton
gradient and subsequent phosphorylation of ADP to ATP (Nicholls and Ferguson
2002).
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Figure 1.1: Illustration of the mitochondrial Electron Transport Chain (ETC).
Electrons from NADH or FADH2 FADH are passed through the ETC in the
following order – a) NADH-ubiquinone oxidoreductase (Complex I) or Succinateubiquinone oxidoreductase (Complex II) b) coenzyme Q (ubiquinone) c)
Ubiquinone-cytochrome c oxidoreductase (Complex III or cytochrome c
reductase) d) Cytochrome c e) Cytochrome c oxidase (Complex IV or
cytochrome a,a3) and donated to oxygen reducing it to water. Protons are
pumped from mitochondrial matrix to the inter-membrane space, that flow back
through F0-F1-ATPase or ATP synthase (Complex V) resulting in generation of
ATP.
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Figure 1.1: Illustration of the mitochondrial Electron Transport Chain (ETC).
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Calcium
The story of calcium (Ca2+) began around 1883 with the publication of a
paper by Sydney Ringer, who observed that Ca2+ is needed for maintaining heart
contraction in the saline medium, now known as Ringer’s solution. It was not until
the 1930’s that anyone paid much attention to this molecule. However, in 1940s,
Heilbrunn proposed that Ca2+ by diffusion was one of the activators for
intracellular processes, especially muscle contraction, that was also observed by
Kamada and Kinoshita. In 1942, Bailey discovered that the ATPase function of
myosin was activated by Ca2+ but not by magnesium (Mg2+) and concluded that
liberation of Ca2+ in the vicinity of ATPase was responsbible for muscle
contraction. Sandow (1950) proposed that Ca2+ released from cortical or
membrane regions of the muscle fibers activated actomyosin ATPase, a process
he named “excitation-contraction coupling”. Miledi’s (1973) studies reporting
release of neurotransmitters from presynaptic terminals, Kanno’s group (1973)
reporting exocytosis in mast cells, Timourian’s group (1972) showing formation of
cleavage furrow in oocytes, and Rose and Lowenstein’s (1975) observations on
the distribution of Ca2+ in the cytoplasm raised its status from just a structural
element to one of the most important molecules required for biological activity
(Carafoli et al. 2001; Carafoli 2002).
Calcium homeostasis is critical for cell survival and hence Ca2+ levels are
maintained in the cytoplasm at a resting level of about 100nM, and can rise upto
1µM upon activation, as opposed to a concentration of approximately 1.2mM
extracellularly (Berridge et al. 2000). It exhibits a wide-ranging spatial and
temporal dynamics resulting in an extensive, but highly regulated, Ca2+ signaling
network (Carafoli et al. 2001). At any given time, intracellular Ca2+ levels are
maintained by a balance of ‘on’ reactions enabling Ca2+ to enter the cell and ‘off’
reactions resulting in its extrusion from the intracellular space, and the variations
of on/off reactions generate Ca2+ transients. The ‘on’ reactions are activated
primarily upon flow of Ca2+, down its concentration gradient, from extracellular
space, upon membrane depolarization via voltage-operated channels (VOC that
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include L-, P/Q-, N-, R- and T-type channels) or agonist binding (glutamate, ATP,
acetylcholine) via receptor-operated channels (ROC; ex: N-methyl-D-aspartate
(NMDA) receptors) or store-operated channels (SOC) on the plasma membrane
(PM). This initiates a signaling cascade engaging G-protein linked receptors,
receptor tyrosine kinases (TyrK) and Phospholipase C (PLC). In a calciuminduced manner, Ca2+ can be released from internal stores such as endoplasmic
reticulum (ER) predominantly via Ca2+-sensitive inositol 1,4,5-trisphosphate
receptors (InsP3R) or ryanodine receptors (RyR) (Michelangeli et al. 2005).
Intracellular Ca2+ can activate Ca2+-dependent enzymes such as protein
kinase C (PKC), protein kinase A (PKA) and protein phophatases 1 and 2a (PP1
and PP2a), and through their phosphorylation/dephosphorylation functions can in
turn modulate InsP3R and RyR activity on the ER. At the same time, most of the
intracellular Ca2+ is sequestered and buffered by calbindin and calretinin in the
cytosol, thereby fine-tuning the amplitude and duration of Ca2+ transients.
Calcium can be buffered by the low affinity and high capacity calnexin and
calreticulin inside the ER lumen, where it is required for chaperone-mediated
protein folding. The Ca2+-binding ratio (Ks) is defined as the ratio of amount of
bound Ca2+ compared to Ca2+ that is free in the cytosol and varies greatly among
different cell types. Calcium can also bind to sensor proteins such as calmodulin
(CaM) and troponin C (TnC) or effector proteins like synaptotagmin, annexins,
adenylyl cyclases, NOS, calpains among others and trigger a multitude of
signaling cascades (Berridge et al. 2000; Berridge et al. 2003; Nicholls 2005).
Calcium can also induce transcription by activating various transcription factors
such as nuclear factor-kappaB (NF-κB), nuclear factor of activated T cells (NFAT), cyclic-AMP response element binding protein (CREB) through NF-kappaB
inhibitory protein (IκB), calcineurin and Ca2+/Calmodulin-dependent calmodulin
kinase II (CaMKII) respectively.
The ‘off’ reactions, on the other hand, include cytosolic calcium uptake by
sarco(endo)plasmic reticulum Ca2+-ATPases (SERCA), secretory-pathway Ca2+ATPases (SPCA) on golgi and mitochondrial calcium uniporter (MCU), while
calcium extrusion is achieved by Na+/ Ca2+ exchangers (NCX) on mitochondria
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and plasma membrane (PM) and plasma membrane Ca2+-ATPases (PMCA)
(Berridge et al. 2000; Berridge et al. 2003; Michelangeli et al. 2005; Saris and
Carafoli 2005). The Ca2+ transients trigger off signaling cascades that can last
from micro-seconds to a few hours and are responsible for synaptic exocytosis in
learning/memory, muscle contraction, metabolism, transcription, fertilization, cell
cycle, cell differentiation and development (Berridge et al. 2000; Berridge et al.
2003).
Mitochondria are one of the important organelles for intracellular calcium
homeostasis and are equipped with a highly regulated Ca2+ transport system.
They sequester Ca2+ rapidly during the development of Ca2+ signal and then
release it back slowly during the recovery phase, thus shaping both the
amplitude and the spatio-temporal patterns of Ca2+ signals. Slater and Cleland
(1953) first observed that isolated mitochondria could take up large amounts of
Ca2+ even at 0°C. Chance (1955) noticed that Ca2+ stimulated State 4 respiration
in isolated mitochondria and concluded that Ca2+ was being ‘consumed’ during
uncoupling phase. This was followed by the finding, in 1959 by Saris, that
addition of Ca2+ to isolated mitochondria acidified the external medium, leading
the author to conclude that proton (H+) and Ca2+ gradients were produced due to
uptake of Ca2+ by mitochondria. Eventually, in 1961-62, Vasington and Murphy
measured directly the uptake of Ca2+ by isolated kidney mitochondria coupled to
oxidative phosphorylation, and extended the observation by showing that the
uptake required respiration and inorganic phosphate. De Luca and Engstrom
(1961) had shown that the process of energized Ca2+ uptake was an alternative
to ADP phosphorylation in the usage of respiratory chain energy. Lehninger’s
group (1963) pointed out that inorganic phosphate was accumulated together
with Ca2+ and a carrier-mediated process was proposed for the uptake of Ca2+ by
Lehninger and Carafoli in 1969. A second pathway separate from that catalyzed
by the Ca2+ uniporter has been described recently, a “rapid” mitochondrial (RaM)
Ca2+ uptake pathway by Gunter’s group in 1998, which is transiently activated by
high [Ca2+].
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Figure 1.2: Illustration of mitochondrial ion transport. Ion transport in
mitochondria is strictly enforced by a set of tranporters and pumps. Calcium
(Ca2+) enters the mitochondria through a Ca2+ uniporter, at the expense of
mitochondrial membrane potential (∆ψ). Calcium leaves the mitochondria
through a sodium-linked (Na+) antiporter, bringing Na+ into the mitochondria.
Sodium, on the other hand, leaves mitochondria through the Na+-H+ (sodiumproton) pump. Lastly, protons are pumped into the inter-membrane space (IMS)
through Complexes I, III and IV and flow back into the matrix through Complex V
or ATP-Synthase.
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Figure 1.2: Illustration of mitochondrial ion transport.
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The excess cytosolic calcium is sequestered into mitochondria via an
electrogenic Ca2+ uniporter that is driven by ∆ψ and has a low sensitivity for Ca2+
(Nicholls and Chalmers 2004). This requires the mitochondria to be in close
proximity to calcium-releasing channels of ER (Sorrentino and Rizzuto 2001;
Hajnoczky et al. 2003) or PM. Work by Benton’s group in 1970’s showed an all
important physiological function for Ca2+ is that it regulates the citric acid cycle by
activating pyruvate dehydrogenase, NAD+-dependent isocitrate dehydrogenase,
α-ketoglutarate dehydrogenase complex (KGDHC) as well as ATP synthase,
causing increases in respiration and ATP production (Gunter et al. 2004), in the
0.1 to 1µM concentration range. Calcium inside the matrix tends to form Ca2+phosphate compound that is readily dissociable, which keeps the free matrix
Ca2+ at low levels (Nicholls and Chalmers 2004).
The Na+-linked efflux pathway was first identified in heart mitochondria by
Carafoli’s group in 1974 and was subsequently shown to be the primary Ca2+
efflux mechanism of most mitochondria. In 1979, Carafoli proposed the
‘mitochondrial Ca2+ cycle’ - the continued operation of the uptake and release
limbs of the transport process results in a futile cycle, in which respiratory energy
is dissipated. This efflux occurs till the extra-mitochondrial concentration is
around 1µM known as the ‘set-point’.
Calcium is taken up by mitochondria if the concentration is above the setpoint and released if below (Nicholls and Chalmers 2004; Nicholls 2005). In
addition to Ca2+ efflux via specific transporters, the inner mitochondrial
membrane may under certain conditions undergo permeability changes,
observed by Beatrice’s group in 1980, leading to the loss of membrane potential
and to the leakage of small ions, induced by high Ca2+ concentrations. It has
been suggested that they are mediated by a high conductance unselective
channel, named permeability transition pore (PTP) and the proposal that
mitochondria could protect the cytosol against the damage induced by excessive
Ca2+. Thus, mitochondria play a key role in Ca2+ homeostasis. However, calcium
dysregulation has been shown to be involved in mitochondria-mediated cell
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death (Nicholls and Ward 2000; Yu et al. 2001; Hajnoczky et al. 2003; Orrenius
et al. 2003; Nicholls 2005).

Nitric oxide synthase (NOS) and Nitric oxide (NO)
The significance of nitric oxide synthase (NOS) and its product nitric oxide
or nitrogen monoxide (NO•) is exemplified by awarding of the Nobel Prize in
Physiology/Medicine to Furchgott, Ignarro and Murad in 1998 and recognizing
Moncada as the most highly cited UK biomedical scientist in 1999 (Alderton et al.
2001). Furchgott, in 1980, made the observation that vascular smooth muscle
relaxation was dependent on a diffusible substance released by the surrounding
endothelium and called it the endothelium-dependent relaxation factor (EDRF)
with

a

short

half-life

that

can

be

destroyed

by

superoxide

(O2•-).

Nitrovasodilators, such as glyceryl trinitrate and sodium nitroprusside, could
cause vascular smooth muscle relaxation, by stimulation of guanylyl cyclase and
increase in cyclic guanosine monophosphate (cGMP), shown by Murad, and
could be inhibited by haemoglobin. Ignarro and Moncada independently
confirmed, in 1987, that NO• was indeed the EDRF. Moncada’s group also
showed that NO synthesis in endothelial cells requires the amino acid L-Arginine.
The first NOS protein was isolated and purified by Bredt and Snyder in 1990
(Vallance 2001; Stuart-Smith 2002; Clementi 2003).
Nitric oxide synthase (NOS) enzyme is one of the most highly conserved
proteins across species and plays a critical role in the normal physiology of the
body via its major product nitric oxide (NO•). Three distinct NOS isoforms have
been identified namely – neuronal NOS (nNOS or NOS-1), inducible NOS (iNOS
or NOS-2) and endothelial NOS (eNOS or NOS-3). The human nNOS gene has
been localized to chromosome 12 and its protein product is 161kDa, with multiple
splice variants, found mainly in the cytosol of neuronal, skeletal and cardiac
muscle cells, neutrophils, pancreatic islets. eNOS gene has been localized to
chromosome 7 with a protein product of 133kDa and, owing to its myristate and
palmitate groups at its N-terminus, is present bound to plasma membrane of
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endothelial cells, smooth muscle and neurons. Both nNOS and eNOS are
constitutively present and activated by binding of Ca2+ and calmodulin (CaM). On
the other hand, iNOS gene is present on chromosome 17 coding for a protein
product of 131kDa, and is predominantly found in the cytosol of macrophages,
neurons, endothelial and other cell types. It is Ca2+-independent for its activation
since it is tightly bound by CaM and mainly controlled at the level of gene
transcription in response to challenges to the immune system (Forstermann et al.
1995; Geller and Billiar 1998; Hobbs et al. 1999; Guix et al. 2005).
The X-ray crystal structures of NOS domains were made available in 1998
and 1999. The primary structure of NOS consists of an N-terminus oxygenase
linked to a C-terminus reductase domain by Ca2+/CaM binding site and is found
typically as a homodimer. The oxygenase domain contains binding sites for LArginine, heme and (6R)-5,6,7,8-tetrahydro-L-biopterin (BH4). Nicotinamide
adenine dinucleotide phosphate (NADPH), flavin adenine dinucleotide (Fadeel
and Orrenius) and flavin mononucleotide (FMN) have their binding sites in the
reductase domain at the C-terminus. In presence of Ca2+/CaM bound to the
NOS, electrons from NADPH are donated to the reductase domain of the
enzyme and proceed via FAD and FMN redox carriers to the oxygenase domain.
They interact with the haem iron and BH4 at the active site of the oxygenase
domain to catalyze the reaction of oxygen with L-arginine, generating L-citrulline
and NO• as products (Forstermann et al. 1995; Bryk and Wolff 1999; Hobbs et al.
1999; Groves and Wang 2000; Alderton et al. 2001; Guix et al. 2005). NOS can
be post-translationally regulated by various mechanisms such as dimerization,
sub-cellular localization, phosphorylation, availability of substrates and cofactors,
feedback inhibition and proteolytic degradation (Forstermann et al. 1995;
Alderton et al. 2001).
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Figure 1.3: Illustration of various Nitric Oxide Synthase (NOS) isoforms.
Three well-known isoforms of Nitric Oxide Synthase (NOS) are depicted below.
Each of the isoform contains a distinct oxygenase and reductase domains with
various sites for binding of substrates and cofactors. In addition, neuronal NOS
(nNOS or NOS-1) contains a PDZ domain and endothelial NOS (eNOS or NOS2) contains myristic and palmitate groups near their N-terminus, both of which
are absent in inducible NOS (iNOS or NOS-3).
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Figure 1.3: Illustration of various Nitric Oxide Synthase (NOS) isoforms.
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Figure 1.4: Illustration of Nitric Oxide Synthase (NOS) enzyme reaction.
Electrons are donated by NADPH to FAD in the reductase domain of one
monomer. They are passed onto FMN and then to haem iron (Fe) bound to the
oxygenase domain of the other monomer in the homo-dimer required for activity.
In presence of cofactors (Ca2+/CaM, BH4), the electrons are then donated to the
NOS substrate L-Arginine (L-Arg) to react with O2 forming L-Citrulline (L-Cit) and
nitric oxide (NO•).
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Figure 1.4: Illustration of Nitric Oxide Synthase (NOS) enzyme reaction.
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In neuronal synapses, nNOS typically interacts, through its unique Nterminal PSD-95 discs large/ZO-1 homology (PDZ) domain, with the PDZ domain
of post-synaptic density protein 95 (PSD-95) that in turn binds to NMDA
receptors and regulates the entry of Ca2+ into the cell. Glutamate-induced Ca2+
entry into the cell results in a Ca2+/CaM complex that then translocates to the PM
and binds to nNOS, where the binding is enhanced by heat-shock protein 90
(Hsp90). Calcineurin dephosphorylates and activates nNOS, which then
translocates to the cytosol where it produces NO•. Nitric oxide (NO•) activates
guanylyl cyclase resulting in production of cyclic guanosine monophosphate
(cGMP) that in turn activates various signaling pathways while PKA or PKC can
inactivate nNOS by phosphorylation. Alternately, nNOS activity is proposed to be
inhibited by protein inhibitor of NOS (PIN) which dissociates the dimerized form
of NOS while others have proposed that PIN only affects translocation of nNOS
(Alderton et al. 2001; Kone et al. 2003).
Endothelial NOS (eNOS) is myristoylated and palmitoylated and trafficked
to caveolae (micro-domains of plasma membrane invaginations) of endothelial
cells. It is inserted into the caveolae membranes and exists in an inactive state
when bound to caveolin-1. Activation of endothelial acetylcholine receptors in
turn activates phospholipase C (PLC) that catalyzes the production of inositol
1,4,5-trisphosphate (IP3) and diacylglycerol (DAG) from phosphatidylinositol 4,5bisphosphate (PIP2). The IP3-induced increase in intracellular Ca2+ activates
calmodulin binding to eNOS, which then dissociates from caveolin and
translocates to the cytoplasm. Heat-shock protein 90 (Hsp90) in this case is
shown to act as an allosteric activator of eNOS, and together with CaM and
caveolin form a dynamic ternary complex. Phosphorylation by protein kinase B
(Akt) activates eNOS while phosphorylation by protein kinase A (PKA) inactivates
the enzyme and is sequestered away from caveolae with diminished activity by
eNOS-interacting protein (NOSIP) and eNOS traffic inducer protein (NOSTRIN).
Finally, a fall in Ca2+ levels dissociates CaM from eNOS, and the inactive form
relocates to the membrane caveolae. Both nNOS and eNOS activities also seem
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to be regulated by certain G-protein coupled receptors such as Bradykinin B2
receptor by binding and inhibiting them (Alderton et al. 2001; Kone et al. 2003).
Upon cytokine interferon-γ (IFN-γ) binding and activation of IFN-γ
receptors, the signal is passed onto the Janus kinase (JAK) family and signal
transducers and activators of transcription (STAT) proteins. Receptor occupation
and dimerization induces the phosphorylation of associated STATs. Activated
STATs dimerize and translocate to the nucleus where they increase expression
of the transcription factor, IFN-γ regulatory factor 1 (IRF-1), that in turn binds to
specific DNA elements in the iNOS gene promoter region to increase iNOS gene
expression. Its activity is found to be increased by Rac1 and Rac2 of Rho-like
GTPases family. On the other hand, iNOS protein is regulated by 3 inhibitory
proteins namely a) NOS-associated protein 110 (NAP-110) b) kalirin and c)
caveolin. While the former two proteins inhibit iNOS activity by preventing its
dimerization, caveolin binds to iNOS and tags it for proteolysis (Kone et al. 2003).
Lastly, nNOS and iNOS are targeted for degradation mostly by calpains or the
ubiquitin-proteasome pathway, the choice of pathway and mechanisms needing
further elucidation (Osawa et al. 2003).
Nitric oxide (NO•) was declared “The Molecule of the Year” by Science
magazine in 1992. Nitric oxide acts a local hormone owing to its solubility in lipid
and water, being a diatomic free radical and having short half-life of a few
seconds in biological fluids. This allows NO• to diffuse across membranes (with a
diffusion coefficient 1.4 times that of oxygen at 37°C) and act as a messenger
within a radius of hundred microns. In vivo, the concentration of NO• can range
from 5nM to 4µM and is buffered and transported by oxyhaemoglobin in red
blood cells and NO• mediates its effects by acting on compounds containing
transition metals, such as iron-sulphur (Fe-S) clusters. Most of these are
transcription factors, while it also reacts with four haem-containing enzymes
namely heme-oxygenase 1 (HO-1), cytochrome c oxidase (COX-IV), catalase
and soluble guanylyl cyclase (sGC) (Hanafy et al. 2001; Ridnour et al. 2004).
Aconitase and hypoxia-inducible factor 1 (HIF-1) are among the NOSregulated transcription factors. Aconitase serves two roles in the cell; it can
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function as a soluble enzyme in the Krebs cycle and as an iron homeostatic
sensor. When iron is plentiful, a tetranuclear iron-sulfur center (4Fe-4S)
aconitase is active as an enzyme in the Krebs cycle, which functions as an
isomerase regulating the equilibrium between citrate and isocitrate. However,
when the serum iron is depleted, there is no longer sufficient iron to form the
tetranuclear iron-sulfur center. Aconitase in the absence of its 4Fe-4S center is
called an iron-regulatory protein (IRP). To maintain iron homeostasis, the IRP
binds to iron-responsive elements (IREs) and stabilize transferrin receptor
mRNA, while they inhibit translation of ferritin mRNA. Ferritin is the major iron
storage protein found in bone marrow. Increasing transferrin receptor and
decreasing ferritin will increase serum iron. Nitric oxide synthase (NOS) also
mediates regulation of the angiogenic transcription factor HIF-1. HIF-1 is a
heterodimeric complex comprising of HIF-1a and ARNT (aryl-hydrocarbon
receptor nuclear translocator)]. Under hypoxic conditions or NO• donation, HIF-1
binds to its response element and stimulates transcription of vascular endothelial
growth factor (VEGF), insulin-like growth factor II (IGF-II) and erythropoietin
(Hanafy et al. 2001; Droge 2002; Ridnour et al. 2004).
Heme-oxygenase 1 (HO-1) catalyzes the degradation of the heme moiety
into biliverdin, carbon monoxide, and iron. HO-1 mRNA is destabilized by NO•,
and since NOS is a heme requiring enzyme, a negative feedback loop is formed.
Therefore, the cell has a system to keep NO• levels from becoming toxic.
Cytochrome c oxidase (COX) is the final component of the electron transport
chain where oxygen is reduced to water. Since NO• reacts on a similar time scale
as oxygen diffusion, it acts as a competitive inhibitor to oxygen binding and thus
reversibly inhibits COX. Catalase, a ferric-containing heme moiety, is involved in
the reduction of hydrogen peroxide to oxygen and water. NO• binding to the ferric
ion results in inhibition of catalase activity (Hanafy et al. 2001; Droge 2002;
Ridnour et al. 2004).
Most of NO• effects are mediated by soluble guanylyl cyclase (sGC).
Soluble guanylyl cyclase is a heterodimer composed of α- and β subunits. Upon
binding of NO•, sGC catalyzes the conversion of 1 mole of guanosine 5’-
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triphosphate to 1 mole of 3’,5’-cyclic guanosine monophosphate and 1 mole of
pyrophosphate. Cyclic GMP mediates its effects through 4 targets: cGMPdependent protein kinase (PKG), cyclic nucleotide-gated channels (CNG), cAMPdependent protein kinase and phosphodiesterase (Hanafy et al. 2001; Droge
2002; Ridnour et al. 2004).
Thus, NOS-derived NO•, at physiological levels, is credited with a role in
angiogenesis, peristalsis, micturition, muscle contraction, wound healing, cardiac
development, reproduction, learning/memory and apoptosis. Neuronal NOS
derived NO• in the central nervous system (CNS) is shown to be involved in
neurotransmission and neuronal plasticity; while in the peripheral nervous system
(PNS), NO• from nitrergic nerves is involved in pain perception and mediates
smooth muscle relaxation affecting gastro-intestinal motility and penile erection.
In the skeletal muscle, nNOS derived NO• is suggested to be involved in
regulation of myotube development, innervation and contractility (Bryk and Wolff
1999; Guix et al. 2005). nNOS knockout mice exhibit aggressiveness, pyloric
sphincter stenosis, resistance to ischemia and stroke (Mashimo and Goyal 1999;
Vallance 2001; Mungrue et al. 2003).
Endothelial NOS derived NO• is shown to maintain blood pressure and
flow in the vasculature by smooth muscle relaxation through its action on soluble
guanylyl cyclase, as well as inhibiting platelet aggregation. Nitric oxide from both
eNOS and nNOS is suspected to be acting as a retrograde messenger involved
in long-term potentiation (LTP) in brain hippocampus. Majority of eNOS knockout
mice die shortly after birth due to cardiovascular abnormalities. Lack of NO•
causes hypertension and enhances the formation of atherosclerotic lesions in the
vessel walls of eNOS knockout mice, while overproduction of NO• itself can
cause profound vascular relaxation resulting in acute drop in blood pressure
(Bryk and Wolff 1999; Mashimo and Goyal 1999; Vallance 2001; Mungrue et al.
2003; Guix et al. 2005).
Inducible NOS (iNOS), on the other hand is transciptionally upregulated in
macrophages, hepatocytes, astrocytes and other cell types by various agents
such as lipopolysaccharide (LPS), cytokines and other microbial products.
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Should such a situation arise, iNOS produces large amounts of NO• and its
derivatives that are toxic to tumors and invading pathogens as well as promotes
would healing and angiogenesis (Bryk and Wolff 1999; Guix et al. 2005).
However, iNOS knockout mice show increased susceptibility to bacterial and viral
pathogens, tumors and resistance to sepsis-induced hypotension (Mashimo and
Goyal 1999; Vallance 2001; Mungrue et al. 2003).
Taken together, there is redundancy in the source and actions of NO• in
normal physiology which also accounts for compensatory mechanisms in the
event of deficiencies in one or more the NOS isoforms. Finally, NO• is also
shown to result in formation of reactive nitrogen species (RNS) such as nitroxyl
(NO-) radicals or peroxynitrite (ONOO-), causing nitrosylation/nitration of key
proteins

thereby

contributing

to

oxidative/nitrosative/nitrative

stress

and

subsequent cell death (Nicotera and Melino 2004) implicated in several
pathologies (Groves 1999; Hobbs et al. 1999; Szabo 2003; Guix et al. 2005).

ROS/RNS and Oxidative Stress
The properties of what constituted air for life has intrigued humans since
recorded history as noted in a Sumerian creation myth stating: “for the sake of
the good things in their pure sheep-folds, Man was given breath.” Da Vinci, in
the late 15th century, observed that air incapable of combustion was also
incapable of supporting life, which he called the ‘vivifying spirit’. Mayow, in 1673,
stated that “an aerial something essential to life, whatever it may be, passes in to
the masses of blood”. In the 18th century, Priestley, Lavoisier and Scheele
discovered oxygen and its multi-faceted properties. The ‘Oxygen Paradox’
emerged as oxygen or dioxygen, apart from sustaining aerobic life, also
possesses a dark side of its own by being toxic to such organisms. Plants and
animals survive only for a few days at oxygen concentrations greater than its
atmospheric level of 20.9%. Joseph Priestley, in 1775, elegantly put that “we
might live out too fast, and the animal powers be too soon exhausted, in this pure
kind of air. A moralist, at least, may say that the air which nature has provided for
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us is as good as we deserve,” (Fridovich 1998; Davies 2000; Freeman 2000;
McCord 2000).
Fenton’s work, in 1890’s, on iron/peroxide chemistry and the recognition
that reactive oxygen species (ROS) could introduce reactive diols and carbonyl
groups into biomolecules, spawned a whole new field known as Fenton
chemistry. Haber, from 1931-34, was responsible for discovery of hydroxyl
.

radical (OH ) and the metal catalyzed peroxide decomposition reaction known as
the Haber-Weiss reaction. Based on quantum mechanics theory, Pauling (Nobel
Prize in Chemistry in 1954 and Nobel Peace Prize in 1962) predicted the
existence of superoxide (O2•-) as early as 1933. However, it was only in 1954
that the first significant scientific contribution towards the ‘oxygen paradox’ was
made in the form of a seminal paper by Gershman and Gilbert. They proposed
that the lethal effects of ionizing radiation might be ascribed to oxygen free
radicals that gave birth to the burgeoning field of free radical biology. In the same
year, Commoner presented the first proof that free radicals exist in biological
organisms and are either proteinaceous or associated with biopolymers (see
reviews by Freeman 2000; Gutteridge and Halliwell 2000; Hensley and Floyd
2002).
In the period 1951-56, Chance worked on the ability of catalase to reduce
hydrogen peroxide (H2O2) and showed that it can be produced by respiring
mitochondria. Based on these observations, Harman in 1956 proposed the
classical hypothesis known as the “Free Radical Theory of Aging (FRTA)”, which
has just turned 50.

FRTA states that aging is a result of a) progressive

deterioration of physiological function due to free radical reactions initiated in
mitochondria at an increasing rate with age and b) the life-span is determined by
the rate of free radical damage to the mitochondria, thus giving rise to the
“Mitochondrial Theory of Aging (MTA)”. The anti-oxidant enzyme copper,zincassociated superoxide dismutase (Cu,Zn-SOD), discovered by McCord and
Fridovich in 1969, followed by Halliwell’s report in 1973, marked the dawn of
anti-oxidant biology. These studies firmly established that oxygen can biologically
be reduced to a diffusible free radical superoxide that can further generate the
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toxic and highly reactive hydroxyl radicals, and that all aerobic organisms survive
in such harsh environment owing to their arsenal of antioxidant defenses. Later in
1973, Babior’s group showed the first physiological role of free radicals in host
defense as well as their pathological role in inflammation (Beckman and Ames
1998; Fridovich 1998; Freeman 2000; Gutteridge and Halliwell 2000; Hensley
and Floyd 2002; Harman 2003; Harman and Harman 2003).
Environmental sources of free radicals are ozone (O3), γ-radiation, ultraviolet (UV) radiation, car exhaust, cigarette smoke, industrial contaminants,
narcotic drugs, anesthetizing gases, xenobiotics (pesticides, herbicides),
chemicals such as alcohol, mustard gas and lastly human diet itself. Major
sources of endogenous free radicals in mammals include the respiratory chain,
monoamine oxidase, xanthine oxidase, NADPH oxidase, myeloperoxidase,
cycloxygenases, cytochrome P-450 system, nitric oxide synthases (NOS) and
non-enzymatic reactions of oxygen (Droge 2002; Kohen and Nyska 2002;
Andreyev et al. 2005).
The reactive molecules can be further divided into radicals and non-radical
species. Radicals are atoms or molecules containing an unpaired electron, such
as nitric oxide radical (NO•), superoxide radical (O2•-), hydroxyl radical (•OH),
peroxyl (ROO•) and alkoxyl radicals (RO•), making them highly reactive. There
are also other reactive non-radical species such as peroxynitrite (ONOO-),
hypochlorous acid (HOCl), hydrogen peroxide (H2O2), organic peroxides,
aldehydes and ozone (O3). Their reactivity renders them with short half-lives that
can range from nano-seconds to minutes. Hydroxyl radical (•OH) is the most
reactive (10-9 sec) and therefore attacks any macro-molecules in the immediate
vicinity, while nitric oxide (NO•) due to its relatively longer half-life (1-10 sec) can
cross membranes and cause damage at a site distant from its origin, whereas
the fate of H2O2 and O2•- is only limited by the presence of their decomposition
enzymes. This makes them unique molecular signaling switches that can
mediate reversible coupled oxidation-reduction reactions of factors involved in
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gene and enzyme regulation (Bergendi et al. 1999; McCord 2000; Kohen and
Nyska 2002).
Several components of mitochondria are known to be involved in the
generation of free radicals as byproducts, mainly in the form of superoxide
(around 2% of available oxygen or dioxygen). Oxygen in its ground state contains
two unpaired electrons with the same spin and hence exists as a relatively
unreactive diradical, which upon partial reduction results in the more reactive
superoxide. Normally, the superoxide is converted into hydrogen peroxide (H2O2)
and oxygen by manganese-superoxide dismutase (Mn-SOD). However,
superoxide can convert Fe3+ to Fe2+ known as the Haber-Weiss reaction. Fe2+ in
turn can react with H2O2 to give Fe3+ and the highly reactive OH• radicals, known
as the Fenton reaction. H2O2 is usually decomposed by catalase or glutathione
peroxidase (GPx) into water (Fridovich 1998; Pedersen 1999; McCord 2000;
Kohen and Nyska 2002; Andreyev et al. 2005; Scandalios 2005). Nitric oxide
(NO•), produced by NOS, can react with superoxide in a diffusion controlled
reaction to produce peroxynitrite (ONOO-) (Beckman and Koppenol 1996; Radi et
al. 2001). This can further react with carbon dioxide (CO2), another gaseous
messenger, forming nitrosoperoxo carbonate (ONOOCO2-) that decomposes into
nitrogen dioxide (•NO2) and carbonate (CO3•-). Instead, ONOO- can also gain a
proton forming peroxynitrous acid (ONOOH). This in turn can decompose into
nitrogen dioxide and hydroxyl radicals which are highly unstable and hence
possess a greater potential to cause damage (Bolanos et al. 1997; Bergendi et
al. 1999; Radi et al. 2001; Kohen and Nyska 2002).
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Figure 1.5: Illustration of the interplay between Reactive Oxygen Species
(ROS) and Reactive Nitrogen Species (RNS). About 2% of molecular oxygen
undergoes partial reduction in the mitochondrial electron transport chain resulting
in the more reactive superoxide (O2•-). Normally, the superoxide is converted into
hydrogen peroxide (H2O2) and oxygen by manganese-superoxide dismutase
(Mn-SOD). However, superoxide can convert Fe3+ to Fe2+ known as the HaberWeiss reaction. Fe2+ in turn can react with H2O2 to give Fe3+ and the highly
reactive •OH radicals, known as the Fenton reaction. H2O2 is usually
decomposed by catalase or glutathione peroxidase (GPx) into water. Nitric oxide
(NO•), produced by NOS, can react with superoxide in a diffusion controlled
reaction to produce peroxynitrite (ONOO-). This can further react with carbon
dioxide (CO2) forming nitrosoperoxo carbonate (ONOOCO2-) that decomposes
into nitrogen dioxide (•NO2) and carbonate (CO3•-). Instead, ONOO- can also
gain a proton forming peroxynitrous acid (ONOOH). This in turn can decompose
into nitrogen dioxide and hydroxyl radicals both of which are highly unstable and
can cause greater damage.
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Figure 1.5: Illustration of the interplay between Reactive Oxygen Species
(ROS) and Reactive Nitrogen Species (RNS).
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Owing to the discovery of NO• and its physiological role, a paradigm shift
happened in the field of free radical biology. Free radicals were now looked,
under new light, as being regulated physiological signaling molecules rather than
damage-causing stochastic entities. This is evident in the roles free radicals play
in regulating gene expression, cell replication, differentiation, host-defense (via
oxidative burst), cell adhesion, and apoptosis by acting as second messengers in
signal transduction pathways. Low levels of oxidants in fact are known to induce
cells to proliferate, moderate oxidative environment is shown to induce transient
growth arrest, upregulation of anti-oxidant enzymes and stress response
proteins, to adapt to the present and cope with future encounters with oxidants
(Davies 2000; Droge 2002; Kohen and Nyska 2002; Scandalios 2005).
A classic case of redox signaling is the oxidative burst by immune cells.
Activated macrophages and neutrophils can produce large amounts of O2•- and
HOCl, upon activation of NADPH oxidase and myeloperoxidase respectively,
induced by lipopolysaccharide (LPS) and pro-inflammatory cytokines such as
interferon-γ (IFN-γ), interleukin-8 (IL-8) and interleukin-1β (IL-1β). Activation of
NADPH oxidase is controlled by G proteins belonging to rac family. The massive
production of antimicrobial and tumoricidal ROS in an inflammatory environment
is called the “oxidative burst” and plays an important role as a first line of defense
against environmental pathogens (Droge 2002; Babior 2004).
Hydrogen peroxide (H2O2) has been shown to oxidatively modify and
inhibit protein tyrosine phosphatases, thus increasing net activity of protein
tyrosine kinases and thereby altering activities of epidermal growth factor (EGF),
insulin receptor kinase (IRK). Hydrogen peroxide (H2O2), among others, is also
shown to activate protein kinase C (PKC), Src family protein tyrosine kinase,
mitogen-activated protein kinases (MAPK) members such as extracellular signalregulated kinase 1 (ERK-1) and ERK-2, c-Jun NH2-terminal kinase (JNK) and
p38, transcription of activator protein 1 (AP-1) consisting of c-Jun and c-Fos.
Finally, ROS can also activate NF-κB, the first transcription factor responding
directly to oxidative stress, by promoting degradation of its partner I-κB by the
proteasome. ROS can also alter the binding sites on DNA, of transcription factors
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such as NF-κB and AP-1, thereby affecting the expression of specific genes. The
redox signaling is further modulated by the redox state of glutathione inside the
cell. However, in vivo, cells function normally in a reducing environment and their
function is invariably altered when the environment is increasingly oxidized,
leading to oxidative stress (Davies 2000; Droge 2002; Kohen and Nyska 2002;
Scandalios 2005).
With the advent of aerobic life, an arsenal of antioxidants and antioxidant
enzymes evolved to protect the cells from oxidative stress and damage.
Antioxidants are defined as substances that are able, at relatively low
concentrations, to compete with other oxidizable substrates and, thus
significantly delay or inhibit the oxidation of these substrates. Mammalian cells
exist in vivo at 2-4% oxygen tension known as tissue normoxia, compared to
21% in the surrounding environment, creating an oxygen tension gradient.
Therefore, multiple layers of defenses will be put forth as per the need, to
maintain redox homeostasis and minimize free radical–induced damage, that
include

low-molecular-weight

antioxidants

(LMWA)

such

as

ascorbate,

tocopherols, glutathione, melatonin, histidine dipeptides, β-carotene, ubiquinone
and uric acid (produced by xanthine dehydrogenase). Ascorbate (Vitamin C), a
water-soluble antioxidant, is available to humans only through diet. It mediates its
antioxidant effects by donating two electrons to ROS, such as O2•-, •OH, ROO•,
HOCl and ONOOH, and removing them. Tocopherols (Vitamin E) stabilize
cellular membranes by donating hydrogens lost by fatty acid radicals, thus acting
as chain-breaking antioxidants. A similar mechanism is utilized by melatonin,
hormone synthesized by the pineal gland. Glutathione (GSH), a reduced
tripeptide (glutamic acid-cysteine-glycine) present in milli-molar concentrations
inside the cell, is involved as a cofactor for peroxidase donating electrons for
decomposition of H2O2 as well as a chelator of Cu+ preventing the Haber-Weiss
reaction. When oxidized, GSH is converted to GSSG formed by joining of two
GSH molecules by a disulfide bridge. It can directly interact with superoxide
radical (O2•-), hydroxyl radical (•OH), peroxyl (ROO•), alkoxyl radicals (RO•) and
hypochlorous acid (HOCl) forming a glutathione radical that can be regenerated
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to its reduced form. Histidine dipeptides, synthesized in the brain and skeletal
muscles, can also directly exert a similar action as GSH. Uric acid, in the form of
urate, can react with •OH, ROO• as well as ONOO- to prevent protein nitration
(Kohen and Nyska 2002; Scandalios 2005).
Endogenous anti-oxidant enzymes include peroxidases (e.g., peroxisomal
catalase and cytosolic glutathione peroxidase), DT diaphorase or quinone
reductase, superoxide dismutases (cytosolic Cu,Zn-SOD, extracellular EC-SOD
and mitochondrial Mn-SOD), cytosolic Fe-binding ferritin and plasma Cu-binding
cerruloplasmin. Apart from above, there are damage repair systems that can be
divided into direct and indirect repair (Davies 2000; Kohen and Nyska 2002;
Andreyev et al. 2005). However, the antioxidant defenses are not adequate and
when in excess, free radicals can react with macromolecules, such as proteins,
lipid membranes and DNA, in a self-perpetuating manner thereby disrupting the
redox homeostasis. The extent of damage is based on their reactivities and halflives, apart from their intracellular source and the surrounding anti-oxidant
environment (Bergendi et al. 1999; Kohen and Nyska 2002; Scandalios 2005).
Lipid peroxidation occurs upon oxidative modification of membrane
phospholipids. It occurs in 3 stages- a) chain initiation b) chain propagation and
c) chain termination. Initiation occurs by the abstraction of a hydrogen atom (from
carbon of a methylene group) in an unsaturated fatty acyl chain. Following
hydrogen abstraction, the remaining fatty acid radical retains 1 electron and is
stabilized by rearrangement of the molecular structure to form a conjugated
diene. In an aerobic environment, oxygen will add to the fatty acid at the carbon
centered lipid radical (L•) to give rise to a lipid peroxyl radical (LOO•). Once
initiated, LOO• can further propagate the peroxidation chain reaction by
abstracting a hydrogen atom from other vicinal unsaturated fatty acids. The
resulting lipid hydroperoxide (LOOH) can easily decompose into several reactive
species

including:

lipid

alkoxyl

radicals

(LO•),

aldehydes

such

as

malondialdehyde (MDA) and 4-hydroxynonenal (4-HNE), alkanes, lipid epoxides,
and alcohols. Chain termination occurs upon interaction of LOO• with another
radical or an antioxidant. Peroxidized membranes become rigid, lose selective
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permeability, and under extreme conditions lose their structural and functional
integrity. Lipid peroxidation is also thought to lead to formation of DNA adducts
as well as inhibition of enzyme function. Oxidized lipid layers are subject to the
actions of phospholipase A2,

which prevents the propagation reactions by

removing the membrane hydroperoxides, or glutathione peroxidase, which acts
by reducing fatty acid hydroperoxides to their corresponding hydroxyl fatty acids
(Davies 2000; Kohen and Nyska 2002).
Protein oxidation refers to oxidative modification of a protein, usually in the
form of highly reactive carbonyl groups (aldehydes and ketones). Cysteine (Cys)
and methionine (Met), owing to their susceptible sulfur atoms, are two amino
acids that are most prone to oxidative attacks. Oxidation of Cys leads to intramolecular disulfide bonds, inter-molecular disulfides (with glutathione etc).
Methionine (Met), on the other hand, undergoes oxidation to give Met sulfoxide.
Both Cys and Met can undergo oxidation directly by γ–radiation through the
highly reactive hydroxyl (•OH) radicals, discovered by Stadtman’s group.
Alternatively, their oxidation can be catalyzed by protein-bound transition metals
iron (Fe2+) and copper (Cu+) as shown by Levine’s group or by ONOO-, O2•-, •OH
and HOCl. Lysine (Lys), histidine (His) and Cys are susceptible to form lipidperoxidation adducts. Disulfide reductase and methionine sulfoxide reductase
directly mediate re-reduction of oxidized sulfhydryl groups on proteins. 3nitrotyrosine (3-NT) is considered to be a specific marker of ONOO- mediated
oxidation. Other amino acids subject to oxidation include arginine (Arg), proline
(Pro), threonine (Thr) and tryptophan (Trp), resulting in aldehydes or ketones.
Oxidative modification of key residues in proteins could result in loss or gain of
function of enzymes or structural proteins (Shacter 2000; Stadtman and Levine
2003).
Intracellular proteolysis can be carried out by mitochondrial proteases,
lysosomal proteases, calcium-activated calpains, or the ubiquitin-proteasome
system found in the cytosol, nucleus and ER of cells. Most of the oxidized
proteins are selectively degraded by the proteasome, which is involved in the
normal turn-over of, regulatory proteins involved in cell cycle, cell surface
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receptors and ion channels, as well as antigen presentation and processing. An
enzyme cascade consisting of ubiquitin ligases tag the proteins on their lysine
residues to be degraded with poly-ubiquitin molecules, except when the proteins
are oxidatively modified, and process them to the proteasome. The removal of
the ubiquitin molecules before degradation requires ATP. (This work on ubiquitinmediated proteolysis, by Ciechanover, Hershko and Rose, was awarded with the
Nobel Prize in Chemistry in 2004). Oxidized proteins, as opposed to native
proteins, are recognized by their hydrophobic surface patches, formed by partial
unfolding and exposure of hydrophobic amino acid residues due to oxidation.
Mitochondria contain three ATP-dependent proteases namely Lon, Clp-like and
AAA. Lon protease is shown to be responsible for degradation of oxidatively
modified proteins in the mitochondrial matrix. It is also shown to bind mtDNA and
act as a chaperone protein. However, during oxidative stress, there may be an
overload on the proteasome system for degradation as well as the proteasome
itself might be oxidatively modified and damaged, leading to formation of
insoluble and stable aggregates of misfolded/damaged proteins, such as
lipofuscin, both inside the cell and extracellularly (Davies 2000; Grune et al.
2003; Stadtman and Levine 2003; Grune et al. 2004; Ciechanover 2006; Friguet
2006).
De-oxyribo nucleic acid (DNA) in the nucleus contains the genetic code
necessary for cell survival, growth and cell division, in other words life. However,
DNA is rather susceptible to free-radical mediated damage, even more so the
case with mitochondrial DNA (mtDNA) due to its close proximity to sites of ROS
generation and the lack of protective histones. Damage occurs in the form of
modification of DNA bases, single- and double-strand breaks, loss of purines and
DNA-protein cross-linkage. Most of the damage to DNA such as 8-hydroxy-2deoxyguanosine (8-OHdG), 8-hydroxyadenine, thymine peroxide and thymine
glycol is caused by •OH radicals (Kohen and Nyska 2002). Modified DNA can be
repaired by DNA glycosylases, endonucleases, polymerases and ligases.
However, if insufficient, oxidized DNA results in mutations leading to transcription
and translation of mutated proteins that in turn may have lost function or gained
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an undesirable one. Such mutations in DNA can also be passed onto the
progeny through the germ-line. The resulting oxidative stress has been
implicated in cancer, diabetes, cardiovascular diseases, chronic inflammation,
aging and neurodegenerative disorders (Dykens 1994; Bolanos et al. 1997;
Droge 2002; Kohen and Nyska 2002; Wallace 2005).

Cell Death
The importance of programmed cell death during development by
Brenner, Horvitz and Sulston was recognized and accorded a Nobel Prize in
Physiology/Medicine in 2002. Cell death signals invariably converge on
mitochondria which then commit the cell to apoptosis and/or necrosis to maintain
tissue homeostasis (Brown et al. 1999; Kroemer and Reed 2000; Lemasters
2005). It should be noted that, although apoptosis and necrosis are considered in
an oversimplified manner to be distinct forms of cell death, there is evidence for
their coexistence. Both forms of cell death are characterized by mitochondrial
permeability transition, defined as the loss of trans-membrane potential across
the mitochondrial inner membrane. The MPT pore itself is described as voltagedependent, cyclosporine-sensitive, high conductance channel involving the inner
mitochondrial membrane. One of the strongest inducers of MPT is Ca2+ that can
be competitively inhibited by Mg2+, manganese (Mn2+) and Pi. Matrix pH below
and above 7.4 also induces MPT. MPT also causes loss of pyridine nucleotides
needed for respiration and membrane depolarization leads to inhibition of ATP
synthesis. The route of cell death is dependent upon severity of the insult and
intracellular levels of ATP, wherein apoptosis requires ATP and necrosis occurs
upon depletion of cellular ATP (Leist et al. 1999; Nicotera and Melino 2004;
Bernardi et al. 2006; Zong and Thompson 2006), with exceptions (Chiarugi
2005).
Apoptosis, coined by Kerr and colleagues in 1972 and synonymously used
with “programmed cell death” and “cell suicide”, is derived from Greek and
stands for “falling off”, referring to an orchestrated physiological process of
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removing individual components with minimal damage to the organism (Kerr
2002). All eukaryotic cells are equipped with genetic machinery, of varying
similarities conserved evolutionarily, for undergoing apoptosis. Apoptosis is
necessary for gametogenesis, embryogenesis and hematopoiesis, cardiac,
immune and neuronal development as well normal adult tissue turnover, owing to
the property of apoptotic cells not causing inflammation or tissue scarring. This
not only ensures stable cell populations but is also important for host survival
during invasions by pathogens (Kerr et al. 1972; Ranger et al. 2001; McHugh and
Turina 2006). On the other hand, inhibition of apoptosis can cause a wide variety
of pathological conditions such as cancer and auto-immunity whereas chronic
activation of apoptosis is implicated in aging (Pollack et al. 2002; Ziegler and
Groscurth 2004; Lemasters 2005) and neurodegeneration (Ranger et al. 2001;
Ameisen 2002; Fadeel and Orrenius 2005).
Apoptosis is an ATP-dependent process and typically characterized by
chromatin condensation and inter-nucleosomal DNA degradation termed as
pyknosis,

cell shrinkage, formation of

numerous small surface blebs,

externalization of phosphatidyl serine (PS) on the plasma membrane, resulting in
condensed apoptotic bodies tagged for phagocytosis (Ziegler and Groscurth
2004; Lemasters 2005). Depending on the source of signal, cells can undergo
apoptosis either by the extrinsic pathway, for normal tissue homeostasis, or
alternately the intrinsic pathway initiated by mitochondria due to cues from the
nucleus or other noxious stimuli (Fadeel and Orrenius 2005).
Both the extrinsic and intrinsic pathways involve caspase activation.
Caspases are constitutively expressed in mammals as inactive zymogens and
proteolytically activated to form active tetramers. They are cysteine proteases
with preference to substrate cleavage after aspartate residues. They can be
divided into initiator (2, 8, 9, 10 and 12), effector (3, 6 and 7) and inflammation (1,
5 and 11) caspases. The initiator caspases contain share conserved motifs
known as caspase recruitment domain (CARD), death effector domain (DED)
and the catalytic domain, while the effector caspases possess a short prodomain. The initiator caspases are activated by an autocatalytic mechanism
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whereas they are required for activation of the effector caspases. Effector
caspases are able to directly cleave their substrates that include proteins
involved in scaffolding of the cytoplasm and nucleus, signal transduction and
transcription-regulatory proteins, cell cycle components, DNA replication and
repair proteins, and apoptosis inhibitors to form a positive feedback loop (Ranger
et al. 2001; Nicotera and Melino 2004; Artal-Sanz and Tavernarakis 2005; Fadeel
and Orrenius 2005).
The extrinsic pathway (death-receptor signaling) is triggered upon binding
of ligands to their receptors such as Fas-ligand/Fas, TNFα/TNFR1, their
association with adapter proteins (FADD and TRADD respectively) forming a
death-inducing signaling complex (DISC) and subsequent activation of initiator
caspases such as caspase-8. It in turn can proteolytically activate execution
caspases - caspase-3. In some cells, caspase-8 further cleaves pro-apoptotic
Bid, resulting in its translocation to mitochondria and subsequent cytochrome c
release in order to generate sufficient caspase-3 activity (Ranger et al. 2001;
Nicotera and Melino 2004; Fadeel and Orrenius 2005).
On the other hand, nuclear DNA damage, kinase inhibition, trophic factor
deprivation, UV and calcium/oxidative stress act as triggers of the intrinsic
pathway of apoptosis. This causes, the pro-apoptotic proteins of Bcl2 family, Bak
and Bax to translocate from cytosol to mitochondria and interact with antiapoptotic BclxL & Bcl2 and induce mitochondrial membrane permeability
transition (MPT). This results in the formation of a MPT pore (MPTP), causing
membrane depolarization and inhibition of respiration. Some reports suggest that
the loss in membrane potential causes more ions to flow into the matrix followed
by influx of water. This leads to swelling of the matrix and rupture of
mitochondrial outer membrane. Other reports indicate that the pro-apoptotic
proteins are released through the formation of a pore, comprising of Bax and
other proteins such as peripheral benzodiazepine receptor (PBR), hexokinase
(HK), and creatine kinase (CK), the exact composition and mechanisms of which
are still unclear (Crompton 2003; Hajnoczky et al. 2003; Kim et al. 2003;
Armstrong 2006; Bernardi et al. 2006). This results in release of cytochrome c,
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second mitocondria-derived activator of caspases/ direct IAP-binding protein with
low pI (Smac/Diablo), procaspases-2,3,8 and 9, apoptotic protease-activating
factor 1 (Apaf-1), apoptosis-inducing factor (AIF), Endonuclease G (Endo G) and
possibly high temperature requirement protein A2 (HtrA2/Omi) (Ranger et al.
2001; Parone et al. 2002; Armstrong 2006).
Apaf-1 binds with cytochrome c, in the presence of ATP, and recruits
procaspase-9, forming a complex called the “apoptosome”. The now activated
caspase-9 activates caspase-3. JNK, a kinase, also utilizes ATP for activation of
pro-apoptotic proteins such as Bid and Bad, while inactivating anti-apoptotic
proteins such as Bcl-2. Smac/Diablo, for its part, binds with the regulatory
inhibitors of apoptosis proteins (IAP), resulting in disinhibition of both the initiator
and effector caspases. On the other hand, in a caspase-independent manner,
AIF and Endo G translocate from cytosol to nucleus and induce chromatin
condensation and inter-nucleosomal DNA fragmentation respectively (Ranger et
al. 2001; Lemasters 2005; Armstrong 2006).
In contrast to apoptosis, necrosis is not programmed and occurs when
cellular ATP is depleted, and is usually initiated by Ca2+ and ROS. Necrosis is
characterized by electron-lucent vacuolation of cytoplasm, mitochondrial
swelling, dilatation of ER and loss of PM integrity and subsequent rupture. MPT,
in the case of necrosis, involves permeability of the inner mitochondrial
membrane, resulting in a regulated high-conductance pore formed by voltagedependent anion channel (VDAC) from the outer membrane, adenine nucleotide
translocator (ANT) from the inner membrane, cyclophilin D (CypD) from the
matrix, or a more unregulated pore formed due to disulfide bridges among
proteins of the inner mitochondrial membrane, the mechanisms of which are yet
unclear. This leads to release of various matrix components into the cytosol that
can be degraded by the proteolytic machinery in the cytosol. Some of them
include the calcium-activated calpain proteases that can be divided into µ-calpain
(calpain I) and m-calpain (calpain II), based on their micro and millimolar
requirements of Ca2+ for activation. They exist as heterodimers consisting of a
large catalytic sub-unit and a smaller regulatory sub-unit and when activated
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bring about degradation of cytoskeletal proteins. Lack of ATP reverses some of
the PM pumps resulting in influx of ions and water into the cell resulting in its
swelling and extrusion of its contents into the extracellular space thereby eliciting
an inflammatory response (Leist et al. 1999; Crompton 2003; Kim et al. 2003;
Nicotera and Melino 2004; Artal-Sanz and Tavernarakis 2005; Wallace 2005;
Armstrong 2006; Bernardi et al. 2006; Zong and Thompson 2006).
When the defective or damaged mitochondria reach a certain threshold
they are tagged for degradation by autophagy, more specifically called
mitophagy. This is preceded by loss of mitochondrial membrane potential and
release of cytochrome c and other pro-apoptotic proteins and usually followed by
cell death. Mitophagy occurs in autophagolysosomes (autolysosomes) formed by
fusion of lysosomes (the work is credited to de Duve who won the Nobel Prize in
Physiology/Medicine
mitochondria.

in

1974)

Autolysosmes

and

autophagic

contain

a

variety

vacuoles
of

containing

catabolic

the

hydrolases

(phosphatases, nucleases, glycosidases, proteases, peptidases, sulphatases
and lipases) that operate at an acidic pH (4-5) and can digest the lysosomal
contents for reuse. Lysosomal cathepsin proteases can be divided into aspartyl
(cathepsin-D) and cysteine (cathepsin-B, H and L), and can cause non-specific
cleavage of proteins in lysosmes and sometimes in the cytosol. They can also
activate pro-apoptotic Bid leading to mitochondrial membrane permeabilization
and release of cytochrome c (Artal-Sanz and Tavernarakis 2005; Kroemer and
Jaattela 2005; Lemasters 2005). However, it is unclear at present if mitophagy is
protective by providing energy generated from catabolic degradation of damaged
mitochondria or if it hastens cell death by removing the major sources of energy
from the cell (Klionsky and Emr 2000; Tolkovsky et al. 2002; Rodriguez-Enriquez
et al. 2004; Golstein and Kroemer 2005; Kundu and Thompson 2005). Finally,
there appears to be cross-talk between caspases, calpains and cathepsins
leading to a continuum between apoptotic and necrotic forms of cell death.
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Aging: A Full Circle
Life of an organism is a function of its resistance to entropy i.e., the
tendency of complex systems to move towards disorder and decay over time.
Hence, life requires and utilizes energy, obtained from the available metabolic
resources, to sustain a delicate balance among the competing processes namely
growth, maintenance/repair and reproduction (Kirkwood and Austad 2000;
Kirkwood 2005; Holliday 2006). Aging can be defined as an irreversible alteration
in the intrinsic homeostasis of an organism, affected by its genetic make-up,
environmental stresses and other stochastic events, leading to a) diminishing
physiological capacity, b) decreased adaptability, c) a decline in fertility, d)
increased vulnerability to disease and e) an exponential increase in mortality
after maturation. Aging particularly increases the risk of occurrence of diseases,
such

as

cancer,

diabetes,

cardio-vascular

conditions

as

well

as

neurodegenerative conditions such as Alzheimer’s disease (AD), Parkinson’s
disease (PD) and dementia, resulting ultimately in death (Troen 2003; Kirkwood
2005; Wallace 2005).
Longevity of a population can be measured by two different parameters –
a) average life expectancy (ALE) and b) maximum lifespan (MLS). Life
expectancy is the average/median age at which 50% of the population survives
whereas maximum lifespan is the age of the longest-living member of that
population. Improved nutrition, better sanitation and advances in health care
have removed the humans from the pressures of natural selection and
dramatically increased the ALE of humans over the past century, whereas the
MLS in humans stands at 122 years indicating an underlying genetic component.
This is particularly important in the context of United States where life expectancy
at birth has increased from being less than 50 years to more than 76 years. It is
projected that by the year 2030 the number of individuals aged 65 years and
older will be around 70 million and those aged 85 years and older is estimated to
be around 19 million by the year 2050. The ethical, medical and economic
ramifications of such an aging population can already be felt by the society today.
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The focus of human aging research is not so much on reversing aging but
geared towards gaining insights of the underlying mechanisms to modulate aging
and thereby ensuring a higher quality of life in the later years (Harman 2003;
Troen 2003).
Aging is not typically observed in natural populations as they do not
survive extrinsic hazards such as starvation, predators, disease and other natural
calamities. The main purpose of such organisms is to reach adulthood and be
able to reproduce and generate progeny. The same animals when placed in
protected environment with adequate resources are likely to live longer and
exhibit an aging phenotype. While longevity refers to the time-frame of the
organism, aging refers to the deleterious process occurring during that time.
There exists an inverse relation between reproduction and longevity i.e.
organisms with larger progeny have reduced life spans and vice versa. This is
dependent on the allocation of limited resources to reproduction as opposed to
somatic maintenance, as stated by the complementary ‘mutation accumulation’,
‘antagonistic pleiotrophy’ and the ‘disposable soma’ theories of aging that
attempt to explain why aging occurs evolutionarily (Kirkwood and Austad 2000;
Kirkwood 2005; Holliday 2006).
Owing to the evolutionary counter-intuitiveness and inherent complexity, a
unifying theory is precluded from successfully elucidating the phenomenon of
aging. Therefore, various theories have been put forth to explain how aging
occurs that can be broadly divided into programmed (ex: longevity genes) and
stochastic (ex: oxidative stress). While such mechanistic theories are not
mutually exclusive and attempt to gain attention in the competing ‘cause vs.
effect’ discussions, the ‘Mitochondrial Theory of Aging (MTA)’ offers to explain
both the stochastic and genetic components associated with aging (Harman
2003; Troen 2003; Kirkwood 2005; Wallace 2005).
Aging of the brain is characterized by mild cognitive impairment (MCI) and
impairment of sensory and motor functions that has the potential to develop into
neurodegenerative diseases such as Alzheimer’s (AD) and Parkinson’s (PD).
The decline or loss of cognitive function with aging is not due to universal loss of
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neuronal cells per se, as previously thought, but primarily due to loss of synaptic
function in distinct cell populations. Selective regions in the cortex and
hippocampus are more susceptible to synaptic reduction, dendritic degeneration
and/or neuronal cell loss thereby affecting learning and memory (Uylings and de
Brabander 2002).
The brain is a unique organ in that it consists of mostly post-mitotic cells,
has a heterogeneous composition of cell types (neurons, astrocytes, glia etc),
has distinct structural (cortex, hippocampus, striatum etc) regions and functional
(motor vs. sensory vs. memory) areas. It has low levels of stored glycogen,
almost exclusively utilizes glucose as its energy source and consumes about
20% of total body oxygen even though it constitutes only 2% of the body weight.
In addition, it contains high amounts of unsaturated fatty acids along with high
iron content and found to be low in antioxidant defenses. All the above reasons
make the brain a prime target for oxidative stress that is believed to increase with
aging. In fact, increased protein oxidation, lipid peroxidation and DNA
modifications, all markers of oxidative damage, were observed with aging that
correlate well with cognitive dysfunction. There is also a strong negative
correlation between energy metabolism and lifespan in mammals, lending
credibility to the free radical theory of aging (Levine and Stadtman 2001; Floyd
and Hensley 2002; Dufour and Larsson 2004; Poon et al. 2004; Stadtman 2006).
Various groups have presented divergent reports on the distribution,
expression, activity of different NOS isoforms in the brain and resultant protein
modifications. Contradictory reports have emerged regarding the role of NO• and
the extent of RNS mediated damage with aging measured by levels of 3-NT in
different regions of the brain. However, there are no reports to date
characterizing mtNOS as a function of age in the brain. None of these studies
addressed the source of 3-NT measured and could plausibly account for the
discrepancies (Bolanos et al. 1997; Drew and Leeuwenburgh 2002; Calabrese et
al. 2006).
According to the Ca2+ hypothesis of brain aging, there is dysregulation of
calcium homeostasis in the brain with aging that has a detrimental cascade effect
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on Ca2+-dependent processes thereby impairing brain synaptic function. This is
evident from the increased vulnerability to excitotoxicity with age, increased
numbers and activity of Ca2+-dependent channels, decreased capacity to recover
after stimulation (although intracellular Ca2+ levels at rest do not change with
age), increased Ca2+ influx into mitochondria or finally due to enhanced
mitochondrial permeability transition pore (MPTP) activation with aging. Such
Ca2+ dysregulation may lead to the undesirable consequence of impaired
memory and cognition (Brown et al. 2004; Toescu and Verkhratsky 2004; Toescu
et al. 2004; Kelly et al. 2006).
Mitochondria occupy the center stage in aging and neurodegeneration
owing to their capacity for- a) providing cellular ATP, b) buffering calcium, c)
being a major source and target of ROS/RNS and finally d) being initiators of cell
death pathways (Beal 2005). Therefore, mitochondria provide the converging
point to successfully combine the ‘calcium dyshomeostasis hypothesis’ (Toescu
et al. 2004) with the ‘free radical theory’ (Miquel 2002; Wei and Lee 2002;
Harman 2003; Wallace 2005; Lenaz et al. 2006) of brain aging into a synergistic
Mitochondrial Theory of Aging (MTA). The MTA postulates that mitochondrial
dysfunction, due to a stochastic and exponential rise in mtDNA mutations leading
to defective ETC complexes causing a reduction in ATP generation/levels and
increased oxidative stress leading to irreversible alterations in mitochondrial
structure and function, is central to the decline in function observed with aging
(Miquel 2002; Wei and Lee 2002; Harman 2003; Wallace 2005; Lenaz et al.
2006).
It has been documented that, with age, brain accumulates mtDNA
deletions, rearrangements and point mutations resulting in a mixed population of
around 1% of total mtDNA. Since mtDNA codes for 13 of the subunits of the ETC
complexes I, III, IV and V, any mutations in their coding regions will result in
synthesis of defective respiratory complexes decreasing their efficiency to carry
out respiration. One of the fallouts of this is the increased leakage of electrons
from the ETC, generating more free radicals. These are in turn shown to cause
oxidative modifications of mtDNA as well as other mitochondrial proteins (ex:
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ANT) and enzymes (ex: MnSOD) reducing or inhibiting their activities. Brain
mitochondrial membranes have a higher concentration of polyunsaturated lipids
and age-related decrease in amounts of cardiolipin which makes them more
susceptible to free radical damage and thereby alters their fluidity, protein-lipid
interactions and ultimately their structure. Taken together, there is a positive
correlation between oxidative damage to mitochondrial components and decline
in ATP generation and levels. Moreover, decreases in mitochondrial membrane
potential, oxygen consumption and respiratory control ratio (RCR) were also
observed with age resulting in a bioenergetic failure of mitochondria. In addition,
aged mitochondria were also more susceptible to Ca2+ and free radical induced
MPT (Bolanos et al. 1997; Toescu et al. 2000; Wei and Lee 2002; Brown et al.
2004; Dufour and Larsson 2004; Liu and Ames 2005; Wallace 2005).
Cell death resulting from mitochondrial dysfunction is not readily evident
with normal aging in the brain (Pollack et al. 2002). One of the reasons for this
difference could be the intra-cellular trafficking and location (soma vs. synapses)
of mitochondria, conditions in their surrounding milieu and their functional status
within the neuron (Chang and Reynolds 2006). The cognitive decline with aging
is explained by the changes in neuronal structure and loss of neuronal function,
resulting from mitochondrial dysfunction, rather than neuronal cell death.
However, cell death was indeed observed in other tissues with aging and more
pronouncedly in age-related neurodegeneration (Uylings and de Brabander
2002; Sastre et al. 2003; Sullivan 2005; Sullivan and Brown 2005; Mattson
2006).

Summary
Mitochondria occupy a unique position inside the cell, in the sense they
are the non-nuclear master regulators of cell’s fate. Their primary and most vital
function is to provide ATP energy for the normal physiology of the cell, with an
unfortunate but an inevitable consequence being generation of free radicals. In
addition, they also possess calcium-buffering capacity. The combination of Ca2+
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and free radicals, under certain conditions, could lead to oxidative stress. And
finally, they also bring about the death of the cell in the form apoptosis/necrosis
that could be beneficial as in development or detrimental as in the case of aging,
neurodegeneration and other pathologies.
Brain mitochondria in particular are more susceptible to oxidative stress
that is greatly modulated by the cellular Ca2+ fluxes as implicated in aging and
age-related neurodegeneration conditions such as Alzheimer’s (AD) and
Parkinson’s (PD). However, the sources of ROS/RNS, how their levels are
altered by calcium and how the resulting oxidative stress is responsible for
mitochondrial dysfunction observed with aging are all questions begging further
clarification.
It is of critical importance to prevent or ameliorate mitochondrial oxidative
stress and preserve mitochondrial bioenergetics in order to maintain cellular
homeostasis. Thus, it becomes imperative to understand the underlying causes,
mechanisms and consequences of mitochondrial oxidative stress. Therefore, the
purpose of this dissertation is to study if there is cross-talk between calcium
and nitric oxide synthase that affects mitochondrial bioenergetics and
contributes to oxidative stress in isolated rat brain mitochondria.
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Figure 1.6: Summary of hypothesis. Flowchart of plausible sequence of events
resulting in mitochondrial dysfunction implicated in aging and neurodegeneration.
Excess cytosolic calcium (Ca2+) is taken up by mitochondria which can activate a
number of enzymes in the mitochondria including Nitric oxide Synthase (NOS).
This leads to production of nitric oxide (NO•) that can react with superoxide (O2•-)
forming peroxynitrite (ONOO-). It inturn can cause oxidative damage to various
mitochondrial components namely mtDNA, proteins and lipids. This will alter
mitochondrial structure and function resulting in reduced energy generation
and/or initiation of cell death cascades. Loss of cell function and cell numbers are
implicated in aging and age-related neurodegenerative conditions such as
Alzheimer’s disease (AD).
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Figure 1.6: Summary of hypothesis.
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Chapter Two

Cryopreservation of Brain Mitochondria: A Novel Methodology for
Functional Studies

Introduction
Mitochondria are essential for aerobic metabolism and ATP production in
the cell [for reviews see (Szewczyk and Wojtczak 2002; Watts and Kline 2003)]
and play a significant role in cell death as relevant to aging and
neurodegenerative diseases (Lemasters et al. 1999; Newmeyer and FergusonMiller 2003). Mitochondrial function is typically analyzed using mitochondria
freshly isolated from tissues and cells because they yield tightly coupled
mitochondria, whereas those from frozen tissue can consist of broken
mitochondria and membrane fragments (Lee 1995). This prevents serial usage
as well as long-term batch storage or ‘banking’ of isolated mitochondria for later
use in functional studies (Kuznetsov et al. 2003). To overcome such limitations,
research has been done to optimize methods to cryopreserve mitochondria
without affecting the structural and functional integrity of isolated mitochondria.
There are various natural and synthetic compounds currently being used
as cryoprotective additives (CPA) such as alcohols, saccharides, heterocyclic
compounds, certain amino-acids and proteins, as well as complex substrates
such as yeast extract and skimmed milk. Of the lot, glycerol and dimethyl
sulfoxide (DMSO) are the most widely used CPA. DMSO in particular is
considered to be an effective cryoprotectant since it is cell-permeable, universal
and well-characterized (Hubalek 2003; Santos et al. 2003). While previous
studies have demonstrated cryopreservation of isolated mitochondria using
DMSO in liver and muscles of rabbits (Araki 1977; Araki 1977), mice (Fishbein
and Griffin 1976), rats (Tsvetkov et al. 1985; Tsvetkov et al. 1985; De Loecker et
al. 1991; Kuznetsov et al. 2003) and humans (Lee 1995; Kuznetsov et al. 2003),
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relatively few studies have directly addressed the effects of cryopreservation on
the mitochondria in rat brain (Lee 1995).
In the present study, cortical mitochondria were isolated from adult
Sprague-Dawley rats. DMSO (10% v/v) was added to the crude or percollpurified fraction and assessed for respiration or allowed to cool at a uniform rate
of ~ 1ºC/min and stored at -80ºC for a week. The cryopreserved mitochondria
were reanimated after a week and assessed for respiration while structural
intactness was verified by electron microscopy. The samples used for respiration
studies were also used to measure the levels of mitochondrial marker proteins
namely COX or COX IV (inner membrane), Cytochrome c (inter-membrane
space) and VDAC (outer membrane).
We conclude that DMSO can be successfully used to cryoprotect rat
cortical mitochondria which could be extended as a possible strategy for
preservation of human brain mitochondria as well. This will considerably expand
the range of biochemical, molecular and metabolic studies that can be performed
on rat or human post-mortem tissues without the constraints of mitochondrial
longevity ex vivo and allow the banking of samples for future comparative
studies.

Materials and Methods

Reagents:
Mannitol, sucrose, bovine serum albumin (BSA), ethylene glycol-bis(2aminoethylether)-N,N,N',N'-tetraacetic acid (EGTA), hydroxyethyl piperazine-1ethanesulfonic acid potassium salt (HEPES), potassium phosphate monobasic
anhydrous (KH2PO4), magnesium chloride (MgCl2), potassium chloride (KCl),
malate, pyruvate, adenosine 5’-diphosphate (ADP), digitonin, succinate and
dimethyl sulfoxide (DMSO) were purchased from Sigma-Aldrich (St. Louis, MO,
USA). Oligomycin A and carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone
(FCCP) were purchased from Biomol (Plymouth Meeting, PA). Bicinchoninic acid
(BCA) protein assay kit was purchased from Pierce (Rockford, IL).
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Isolation and Purification of Brain Mitochondria:
All experimental protocols involving animals were approved by the
University of Kentucky Animal Use and Care Committee. This protocol contains
modifications of previously described procedures (Brown et al. 2004; Sullivan et
al. 2004). All procedures were performed on ice throughout the protocol.
Depending on the sample size, this protocol requires about 2.5 – 3hrs of total
preparation time. Male Sprague-Dawley rats (~250g) were decapitated and the
brains were rapidly removed. The cortices were dissected out and placed in an
all-glass dounce homogenizer containing five times the volume of isolation buffer
with 1mM EGTA (215 mM mannitol, 75mM sucrose, 0.1% BSA, 20mM HEPES,
1mM EGTA and pH is adjusted to 7.2 with KOH). The tissue was homogenized
and mitochondria were isolated by differential centrifugation. Briefly, the
homogenate was centrifuged at 1300 x g for 3 minutes in an eppendorf
microcentrifuge at 4ºC and the supernatant was transferred to new tubes. The
loose pellet was resuspended in isolation buffer with EGTA and was centrifuged
again at 1300 x g for 3 minutes. The resulting supernatant was transferred to
new microcentrifuge tubes and topped off with isolation buffer with EGTA and
centrifuged at 13,000 x g for 10 minutes. The supernatant was discarded and the
pellet was resuspended in 500 µL of isolation buffer with EGTA. A fraction of the
sample was aliquoted for cryopreservation. To obtain maximal yield of total
(synaptic and non-synaptic) mitochondria, synaptosomal membranes were
disrupted by adding 0.01% Digitonin (from 10X stock) to the sample and
incubated on ice for 10 min. To remove the digitonin, the sample was topped off
with isolation buffer and centrifuged at 10000 x g for 10 min. The sample was
further purified by percoll density gradient centrifugation. Stocks of 40%, 26%
and 24% percoll were prepared fresh in isolation buffer with EGTA. 3.5 ml of 26%
stock was carefully layered over 3.5 ml of 40% in 13 ml ultra-clear tubes. Equal
volume of 24% percoll was added to the sample to get a 12% final concentration
and loaded gently on top of the 26% layer. The sample was centrifuged in fixed
angle type 50.2 Ti rotor at 32,000 x g for 10 min at 4ºC in Optima L-90K
ultracentrifuge (Beckman Coulter). Fraction 3 containing total mitochondria
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formed at the interphase of 40% and 26% layers was carefully removed and
placed in fresh ultra-clear tubes. The tubes were topped off with isolation buffer
and centrifuged in type 50.2 Ti fixed angle rotor at 16,700 x g for 10 min at 4ºC in
Optima L-90K ultracentrifuge (Beckman Coulter). The supernatants were
carefully removed and the loose pellets at the bottom were transferred to
microcentrifuge tubes. The tubes were topped off with isolation buffer without
EGTA (215mM mannitol, 75mM sucrose, 0.1% BSA, 20mM HEPES and pH is
adjusted to 7.2 with KOH) and centrifuged at 13,000 x g for 10 min at 4ºC. The
supernatants were carefully removed and the pellets were resuspended in 500
µL of isolation buffer without EGTA. The tubes were topped off with isolation
buffer without EGTA and centrifuged at 10,000 x g for 10 min at 4ºC. The
supernatants were carefully removed and the pellets were resuspended in 500
µL of isolation buffer without EGTA. The tubes were topped off with isolation
buffer without EGTA and centrifuged at 10,000 x g for 5 min at 4ºC to yield a
tighter pellet. The final mitochondrial pellet was resuspended in isolation buffer
without EGTA to yield a concentration of ~ 10mg/ml. The protein concentration
was determined using the BCA protein assay kit measuring absorbance at 562
nm with a BioTek Synergy HT plate reader (Winooski, Vermont).

Cryopreservation of Brain Mitochondria:
Brain Mitochondria were preserved before or after percoll purification.
Dimethyl sulfoxide (DMSO) was added to the mitochondria (10% v/v). The
sample was then placed in Nalgene freezing container (catalog number: 51000001) and allowed to cool to -80ºC at a uniform rate of ~ -1ºC/min. The sample
can be stored at -80ºC for up to 6 months for later use.

Reanimation of Brain Mitochondria:
To reanimate the mitochondria, frozen samples were briefly thawed on
ice. The sample tubes were topped off with isolation buffer with EGTA and
centrifuged at 13000 x g for 10 min at 4ºC. The pellets were resuspended in
500ul isolation buffer with or without EGTA, topped off and centrifuged at 10000
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x g for 10 min @ at 4ºC. The pellets were resuspended in appropriate volume. If
needed, the sample can then percoll purified as described above for subsequent
analysis.

Electron Microscopy:
After the last 10,000 × g centrifugation, the mitochondrial pellets were
fixed in 4% glutaraldehyde overnight at 4ºC before being embedded for electron
microscopy. Next, the pellets were washed overnight at 4ºC in 0.1M sodium
cacodylate buffer, followed by 1 hr secondary fixation at room temperature in 1%
osmium tetroxide. Then, the mitochondrial pellets were rinsed with distilled water
and dehydrated for 10 min each in 70%, 85%, 95%, twice in 100% ethanol and
twice in propylene oxide. The pellets were placed in a 1:1 mixture of propylene
oxide and Epon/Araldite resin and infiltrated overnight on a rotator. Next, 100%
Epon/Araldite resin was added and rotated for 1hr at room temperature. Finally
fresh resin was prepared and degassed using a vacuum chamber. The
mitochondrial pellets were added to the flat molds, filled with fresh resin, and
baked overnight at 60ºC. The 90 nm sections were cut using an RMC MT-7000
ultramicrotome mounted on 150 mesh copper grids and stained with uranyl
acetate and lead citrate. The sections were examined using a Zeiss 902
transmission electron microscope.

Respiration Studies:
The respiratory activity of isolated mitochondria was measured using a
Clark-type oxygen electrode (Hansatech Instruments, Norfolk, England) as
previously described (Brown et al. 2004; Sullivan et al. 2004). 100-120 ug/mL of
isolated mitochondria were suspended in a sealed, constantly stirred, and
thermostatically-controlled chamber at 37ºC in respiration buffer (125mM KCl,
2mM MgCl2, 2.5mM KH2PO4, 0.1% BSA, 20mM HEPES at pH 7.2). The rate of
oxygen consumption was calculated based on the slope of the response of
isolated mitochondria to oxidative substrates, 5mM pyruvate and 2.5mM malate;
150µM ADP; 2µM oligomycin; 2µM FCCP; and finally 10mM succinate.
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Enzyme-Linked Immunosorbent Assay (ELISA) for Cytochrome c:
Cytochrome c levels were analyzed according to the quantitative sandwich
enzyme immunoassay protocol from the manufacturer (Quantikine kit; RnD
Systems, Minneapolis) with slight modifications. Briefly, samples used for
respiration were centrifuged at 10,000 x g for 5 min at 4ºC. The pellets were
diluted to 0.01-0.03ug/ul with isolation buffer without EGTA. Samples were added
to wells pre-incubated with Cytochrome c conjugate alongside known
concentrations of standards. The plate was incubated in the dark for 2hr at room
temperature. The contents of the wells were washed to remove unbound protein;
colorimetric solution was added and incubated for 30min. Lastly, stop solution
was added which turns the enzyme reaction from blue to yellow. The
concentration of Cytochrome c was determined from optical density readings at
450nm (background was measured at 570nm) using Multiskan Plus (Thermo
LabSystems) and expressed as ng/mg protein (% Fresh mitochondria).

Western Blotting:
Western blots for COX and VDAC were carried out as described
previously (Brown et al. 2004). Briefly, samples used for respiration were
centrifuged at 10,000 x g for 5 min at 4ºC. The resulting mitochondrial pellet was
diluted to 1ug/ul in isolation buffer without EGTA and used for western blots.
Sample buffer was added to the samples based on relative protein
concentrations and boiled for 10min. Samples (5ug each) were separated by
SDS-PAGE 12% Tris-bisacrylamide gels (NuPage), along with molecular weight
markers (Multi-Marker, Invitrogen).
transferred

electrophoretically

Following SDS-PAGE, polypeptides were

onto

0.2 µM

nitrocellulose

membranes.

Membranes were incubated at room temperature for 1 hour in 5% non-fat milk in
50 mM Tris-saline containing 0.05% Tween-20 at pH 7.5 (TTBS). The blots were
incubated overnight in the primary antibody in TTBS at room temperature. The
primary antibodies used in study included monoclonal cytochrome c oxidase
subunit IV (COX IV) at 1:20,000 from Molecular Probes (Eugene, OR, USA); and
polyclonal voltage-dependent anion channel (VDAC) at 1:10,000 from Affinity
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Bioreagents (Golden, CO, USA). After overnight incubation in primary antibody,
the membranes were rinsed three times in TTBS and incubated in secondary
antibody for one hour in either HRP-conjugated goat anti-mouse IgG (1:6000) for
COXIV, or HRP-conjugated goat anti-rabbit IgG (1:6000) for VDAC. The blots
were rinsed thoroughly in TTBS and were developed using Pierce SuperSignal
West Pico chemi-luminescent substrate and analyzed using Kodak ImageStation.

Statistical Analysis:
All results are expressed as means ± standard deviations (SD). For
statistical evaluation, One-way analysis of variance (ANOVA) was performed
followed by Student-Newman-Keuls post-hoc test. Significance was set at p <
0.05 for all analyses.

Results

Effect of Cryopreservation on Ultrastructure of Brain Mitochondria:
To determine the effects of cryopreservation on the ultra-structure of brain
mitochondria, electron microscopy was performed on fresh and cryopreserved
mitochondria.

DMSO

preserves

the

structure

of

cryopreserved

brain

mitochondria. Both the freshly isolated mitochondria (Figure 1A) and the
cryopreserved mitochondria (Figure 1B) had intact inner and outer membranes,
as well as tight cristae.

Effect of Cryopreservation on Brain Mitochondrial Bioenergetics:
To determine the effects of cryopreservation on the respiratory control
ratio of brain mitochondria, oxygen consumption measurements were carried out.
Freshly isolated brain mitochondria with respiratory control ratio (RCR) of greater
than 5 only, obtained by dividing State 3 (presence of ADP) over State 4
respiration (absence of ADP), were used for subsequent experiments. Oxygen
consumption measurements revealed that there were no significant differences in
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the RCR between percoll-purified non-cryopreserved mitochondria with DMSO
and crude- or purified-cryopreserved mitochondria with DMSO (Figure 2.2 and
2.3). This indicates that the electron transport system (ETS) is well coupled to the
oxidative phosphorylation even upon cryopreservation. The RCR of mitochondria
cryopreserved with DMSO was significantly higher from mitochondria frozen
without DMSO.
To determine effects of cryopreservation on the respiratory activity of brain
mitochondria, the respiratory values of each state were analyzed for fresh and
cryopreserved mitochondria. We observed a significant reduction in activity in
fresh mitochondria washed with DMSO compared to freshly isolated brain
mitochondria in all the respiration states except States II and IV. The reduction in
activity suggests a DMSO effect on the mitochondrial bioenergetics. This
reduction in activity is further exacerbated in the crude and purified mitochondria
cryopreserved

with

DMSO

(Figure

2.4).

However,

the

cryopreserved

mitochondria had significantly higher activity in all states compared to the
mitochondria frozen without DMSO (data not shown) indicating that DMSO, in
spite of lowering the respiration by itself, does indeed preserve mitochondrial
bioenergetics.

Effect of Cryopreservation on Cytochrome c levels of Brain Mitochondria:
To determine the reduction in respiratory activity upon cryopreservation,
we used ELISA to analyze Cytochrome c levels of all groups. Mitochondria
cryopreserved with DMSO retain significantly higher Cytochrome c levels
compared to the mitochondria frozen without DMSO (Figure 2.5). However, all
groups were significantly lower than the fresh non-cryopreserved brain
mitochondria. Surprisingly, DMSO alone significantly reduced Cytochrome c
content in the mitochondria. This loss of Cytochrome c could account for the
observed reduction in the bioenergetics upon cryopreservation.
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Effect of Cryopreservation on Membrane Markers of Brain Mitochondria:
Finally, to determine the possibility of mitochondrial membrane rupture
resulting in reduction in cytochrome c levels, we carried out western blots for
mitochondrial membrane marker proteins namely COX (inner membrane) and
VDAC (outer membrane). Western blots of brain mitochondria cryopreserved
with or without DMSO (Figure 2.6) demonstrated no significant differences in
immunoreactivity of markers COX IV or VDAC. These data support our EM
findings and taken together indicate that the mitochondrial membranes remain
intact following cryopreservation.
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Figure 2.1: Cryopreservation of brain mitochondria does not alter their
ultra-structure.

Electron microscopy pictures of fresh and cryopreserved

mitochondria. The top panel (A) is a photograph of freshly isolated brain
mitochondria. The bottom panel (B) is a photograph of cryopreserved
mitochondria isolated from the same preparation. The small arrows indicate
intact outer mitochondrial membranes whereas the large arrows indicate wellformed cristae in both the freshly isolated and cryopreserved mitochondria.
(Scale bar =0.25 µm).
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Figure 2.1: Cryopreservation of brain mitochondria does not alter their
ultra-structure.
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Figure 2.2: Representative Oxymetric traces of fresh and cryopreserved
mitochondria obtained using a Clark-type oxygen electrode. Baseline
respiration is termed as State I containing 125mM KCl respiration buffer and
mitochondria (25-30ug). State II is initiated by addition of 5mM Pyruvate and
2.5mM Malate as substrates for Complex I of the electron transport chain (ETC).
State III is initiated by activation of ATP Synthase (Complex V) with addition of
ADP (150µM). State IV occurs when ATP Synthase is inhibited by addition of
Oligomycin (2µM). FCCP (2µM) induces State V by uncoupling electron transport
from oxidative phosphorylation followed by Succinate (10mM) to verify electron
transport through Complex II. Freshly isolated brain mitochondria or those
washed in DMSO responded very similar to crude- or purified-cryopreserved
brain mitochondria whereas brain mitochondria that were frozen without
cryopreservation demonstrated an obvious loss of bioenergetics.
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Figure 2.2: Representative Oxymetric traces of fresh and cryopreserved
mitochondria obtained using a Clark-type oxygen electrode.
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Figure 2.3: Cryopreservation of brain mitochondria preserves respiratory
control ratio (RCR). Respiratory control ratios (RCR) of mitochondria, measured
as State III (presence of ADP) over State IV (presence of oligomycin),
demonstrate that cryopreserved brain mitochondria are well-coupled. However
their RCRs were significantly lower than freshly isolated mitochondria, but no
different than freshly isolated mitochondria washed with DMSO. The line
represents the RCR of frozen, non-cryopreserved brain mitochondria. Data
represent group means ± SD; n = 3 per group except for Fresh + DMSO + Wash
(n = 2) and Frozen (n = 2). One-Way ANOVA; Student-Newman-Keuls post-hoc
test; # indicates p < 0.05 compared to fresh mitochondria.
Measurement

DF

F – value

P – value

Power

RCR

3

8.016

0.0115

0.885
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Figure 2.3: Cryopreservation of brain mitochondria preserves
respiratory control ratio (RCR).
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Figure 2.4: Cryopreservation of brain mitochondria preserves active
bioenergetics. Although cryopreserved brain mitochondria remain well-coupled
demonstrated by their RCR, they do demonstrate a significant loss of
bioenergetics compared to freshly isolated mitochondria or DMSO washed
mitochondria. However, this loss of electron transport system (ETS) function was
also significant in DMSO washed mitochondria in States III A, III B, V and VI
compared to freshly isolated mitochondria. Between the cryopreserved
mitochondria, the loss in bioenergetics is markedly higher in the crude
cryopreserved

mitochondria

compared

to

the

purified

mitochondria

cryopreserved with DMSO. Data represent group means ± SD; n = 3 per group
except for Fresh + DMSO + Wash (n = 2). One-Way ANOVA; Student-NewmanKeuls post-hoc test; # indicates p < 0.05 compared to fresh mitochondria; *
indicates p < 0.05 compared to DMSO washed fresh mitochondria.
Measurement

DF

F – value

P – value

Power

Pyr/Mal

3

14.722

0.0021

0.992

ADP 1

3

13.658

0.0026

0.987

ADP 2

3

19.374

0.0009

0.999

Oligo

3

14.233

0.0023

0.990

FCCP

3

22.955

0.0005

1.000

Succ

3

18.626

0.0010

0.998
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Figure 2.4: Cryopreservation of brain mitochondria preserves
active bioenergetics.
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Figure 2.5: Loss of Cytochrome c in mitochondria upon cryopreservation.
Mitochondrial samples were collected after respiration studies and used to
assess Cytochrome c levels using ELISA. It demonstrated a significant loss of
Cytochrome c in both the fresh mitochondria washed with DMSO and crude- or
purified-cryopreserved

mitochondria

compared

to

freshly

isolated

brain

mitochondria. However, mitochondria frozen without DMSO have significantly
lower amounts of Cytochrome c compared to crude- or purified-cryopreserved as
well as fresh mitochondria and those washed with DMSO. Data represent group
means ± SD; n = 3 per group except for Fresh + DMSO + Wash (n = 2) and
Frozen (n = 2). One-Way ANOVA; Student-Newman-Keuls post-hoc test; #
indicates p < 0.05 compared to fresh mitochondria; * indicates p < 0.05
compared to DMSO washed fresh mitochondria; @ indicates p < 0.05 compared
to purified-cryopreserved mitochondria.
Measurement

DF

F – value

P – value

Power

Cytochrome c

4

22.810

0.0002

1.000
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Figure 2.5: Loss of Cytochrome c in mitochondria upon cryopreservation.
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Figure 2.6: Outer and inner mitochondrial membrane marker protein
levels are maintained upon cryopreservation. Aliquots of mitochondrial
samples collected from respiration studies were used for Western blot analysis
using a monoclonal antibody (1:20,000) against Cytochrome c oxidase (COX IV)
and a polyclonal antibody against (1:10,000) against Voltage dependent anion
channel (VDAC). Representative Western blots demonstrated no significant
differences in COX IV (inner membrane marker) or VDAC (outer membrane
marker) protein levels between fresh and cryopreserved brain mitochondria
indicating that both membranes are intact.
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Figure 2.6: Outer and inner mitochondrial membrane marker protein
levels are maintained upon cryopreservation.
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Discussion
In the present study, we show that DMSO (10% v/v) can be used for
successful cryopreservation of brain mitochondria. Reanimated mitochondria
exhibited preserved bioenergetics as well as intact structure. There was a
reduction in Cytochrome c levels with the addition of DMSO alone which further
decreased upon cryopreservation. This observation could help explain, the
reduction in respiratory activity of cryopreserved mitochondria. It is not however
due to rupture of mitochondrial membranes as evident both at the EM level and
retention of mitochondrial membrane marker proteins upon cryopreservation.
DMSO has been initially reported to cryoprotect bull spermatozoa and
human and bovine red blood cells (Lovelock and Bishop 1959) and used for
cryopreservation of several other cell types. It is an oxidized thioether with a
chemical formula of (CH3)2SO, thus making it water-soluble whereas its further
oxidized form called as dimethyl sulfone does not exhibit any cryoprotective
properties. Permeable CPAs like DMSO are highly hydrophilic and act by binding
to intracellular water preventing excessive dehydration, reducing salt toxicity and
thereby preventing formation of ice crystals inside the cell or in this case of
isolated mitochondria. DMSO is also shown to possess hydroxyl radical
scavenging capacity thus acting as an anti-oxidant (Santos et al. 2003).
One of the first reports of cryopreservation of mitochondria using DMSO
appeared in the 1960’s. It has been shown that DMSO and glycerol prevented
decreases in respiration and oxidative phosphorylation in frozen rat liver
mitochondria (Greiff and Myers 1961; Greiff et al. 1961) which was later
confirmed by various groups (Lusena 1965; Lusena and Dass 1966; Dickinson et
al. 1967; Fishbein and Griffin 1976). DMSO was shown to be more convenient
for usage owing to its less viscosity and rapid penetration compared to glycerol.
Mitochondria isolated from rat liver homogenates that had been frozen for
months retained their energy-linked functions, even though DMSO by itself
lowered the respiratory control ratio (Fleischer 1979; Fuller et al. 1989; De
Loecker et al. 1991; Kuznetsov et al. 2003). Cryopreservation was also
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successfully applied to primary rat hippocampal neurons (Mattson and Kater
1988), rat brain synaptosomes (Begley et al. 1998), rat cardiac and skeletal
muscles and human biopsy samples (Kuznetsov et al. 2003). Begley et al. (1998)
have shown that glucose and glutamate transport activities, mitochondrial
transmembrane potential and electron transport systems maintained in
cryopreserved synaptosomes were identical to freshly isolated synaptosomes
and also can be successfully applied to human post-mortem brain tissues. These
data indirectly provide evidence that mitochondria present in the neurons and
synaptosomes were also preserved and functional.
Taking these studies into account, we decided to test whether DMSO
could act as an effective CPA when added to rat cortical mitochondria. Our
results support that DMSO (10% v/v) can be successfully used to cryopreserve
brain mitochondria. Our lab previously demonstrated that there are no significant
differences in RCR or marker proteins (COX and VDAC) in mitochondria
prepared either by nitrogen-cell disruption or digitonin (Brown, Sullivan et al.
2004).

In this study, we employed 0.01% digitonin to rupture the

synaptoneurosomes which were further separated by discontinuous percoll
gradient centrifugation to yield total (synaptic and non-synaptic pools of)
mitochondria.

These

mitochondria

were

robust

and

well-coupled

as

demonstrated by their RCR. The current findings also demonstrate that freezing
mitochondria without DMSO destroys their structural integrity and functional
viability. Infact, freeze-thaw procedure is routinely employed to disrupt
mitochondria and obtain sub-mitochondrial fractions. However, significantly
higher cytochrome c levels are maintained in mitochondria cryopreserved with
addition of DMSO as evident by respiration measurements. This suggests that
the freeze-thaw procedures do disrupt mitochondrial membranes and that DMSO
prevents most but not all damage. Infact, we did not observe any significant loss
of mitochondrial membrane marker proteins (COX and VDAC) which indicates
that the membranes are not ruptured and are intact, that was also evident by
electron microscopy.
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Clayton’s group (2005) have shown that the release of cytochrome c is
mediated, in part, by mitochondrial outer membrane components such as Bak
and VDAC forming pores rather than by non-specific rupture or by Bax and
VDAC (Brustovetsky et al. 2003). This further supports our data that cytochrome
c release is due to increased leakiness of the mitochondrial outer membrane and
not due to its rupture per se. One possible explanation for this observation is that
cytochrome c is a low molecular weight (12kD) protein that is present in the intermembrane space loosely bound to the mitochondrial inner membrane.
We observed a DMSO effect on the RCR and respiratory states between
fresh non-cryopreserved mitochondria and the mitochondria that were incubated
with 10% DMSO that was washed out immediately. This loss in activity could
possibly be due to exchange of DMSO and water across the membranes and in
the process causing leaking of cytochrome c as well. The loss of cytochrome c is
further exacerbated upon cryopreservation. However, addition of DMSO retained
significantly higher levels of cytochrome c in cryopreserved mitochondria
compared to those frozen without DMSO indicating that it is indeed
cryoprotective.
Kuznetsov’s group (2003) have done a comparative analysis of the
cryopreservative properties of glycerol and DMSO using mitochondria from
permeabilized human skeletal muscles and concluded that DMSO was clearly
more effective than glycerol with a better preservation obtained at concentrations
between 20 to 50% with an optimal around 30%. They also observed that
cryopreserved mitochondria demonstrated functional integrity, normal ATP
production and energy transfer as well as structural intactness of outer
mitochondrial membranes. This is in contrast to our findings that 10% DMSO
causes a reduction of mitochondrial bioenergetics in part due to loss of
cytochrome c.
We observed no obvious differences in the ultra-structures between the
crude cryopreserved mitochondria and the percoll-purified cryopreserved
mitochondria. Both the crude mitochondria cryopreserved with DMSO and the
percoll-purified mitochondria cryopreserved with DMSO showed similar RCR

72

(>5). This suggests that the stage of cryopreservation of mitochondria (crude or
purified) is not critical. Furthermore, we observed similar levels of cytochrome c
and membrane marker proteins (COX and VDAC) in both the groups
(Unpublished Data). This would give an opportunity to bank the crude
mitochondria and reanimate and purify them at a later time for functional studies.
In summary, we report here for the first time, a practical and novel method
for cryopreservation of brain mitochondria. The use of this methodology to retain
the functional viability of cryopreserved mitochondria allows the banking of CNS
mitochondria

for

comparative

studies

or

studies

to

geographically isolated laboratories.
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be

performed

in

Chapter Three

Analysis of Mitochondrial Function in Post-mortem Brains of
Alzheimer’s (AD) and Control Patients

Introduction
Alzheimer’s disease (AD) is a neurodegenerative condition marked by
progressive loss of cognitive function and memory that currently affects 4 million
Americans. Age is the major risk factor predisposing individuals over 65 years, in
an exponential manner, to AD. Over 90-95% of AD incidences are sporadic while
the rest are familial cases. Loss of synapses, deposition of extra-cellular plaques
composed of β-Amyloid (Aβ) and intracellular accumulation of neurofibrillary
tangles consisting mostly of tau protein polymers are hallmarks in both forms of
AD pathology (Markesbery 1997; Mattson 2004; Harman 2006).
AD associated dementia is invariably accompanied by reductions in
cerebral metabolic rate for glucose and cerebral blood flow, as measured in vivo
by positron emission tomography (PET) and functional magnetic resonance
imaging (fMRI) (Farkas and Luiten 2001). They precede neuroanatomic evidence
for the disease, such as increased expression of amyloid precursor protein
(APP), cytoskeletal abnormalities, synaptic dysfunction and selective loss of
neurons, and neuropsychological symptoms (Blass 2001).
Frontal, parietal and temporal cortices and hippocampus are some of the
brain regions more vulnerable to such damage, whereas primary sensory cortex
and cerebellum are not affected in AD (Scheff and Price 2003). Although altered
metal ion homeostasis, aberrant protein accumulation and inflammation are
shown to be involved, mechanisms implicated in aging, namely calcium
dysregulation (LaFerla 2002), oxidative damage such as increased DNA
oxidation, protein oxidation or nitration and lipid peroxidation (Markesbery 1997;
Floyd and Hensley 2002; Perry et al. 2002; Butterfield et al. 2006; Moreira et al.
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2006), are naturally extended and, in combination with impaired proteasome
activity (Keller et al. 2000; Sullivan et al. 2004) and cell death by apoptosis
(Mattson 2006), are shown to play an increasingly important role in the
pathophysiology of AD (Mattson 2004).
Mitochondrial dysfunction is considered to play a major role in the altered
metabolism observed with AD (Beal 2005; Sullivan 2005; Sullivan and Brown
2005; Parihar and Brewer 2007). This includes increased mtDNA mutations
(Wallace 2005) and oxidation (Reddy and Beal 2005) and changes in mtDNA
content (Hirai et al. 2001). Moreover, changes in the gene expression of ETC
complexes (Manczak et al. 2004) were accompanied by decreases in activities of
key mitochondrial enzymes (Gibson et al. 1998). Lastly, specific mitochondrial
proteins are also shown to undergo oxidation and/or nitration (Sultana et al.
2006; Sultana et al. 2006).
Although several lines of evidence have implicated a role for mitochondrial
dysfunction in AD none of the studies have directly assessed mitochondrial
homeostasis. Studies that have assessed mitochondrial enzyme activities have
been hindered by inconsistent results or called into question due to long (some
greater than 24 hrs) postmortem intervals of the tissue (Sims 1996). The present
study assessed region-specific alterations in mitochondrial homeostasis under
tightly controlled conditions and a post-mortem interval (PMI) of less than 4
hours. We successfully employed the mitochondrial cryopreservation method
described in Chapter 2 (Nukala et al. 2006). Synaptic and non-synaptic
mitochondria were isolated from 3 regions of brain which are differentially
affected in Alzheimer’s disease. Mitochondria were used to measure respiration,
ROS/RNS generation and oxidative damage.
Our preliminary data shows that there is a decrease in the Respiratory
Control Ratios (RCR) in synaptic mitochondria isolated from AD patients
compared with Control group. The respiration measured as maximum Complex I
activity also decreased across all the regions in AD patients compared to
Controls. While we did not notice changes in the ROS/RNS levels across the
regions or between AD and Controls, we observed an increase in the levels of
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protein carbonyls in all regions and across groups of AD patients. Taken together
these data do suggest a role for oxidative stress and mitochondrial dysfunction in
AD pathology.

Materials and Methods

Reagents:
Mannitol, sucrose, bovine serum albumin (BSA), ethylene glycol-bis(2aminoethylether)-N,N,N',N'-tetraacetic acid (EGTA), hydroxyethyl piperazine-1ethanesulfonic acid potassium salt (HEPES), potassium phosphate monobasic
anhydrous (KH2PO4), magnesium chloride (MgCl2), potassium chloride (KCl),
malate, pyruvate, adenosine 5’-diphosphate (ADP), digitonin, succinate and
dimethyl sulfoxide (DMSO) were purchased from Sigma-Aldrich (St. Louis, MO,
USA). Oligomycin A and carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone
(FCCP) were purchased from Biomol (Plymouth Meeting, PA). Dihydrodichloro
fluorescein diacetate (H2DCF-DA) was obtained from Molecular Probes (Eugene,
OR) and bicinchoninic acid (BCA) protein assay kit was purchased from Pierce
(Rockford, IL).

Brain Autopsy Samples from AD and Control Patients:
The graduate student was on-call to collect brain tissue samples from
Alzheimer’s patients (n=4; PMI ≈ 3.125hrs) and age-matched controls (n=2; PMI
≈ 2.5hrs) enrolled and longitudinally followed by the Sanders-Brown Center on
Aging Alzheimer’s Disease Research Center (ADRC). Dr. William Markesbery,
Director of Neuropathology Core, led the Rapid Autopsy Team to perform short
postmortem interval (PMI) autopsies using a standardized protocol on
longitudinally followed patients with AD and other age-related dementing
disorders and cognitively normal aged, longitudinally followed, control subjects.
Dr. David Wekstein, Director of Education and Information Core, chief contact
person along with Dr. James Geddes and Dr. Steve Scheff were available at the
autopsies.
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Table 3.1: Brain Autopsy Samples from AD and Control Patients

Case #

Group

Sex (M/F)

Age (yrs) PMI (hrs)

1094

Control

Male

70

3.0

1097

Control

Female

89

1.75

1086

AD

Female

90

2.75

1090

AD

Female

84

1.75

1096

AD

Male

84

4.5

1101

AD

Female

86

3.25

Isolation and Purification of Brain Mitochondria:
This protocol contains modifications of previously described procedures
(Brown et al. 2004; Brown et al. 2006; Nukala et al. 2006). All procedures were
performed on ice throughout the protocol. A 1-2 cm punch of tissue from frontal
(F) cortex, middle temporal (MT) gyrus and sensory (S) cortex were collected at
autopsy, minced and placed into a large manual glass dounce homogenizer
containing 15 ml of ice-cold isolation buffer with EGTA and protease-inhibitor
cocktail (215 mM mannitol, 75 mM sucrose, 0.1% BSA, 1 mM EGTA, 20 mM
HEPES, pH adjusted to 7.2 with KOH). The tissue was homogenized and
mitochondria were isolated by differential centrifugation. The homogenate is
transferred to 50ml conical tubes (total volume of 35-40mls) and centrifuged at
1300 x g for 5 min @ 4ºC using Eppendorf 5810-R table-top centrifuge. The
resulting supernatant transferred to fresh tubes to a total volume of 35-40mls.
The pellet is resuspended in the buffer again and centrifuged at 1300 x g for 5
min @ 4ºC as above and the resulting supernatant transferred is to fresh tubes.
The supernatants from these two spins are centrifuged at 13,000 x g for 10 min
@ 4ºC. The supernatant was discarded and the resulting pellet was resuspended
in 1-2mls of isolation buffer with EGTA. At this point, 10% (v/v) DMSO was added
to the mitochondria, and were cryopreserved as described in chapter 1 (Nukala
et al. 2006).
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Upon reanimation, the samples were further purified by percoll density
gradient centrifugation. Stocks of 40%, 26% and 24% percoll were prepared
fresh in isolation buffer with EGTA. 3.5 ml of 26% stock was carefully layered
over 3.5 ml of 40% in 13 ml ultra-clear tubes. Equal volume of 24% percoll was
added to the sample to get a 12% final concentration and loaded gently on top of
the 26% layer. The sample was centrifuged in fixed angle type 50.2 Ti rotor at
32,000 x g for 10 min at 4ºC in Optima L-90K ultracentrifuge (Beckman Coulter).
Non-synaptic mitochondria are collected as Fraction 3 formed at the interphase
of 40% and 26% layers and was carefully removed and placed in fresh ultra-clear
tubes. The synaptoneurosomes as Fraction 2 at the interphase of 26% and 24%
are carefully removed. The synaptoneurosomal mitochondria are then released
by use of a nitrogen cell bomb to avoid the conflicts of detergent based methods
of synaptoneurosome rupture. The tubes were topped off with isolation buffer
with EGTA and centrifuged in type 50.2 Ti fixed angle rotor at 16,700 x g for 10
min at 4ºC in Optima L-90K ultracentrifuge (Beckman Coulter). The supernatants
were carefully removed and the loose pellets at the bottom were transferred to
microcentrifuge tubes. The tubes were topped off with isolation buffer without
EGTA (215mM mannitol, 75mM sucrose, 0.1% BSA, 20mM HEPES and pH is
adjusted to 7.2 with KOH) and centrifuged at 10,000 x g for 10 min at 4ºC. The
final mitochondrial pellet was resuspended in isolation buffer without EGTA to
yield a concentration of ~ 10mg/ml. This method yields synaptic and non-synaptic
mitochondria from each region of interest. The protein concentration was
determined using the BCA protein assay kit measuring absorbance at 562 nm
with a BioTek Synergy HT plate reader (Winooski, Vermont).

Respiration Studies:
The respiratory activity of isolated mitochondria was measured using a
Clark-type oxygen electrode (Hansatech Instruments, Norfolk, England) as
previously described (Brown et al. 2004; Nukala et al. 2006). Mitochondria were
suspended in a sealed, constantly stirred, and thermostatically-controlled
chamber at 37ºC in respiration buffer (215 mM Mannitol, 75 mM Sucrose, 2mM
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MgCl2, 2.5mM KH2PO4, 0.1% BSA, 20mM HEPES at pH 7.2). The rate of oxygen
consumption was calculated based on the slope of the response of isolated
mitochondria to oxidative substrates, 5mM pyruvate and 2.5mM malate; 150µM
ADP; 2µM oligomycin; 2µM FCCP; and finally 10mM succinate.

Fluorescent Spectrometry to Measure Mitochondrial ROS/RNS Generation:
Mitochondrial

ROS/RNS

production

was

measured

using

10µM

dihydrodichloro fluorescein diacetate (H2DCF-DA) obtained from Molecular
Probes (Eugene, OR) with Ex: 485nm and Em: 530nm in presence of 25U/ml
HRP in the Biotek Synergy HT plate reader as previously described (Brown et al.
2006). Isolated mitochondria (100ug) were added to 100 µl of respiration buffer
(see above) with 5 mM pyruvate and 2.5 mM malate as oxidative substrates and
incubated at 37ºC. ROS production was calculated as the rate of dichloro
fluorescein (DCF) fluorescence over 15min of incubation, expressed in arbitrary
fluorescence units.

Western Blotting:
For determination of protein carbonyls, the OxyBlot Protein Oxidation
Detection Kit (Chemicon) was used according to manufacturer’s specifications.
Each sample (20ug) was loaded onto SDS-PAGE 12% gels and ran at 100volts
for

about

1.5hrs

at

room

temperature

following

which

they

were

electrophoretically transferred onto nitrocellulose membranes over 1hr at 4ºC.
The membranes were blocked in 5% non-fat milk in TTBS for 1hr. The
membranes were then incubated with polyclonal antibody against dinitrophenyl
hydrazone (DNP) at 1:1000 overnight with agitation at 4ºC. The membranes were
washed with TTBS three times and incubated with the secondary Goat-α-Rabbit
antibody for 2hrs. The membranes were washed three times with TTBS and
incubated with the ECL reagent (GE Healthcare) and the film was developed in a
dark room.
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Statistical Analysis:
All results are expressed as means ± SD. For statistical evaluation,
Student’s t-test was performed. Significance was set at p < 0.05 for all analyses.

Results:

Mitochondrial RCR in AD and Control Patients:
To assess the extent of mitochondrial dysfunction in Alzheimer’s disease
(AD), we carried out respiration studies directly in synaptic mitochondria isolated
from various regions of post-mortem brains from AD and control patients. The
respiratory control ratio, described as State III/State IV and expressed as
average of all the regions, is lower (~ 60%) in brain samples from AD patients
(RCR = 2.69 ± 0.68) compared to Control group (RCR = 6.4 ± 2.97), approaching
significance (p = 0.0551) (Figure 3.1).

Mitochondrial Maximum Complex I Activity in AD and Control Patients:
We analyzed the maximum Complex I activity in synaptic mitochondria
(defined as the respiration induced by FCCP in presence of Complex I
substrates) and observed that it is lower in the entire three – mid-temporal (MT),
frontal (F) and sensory (S) regions of AD patients compared to control patients.
The differences were most prominent, approaching significance (p = 0.0669),
between the frontal region (~ 75%) of AD and Control patients. The activity was
lower by ~ 50% in MT and ~ 70% in S regions of AD compared to those of
Control patients but not significant.

Mitochondrial ROS/RNS Generation in AD and Control Patients:
We did not observe any changes in ROS/RNS levels in synaptic
mitochondria from any of the regions between AD and Control patients. However,
within AD, middle-temporal (MT) seems to have a higher ROS/RNS generation
compared to frontal (F) and sensory (S) regions.

80

Mitochondrial Oxidative Damage in AD and Control Patients:
Finally, we measured levels of protein carbonyls, using western blots, as a
measure of the extent of protein oxidation in both synaptic and non-synaptic
mitochondria. The synaptic mitochondria show increased protein carbonyls in AD
patients compared to synaptic mitochondria of Control group. Further, the nonsynaptic mitochondria of AD patients tend to show increased protein carbonyls
across all regions compared to non-synaptic mitochondria of Control group.
Lastly, we also observed increased protein carbonyls in non-synaptic
mitochondria compared to synaptic mitochondria across all regions within AD
and Controls. Overall, there is higher oxidative damage in mitochondria from AD
patients compared to Control group.
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Figure 3.1: Mitochondrial RCR decreased in AD patients. Mitochondrial
respiration was carried out at 37ºC by incubating mitochondria in respiration
buffer and oxygen consumption of mitochondria was measured in response to
addition of various substrates and inhibitors. The respiratory control ratio (RCR),
measured as State III (presence of ADP) over State IV (presence of Oligomycin)
respiration, is lower, approaching significance (p = 0.0551) , in mitochondria from
AD patients compared to Control group. Data represent group means ± SD; n = 4
per AD group and n = 2 per Control group; Student’s t-test.
Measurement

DF

t – value

P – value

RCR

4

- 2.682

0.0551
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Figure 3.1: Mitochondrial RCR decreases in AD patients.
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Figure 3.2: Mitochondrial maximum Complex I activity decreased in AD
patients. The maximum Complex I activity, defined as the FCCP induced
respiration in presence of Complex I substrates (pyruvate and malate) is lower in
middle-temporal (MTs), frontal (Fs) and sensory (Ss) regions of synaptic
mitochondria from AD compared to Control group. However, the differences are
not significant in any of the regions assessed. Data represent group means ± SD;
n = 4 per AD group and n = 2 per Control group; Student’s t-test.
Measurement

DF

t – value

P – value

Mid-temporal (MT)

4

- 2.044

0.1105

Frontal (F)

4

- 2.499

0.0669

Sensory (S)

3

- 1.666

0.1944
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Figure 3.2: Mitochondrial maximum Complex I activity decreased in
AD patients.
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Figure 3.3: No changes in mitochondrial ROS/RNS levels in AD and Control
patients. Mitochondria were incubated in respiration buffer at 37ºC containing 5
mM pyruvate and 2.5 mM malate as oxidative substrates and the reaction was
carried out for 15min. There were no changes in DCF fluorescence (Ex: 485nm;
Em: 530nm), as a measure of free radical production, in middle-temporal (MTs),
frontal (Fs) and sensory (Ss) regions of synaptic mitochondria from AD compared
to Control group. Data represent group means ± SD; n = 4 per AD group and n =
2 per Control group; Student’s t-test.
Measurement

DF

t – value

P – value

Mid-temporal (MT)

4

0.635

0.5602

Frontal (F)

3

-

-

Sensory (S)

3

- 1.173

0.3255
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Figure 3.3: No changes in mitochondrial ROS/RNS levels in AD and Control
patients.
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Figure 3.4: Mitochondrial oxidative damage is higher in AD patients. A
OxyBlot Protein Oxidation Detection Kit was used in combination with western
blots. The levels of protein carbonyls were probed using an antibody against
DNP moieties (1:1000) of oxidized proteins. They were found to be higher in both
synaptic and non-synaptic mitochondria across all regions of AD patients
compared to Controls. Moreover, the protein carbonyls were higher in nonsynaptic [Mid-Temporal (MT), Frontal (F) and Sensory (S)] mitochondria
compared to synaptic [Mid-Temporal (MTs), Frontal (Fs) and Sensory (Ss)]
mitochondria across all regions within AD and Controls. n = 4 per AD group and
n = 2 per Control group.
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Figure 3.4: Mitochondrial oxidative damage is higher in AD patients.
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Discussion:
In the present study, we carried out experiments directly on mitochondria
isolated from various regions of post-mortem brains and show mitochondrial
dysfunction in AD patients compared to age-matched Control group. We were
able to successfully use cryopreserved mitochondria as described in Chapter 1.
We observed lower respiratory control ratio (RCR) as well as decreases in the
maximum Complex I activity in synaptic mitochondria from middle-temporal (MT),
frontal (F) and sensory (S) regions of AD brains. While we did not observe any
changes in mitochondrial ROS/RNS levels in any of the groups, we were able to
detect increased oxidative damage in AD mitochondria compared to Controls.
Most of the studies involving mitochondria in AD were performed on
mitochondria isolated from biopsy samples or post-mortem brains (Sims 1996).
This resulted in data where no changes were observed with biopsy tissue or data
with highly variable results due to the differences in the post-mortem intervals
(PMI). We had the distinct advantage of having the graduate student available on
an on-call basis to obtain brain samples from the University of Kentucky
Alzheimer’s Disease Research Center (ADRC) with a post-mortem interval of
under 4hours. This eliminates some of the variability observed and helps achieve
more consistent data (Hynd et al. 2003).
Mitochondria can be cryopreserved using dimethyl sulfoxide (DMSO) and
can be retrieved with preserved structure and function (Nukala et al. 2006). We
employed this technique to cryopreserve mitochondria obtained from postmortem samples from AD and Control brains. We were able to rapidly isolate
mitochondria after collecting the brain samples within a couple of hours from the
time of death. This is the first such study that enables laboratories to bank
valuable post-mortem samples as well as conduct functional studies directly on
mitochondria from such tissues.
Mitochondrial dysfunction and the resulting altered metabolism is
implicated in both aging and Alzheimer’s disease (Beal 2005; Sullivan and Brown
2005; Parihar and Brewer 2007). There are increased mitochondrial DNA
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(mtDNA) mutations in AD brains, in the form of point mutations (Lin et al. 2002)
or rearrangements preferentially in the transcription and replication regulatory
elements of mtDNA, with the inevitable consequence of defective ETC
complexes (Wallace 2005). This is also evident from altered mRNA expression in
NADH dehydrogenase and ATP Synthase, down-regulation of expression of
Complex I and up-regulation of Complex III and IV subunits (Manczak et al.
2004). Moreover, mtDNA had higher oxidized bases in the frontal, parietal and
temporal lobes of AD brains and was 10-fold higher than nuclear DNA (nDNA) in
the same tissues (Hirai et al. 2001; Wang et al. 2005). Lastly, significant
decreases of mitochondria in selective neuronal cell populations were observed
with AD. This was accompanied by increased mtDNA and protein content mainly
in autophagic vacuoles and the cytoplasm (Hirai et al. 2001).
In addition, reductions in key enzymatic activities were observed in
mitochondria of AD patients (Gibson et al. 1998). Specifically, pyruvate
dehydrogenase complex (PDHC), α-ketoglutarate dehydrogenase complex
(KGDHC) and cytochrome c oxidase (COX) show decreased activity in the
regions affected in AD. PDHC catalyzes the conversion of pyruvate from
glycolysis to acetyl-CoA that enters the Kreb’s cycle. Interestingly, pyruvate
dehydrogenase (PDHC) and α-ketoglutarate dehydrogenase complex (KGDHC)
are two of the three mitochondrial dehydrogenases that are activated by calcium
(Gunter et al. 2004). KGDHC converts α-ketoglutarate to succinyl-CoA within
Kreb’s cycle. Alternately, KGDHC can also convert α-ketoglutarate to glutamic
acid involved with glutamate metabolism. COX, on the other hand, is the last
electron acceptor and donator in the ETC where, oxygen is reduced to water.
Inhibition or decrease in activity of any the above enzymes would limit the
substrate availability to the ETC and therefore reduce ATP generation (Blass
2000).
Based on above observations, we assessed mitochondrial respiration
directly

by

measuring

mitochondrial

oxygen

consumption

in

synaptic

mitochondria. We observed a decrease in the respiratory control ratio (RCR) in
AD patients of about ~ 45% of the age-matched control group (Figure 3.1). This
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supports a previous report by Sims. et al., where they have observed a similar
decrease in RCR (~ 60% of controls) in brain homogenates from regions affected
in AD patients (Sims et al. 1987). In the same study, they did not observe
changes in the maximal respiratory rate (in presence of an uncoupling agent)
between AD and control subjects. In contrast, our data shows a marked
decrease in the maximal respiration activity (induced by Complex I substrate) in
presence of FCCP (Figure 3.2) in mitochondria of AD subjects. The discrepancy
could possibly be due to the source of the mitochondria i.e. brain homogenates in
the former versus purified mitochondria in the present study (Sims 1996).
Moreover, the decreases were observed in all the three regions assessed, with
most pronounced decreases in the frontal cortex.
β-Amyloid (Aβ) is one of the mechanisms shown to increase oxidative
stress in the mitochondria (Canevari et al. 2004; Caspersen et al. 2005; Reddy
2006). In fact, both Aβ and its precursor protein APP are shown to be capable of
entering mitochondria. Aβ can interact with pyruvate dehydrogenase complex
(PDHC) and also inhibit Complexes III and IV of the ETC thus inhibiting
mitochondrial respiration. It is also shown to lower mitochondrial membrane
potential and ATP levels and increase free radicals. These free radicals in turn
can activate secretases that can cleave APP into Aβ. Furthermore, Aβ is also
shown to cause release of cytochrome c and caspase activation in functional
mitochondria. Another source of mitochondrial superoxide, besides the ETC, is
the KGDHC (Markesbery 1997; Perry et al. 2002; Starkov et al. 2004; Moreira et
al. 2006) that also interacts with Aβ. All the above reasons make mitochondria a
prime breeding ground for oxidative stress and damage leading to their
dysfunction as seen with AD.
We therefore carried out experiments to measure the free radical
generation in synaptic mitochondria from AD and control subjects. We did not
detect any differences in ROS/RNS levels in any of the regions from either group
(Figure 3.3). This could be due to the fact that these studies were carried out in
post-mortem tissues and might have missed out on the window to detect such
changes. Moreover, such tissues might have altered antioxidant enzyme
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activities or increased scavenging activity for which there are no consistent
reports. Alternately, Aβ-induced free radical generation may not be a major
pathway for the observed oxidative stress. Therefore, a more reliable indicator
would be to measure the markers of oxidative damage as seen with numerous
published studies (Markesbery 1997; Perry et al. 2002; Moreira et al. 2006). We
measured changes in protein carbonyls as a marker for protein oxidation,
although it detects protein-lipid peroxidation adducts as well (Sultana et al. 2006).
They were higher in both synaptic and non-synaptic mitochondria across all
regions of AD patients compared to Controls. Moreover, the protein carbonyls
were higher in non-synaptic mitochondria compared to synaptic mitochondria
across all regions within AD and Controls. These differences could be due to the
variable properties of neuronal (synaptic) and non-neuronal mitochondria (Park
et al. 2001; Brown et al. 2004; Vergun and Reynolds 2005; Brown et al. 2006;
Chang and Reynolds 2006).
In fact our lab (Brown et al. 2004; Brown et al. 2006) and others (Park et
al. 2001; Vergun and Reynolds 2005) have shown that the different sets of
mitochondria respond differently in undergoing mitochondrial membrane
permeability transition (MPT) to similar calcium loads. In addition, Butterfield’s
group, using redox proteomics, has shown that key mitochondrial proteins such
as VDAC and ATP Synthase α-chain undergo protein oxidation as well as
nitration (Sultana et al. 2006; Sultana et al. 2006). Lastly, It is well known that
cytochrome c oxidase (COX) is reversibly inhibited by nitric oxide at low
concentrations and irreversibly at higher concentrations through peroxynitrite
(Brown and Borutaite 2002; Moncada and Bolanos 2006). This is possibly
induced through a calcium-activated nitric oxide synthase (mtNOS) localized to
the mitochondria (Giulivi et al. 2006; Cooper and Giulivi 2007). Based on
previous literature on calcium dysregulation, increases in free radicals and our
own data showing decreases in mitochondrial respiration and higher oxidative
damage, the existence of and role for a mitochondrial nitric oxide synthase
(mtNOS) requires further elucidation and therefore explored in the next chapter.
Copyright © Vidya Nag Nukala 2007
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Chapter Four

Relationship Between Calcium and Nitric Oxide Synthase in Brain
Mitochondrial Dysfunction

Introduction
Various reports can be found in recent literature on the existence of nitric
oxide synthase enzyme (mtNOS) localized to mitochondria (Bates et al. 1995;
Tatoyan and Giulivi 1998; Kanai et al. 2001; Lacza et al. 2001; Elfering et al.
2002; Riobo et al. 2002; Haynes et al. 2004). Evidence in rat liver mitochondria
indicates that mtNOS exhibited Ca2+–dependent increase in activity, which was
blocked by NOS inhibitors and might be involved in mitochondrial O2
consumption and membrane potential (Ghafourifar and Richter 1997). It has
been suggested that NOS present within the mitochondria could be the source of
NO• observed (Giulivi et al. 1998). Various groups have clearly established that
NO• inhibits cytochrome c oxidase in intact mitochondria reversibly by competing
with oxygen (Radi et al. 2002; Persichini et al. 2005). In vitro studies indicated
that peroxynitrite (ONOO-) is involved in release of Ca2+ thereby preserving
membrane potential (Bringold et al. 2000).
It was shown that uptake of Ca2+ by mitochondria stimulates mtNOS
causing release of cytochrome c involving ONOO-, suggesting that Ca2+ –
induced apoptosis is partly mediated via mtNOS (Ghafourifar et al. 1999). There
is ample evidence showing that NO• and its derivatives such as ONOO- are
involved in inhibition of respiration at the level of ETC as well as alter other
mitochondrial proteins (Brown and Borutaite 2002; Radi et al. 2002; Elfering et al.
2004; Traaseth et al. 2004). Peroxynitrite (ONOO-) is also capable of causing
lipid peroxidation (Violi et al. 1999) as well as DNA modification (Aust and
Eveleigh 1999). On the other hand, the type of NOS isoform in the mitochondria,
the availability of substrates and cofactors for the enzyme, Ca2+ dependency and
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it putative physiological function and pathological effects have been called into
question (French et al. 2001; Lacza et al. 2003; Brookes 2004; Gao et al. 2004;
Ghafourifar and Cadenas 2005; Lacza et al. 2006).
Several lines of evidence suggest that perturbations in intracellular Ca2+
homeostasis are involved in mitochondrial mediated apoptotic pathway.
However, the sequelae of events leading from mitochondrial Ca2+ overload to
RNS mediated damage in the mitochondria are still unclear. It can be postulated
that inactivation of key respiratory and anti-oxidant enzymes, lipid peroxidation
and DNA modifications by NO• and ONOO- could cause increased oxidative
stress, ATP depletion due to mitochondrial dysfunction and subsequent cell
death. The sources of NO• and its derivatives responsible for the observed
effects are not yet understood completely. In light of these findings and gaps
therein, we measured the effects of calcium on mitochondrial respiration, free
radical generation and oxidative damage markers, in addition to NOS activity and
NOS protein in purified mitochondria.
Our results confirm the presence of an active NOS enzyme inside the
mitochondria that is not due to cytosolic contamination. We also show that
calcium inhibits mitochondrial respiration in a dose- and time-dependent manner
as well as increases ROS/RNS levels, although either of those two parameters
was not reversed in presence of NOS inhibitors. There were detectable but not
significant changes in levels of oxidative damage markers with exposure to
patho-physiological doses of calcium. Taken together, our data suggests that
although calcium induces mitochondrial dysfunction the mechanism may not
entirely be via the mtNOS pathway.

Materials & Methods

Reagents:
Mannitol, sucrose, bovine serum albumin (BSA), ethylene glycol-bis(2aminoethylether)-N,N,N',N'-tetraacetic acid (EGTA), hydroxyethyl piperazine-1-
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ethanesulfonic acid potassium salt (HEPES), potassium phosphate monobasic
anhydrous (KH2PO4), magnesium chloride (MgCl2), malate, pyruvate, adenosine
5’-diphosphate (ADP), succinate, calcium chloride (CaCl2), L-Arginine (L-Arg),
potassium chloride (KCl), proteinase-K and horseradish peroxidase (HRP) were
purchased from Sigma-Aldrich (St. Louis, MO, USA). Dihydro dichlorofluorescin
diacetate

(H2DCF-DA),

tetramethylrhodamine

ethyl

ester

(TMRE)

were

purchased from Molecular Probes (Eugene, OR). Oligomycin A, rotenone and
carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone (FCCP) were purchased
from Biomol (Plymouth Meeting, PA). NG-Nitro-L-arginine (L-NNA) and NG-NitroL-arginine methyl ester, hydrochloride (L-NAME) were purchased from
Calbiochem (San Diego, CA). Bicinchoninic acid (BCA) protein assay kit was
purchased from Pierce (Rockford, IL).

Isolation and Purification of Brain Mitochondria:
All experimental protocols involving animals were approved by the
University of Kentucky Animal Use and Care Committee. This protocol contains
modifications of previously described procedures (Brown et al. 2004; Nukala et
al. 2006). All procedures were performed on ice throughout the protocol. Male
Sprague-Dawley rats (~250-300g) were decapitated and the brains were rapidly
removed. The cortices were dissected out and placed in an all-glass dounce
homogenizer containing five times the volume of isolation buffer with 1 mM
EGTA (215 mM mannitol, 75 mM sucrose, 0.1 % BSA, 20 mM HEPES, 1 mM
EGTA and pH is adjusted to 7.2 with KOH). The tissue was homogenized and
mitochondria were isolated by differential centrifugation. Briefly, the homogenate
was centrifuged at 1300 x g for 3 minutes twice in an eppendorf microcentrifuge
at 4ºC and the supernatant was transferred to new tubes. The resulting
supernatant was transferred to new microcentrifuge tubes and topped off with
isolation buffer with EGTA and centrifuged at 13,000 x g for 10 minutes. The
supernatant was discarded and the pellet was resuspended in 500 µL of isolation
buffer with EGTA. To obtain maximal yield of total (synaptic and non-synaptic)
mitochondria, synaptosomal membranes were disrupted by nitrogen cell
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disrupter incubated for 10 min at 1200psi. The sample was further purified by
percoll density gradient centrifugation. Stocks of 40%, 24% and 30% percoll were
prepared fresh in isolation buffer with EGTA. 3.5 ml of 24% stock was carefully
layered over 3.5 ml of 40% in 13 ml ultraclear tubes. Equal volume of 30%
percoll was added to the sample to get a 15% final concentration and loaded
gently on top of the 24% layer. The sample was centrifuged in fixed angle type
SE-12 rotor at 30,400 x g for 10 min at 4ºC in RC 5C Plus (Sorvall) high-speed
centrifuge. Fraction 3 containing total mitochondria formed at the interphase of
40% and 24% layers was carefully removed and placed in fresh ultraclear tubes.
The tubes were topped off with isolation buffer without EGTA (215 mM mannitol,
75 mM sucrose, 0.1 % BSA, 20 mM HEPES and pH is adjusted to 7.2 with KOH)
and centrifuged in fixed angle SE-12 rotor at 16,700 x g for 15 min at 4ºC in RC
5C Plus (Sorvall) high-speed centrifuge. The supernatants are carefully removed.
The tubes were topped off with isolation buffer without EGTA and centrifuged in
fixed angle SE-12 rotor at 13,000 x g for 10 min at 4ºC in RC 5C Plus (Sorvall)
high-speed centrifuge. The supernatants were carefully removed and the loose
pellets at the bottom were transferred to microcentrifuge tubes. The tubes were
topped off with isolation buffer without EGTA and centrifuged at 13,000 x g for 10
min at 4ºC. The supernatants were carefully removed and the pellets were
resuspended in 500 µL of isolation buffer without EGTA. The tubes were topped
off with isolation buffer without EGTA and centrifuged at 10,000 x g for 5 min at
4ºC to yield a tighter pellet. The final mitochondrial pellet was resuspended in
isolation buffer without EGTA to yield a concentration of ~ 10mg/ml. The protein
concentration was determined using the BCA protein assay kit measuring
absorbance at 562 nm with a BioTek Synergy HT plate reader (Winooski,
Vermont).

Electron Microscopy:
After the last 10,000 × g centrifugation, the mitochondrial pellets were
fixed in 4% glutaraldehyde overnight at 4ºC before being embedded for electron
microscopy. Next, the pellets were washed overnight at 4ºC in 0.1M sodium
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cacodylate buffer, followed by 1 hr secondary fixation at room temperature in 1%
osmium tetroxide. Then, the mitochondrial pellets were rinsed with distilled water
and dehydrated for 10 min each in 70%, 85%, 95%, twice in 100% ethanol and
twice in propylene oxide. The pellets were placed in a 1:1 mixture of propylene
oxide and Epon/Araldite resin and infiltrated overnight on a rotator. Next, 100%
Epon/Araldite resin was added and rotated for 1hr at room temperature. Finally
fresh resin was prepared and degassed using a vacuum chamber. The
mitochondrial pellets were added to the flat molds, filled with fresh resin, and
baked overnight at 60ºC. The 90 nm sections were cut using an RMC MT-7000
ultramicrotome mounted on 150 mesh copper grids and stained with uranyl
acetate and lead citrate. The sections were examined using a Zeiss 902 electron
microscope.

Respiration Studies:
The respiratory activity of isolated mitochondria was measured using a
Clark-type oxygen electrode (Hansatech Instruments, Norfolk, England) (Brown
et al. 2004; Nukala et al. 2006). 120-160 ug/mL of isolated mitochondria were
suspended in a sealed, constantly stirred, and thermostatically-controlled
chamber at 37ºC in respiration buffer (125 mM KCl, 2 mM MgCl2, 2.5 mM
KH2PO4, 0.1 % BSA, 20 mM HEPES at pH 7.2). The rate of oxygen consumption
was calculated based on the slope of the response of isolated mitochondria to
oxidative substrates in the order- 5 mM pyruvate and 2.5 mM malate; 150 µM
ADP; 2 µM of oligomycin; 2 µM FCCP; 1µM Rotenone and 10mM succinate.

Affinity Purification by 2’,5’-ADP-Sepharose Beads:
NADPH immobilized to 2’,5’-ADP-Sepharose beads (50ug; Amersham
Biosciences), with modifications (Lacza et al. 2003), were allowed to swell in
dH2O at 4ºC. They were centrifuged at 10,000 x g for 10 min and resuspended in
binding buffer consisting of 10mM phosphate (PO-4) buffer and 0.15M sodium
chloride (NaCl) in 3:1 ratio. Mitochondria (1mg/ml; 50-100ug) were incubated
with the beads in 1:1 ratio overnight with rocking at 4°C. The samples were
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centrifuged at 1300 x g for 5min. The pelleted beads were washed 3 times with
isolation buffer without EGTA and treated with sample buffer (containing SDS).
The supernatants were centrifuged at 10,000 x g for 10min twice and the
resulting pellet was processed for Western blots.

Proteinase-K Treatment:
Mitochondrial aliquots (100ug each at 1mg/ml concentration) were
incubated with and without Proteinase-K (50-200ug/ml final; Sigma) for 30
minutes at 4°C or 25°C (Gao et al. 2004) or alternately at 37°C.
Phenylmethylsulfonyl fluoride (PMSF; 1-2mM final; Roche) was added to the
aliquots to stop the reaction and incubated for 10 min at 4°C or 25°C or
alternately at 37°C. The samples were centrifuged at 10,000 x g for 10 min. The
pellets and supernatants were collected and processed for Western blots.

Western Blotting:
Western blots for nNOS, PSD-95 and VDAC were carried out as
described previously (Brown et al. 2004; Nukala et al. 2006). Briefly, the percollpurified mitochondria were diluted to 1ug/ul in isolation buffer without EGTA and
used for western blots.

Sample buffer was added to the samples based on

relative protein concentrations and boiled for 10min. Samples (5-20ug each)
were separated by SDS-PAGE 3-8% Tris-acetate gels (NuPage), along with
molecular weight markers (Multi-Marker, Invitrogen).

Following SDS-PAGE,

polypeptides were transferred electrophoretically onto 0.2 µm nitrocellulose
membranes. Membranes were incubated at room temperature for 1-2 hour in 5%
non-fat milk in 50 mM Tris-saline containing 0.05% Tween-20 at pH 7.5 (TTBS).
The blots were incubated overnight in the primary antibody in TTBS at room
temperature. The primary antibodies used in study included polyclonal neuronal
nitric oxide synthase (nNOS) at 1:250 donated by Dr.Tim Miller; monoclonal postsynaptic density 95 (PSD-95) at 1:20,000 from BD-Transduction; monoclonal
cytochrome c oxidase subunit IV (COX IV) at 1:20,000 from Molecular Probes
(Eugene, OR, USA); polyclonal extracellular signal-regulated protein kinase 1/2
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(Erk-1/2) at 1:1000 and polyclonal voltage-dependent anion channel (VDAC) at
1:10,000 from Affinity Bioreagents. After overnight incubation in primary antibody,
the membranes were rinsed three times in TTBS and incubated in secondary
antibody for 1-2 hours in either HRP-conjugated goat anti-mouse IgG (1:6000) for
PSD-95, or HRP-conjugated goat anti-rabbit IgG (1:3000) for nNOS and (1:6000)
for VDAC. The blots were rinsed thoroughly in TTBS and were developed using
Pierce SuperSignal West Pico chemi-luminescent substrate and analyzed using
Kodak Image-Station. Alternately, the nNOS and VDAC blots were incubated
with fluorescent secondary anti-body (Rockland) (goat-α-rabbit, 1:10,000 in
TTBS) or (1:5000) for Erk1/2 for 2hrs, with agitation, at room temperature. Blots
were rinsed with TTBS, dried, scanned and quantified using a Licor scanner and
Odyssey software.

NOS Activity (L-Arginine to L-Citrulline Conversion) Assay:
Briefly, increasing amounts of percoll-purified intact mitochondria were
added to each reaction (total volume of 500µl) in duplicates consisting of C14
cocktail mix (50mM HEPES, 10mM L-Arg, 40mM CaCl2, 50µM CaM, C14 L-Arg)
in presence of NADPH and BH4 (Bredt et al. 1990; Bredt and Snyder 1990; Miller
2002). Purified NOS is used as a positive control. The tubes are vortexed and
flash centrifuged and incubated at room temperature for 15min.The reaction is
stopped by adding STOP buffer (100mM HEPES; 1mM L-Cit; 10mM EDTA; pH
5.5) to each reaction. The tubes are vortexed and flash centrifuged and the
contents are transferred to columns. The columns were washed with 1ml of
distilled water twice. 10ul of cocktail mix is added to a BLANK vial. Approximately
8mls of ScintiSafe (Fisher SX25.5) scintillation liquid is added to each vial. The
vials are read using scintillation counter and activity calculated as percent of
control (no mitochondria).
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Fluorescent Spectrometry to Measure Mitochondrial ROS/RNS Generation
and Membrane Potential:
Mitochondrial ROS/RNS levels and membrane potential were measured
using Shimadzu spectrofluorophotometer (RF-5301) as described previously
(Brown et al. 2006). Mitochondria (100ug) were added to a thermostatically
controlled (37ºC), constantly stirred cuvette in a total volume of 2mls of 125mM
KCl buffer, containing 5mM pyruvate and 2.5mM malate, 150 µM ADP, 2 µM of
oligomycin, 1mM L-Arg, 10µM H2DCF-DA (Ex: 485nm, Em: 530nm), 150nM
TMRE (Ex: 550nm, Em: 575nm) and 25U/ml HRP. Each run was performed with
a baseline reading of buffer. Mitochondria, calcium and the substrates/inhibitors
were added as indicated. The slope of DCF fluorescence was quantified for the
respective conditions including baseline and expressed in arbitrary units.
Alternately, mitochondrial ROS production was measured using 10µM
H2DCF-DA (Ex: 485nm, Em: 530nm) and 25U/ml HRP in the Biotek Synergy HT
plate reader as previously described (Brown et al. 2006). Isolated mitochondria
(100ug) were added to 100 µl of 125mM KCl respiration buffer with 5 mM
pyruvate and 2.5 mM malate as oxidative substrates and incubated at 37ºC. ROS
production was calculated as the rate of DCF fluorescence over 15-30min of
incubation, expressed in arbitrary fluorescence units.

Slot-blots for Oxidative Markers:
Samples used for respiration were centrifuged for 5min @ 10,000g. Buffer
containing 0.1M PBS and protease inhibitor cocktail (Roche) was added to
samples, then diluted to 200ng/ml with the protease inhibitor cocktail in 0.1M
PBS. For oxidative damage determination, the OxyBlot Protein Oxidation
Detection Kit (Chemicon) was used according to manufacturer’s specifications.
Samples were loaded at 1ug/well onto the slot blot apparatus and transferred
onto 0.2µm thick nitrocellulose membrane under vacuum. The membranes were
blocked for 2hrs, with agitation, in 1% Casein/PBS at room temperature. Primary
antibodies were diluted in 0.1% casein/PBST and used as follows - rabbit-α-DNP
(Chemicon) at 1:1000, mouse-α-3NT (Upstate) at 1:2000, rabbit-α-HNE
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(Calbiochem) at 1:10,000. Blots were incubated in primary antibody overnight,
with agitation, at 4ºC. Blots were rinsed with PBST and incubated Goat-α-Mouse
(Jackson, for 3-NT) and Goat-α-Rabbit (Upstate; for HNE & DNP) for 2hrs, with
agitation, at room temperature. Blots were rinsed with PBST, dried, scanned and
quantified using a Bio-Rad scanner.

Statistical Analysis:
All results are expressed as means ± SD. For statistical evaluation, Oneway analysis of variance (ANOVA) was used to test for differences involving
multiple experimental groups or Student’s t test was employed for data analysis
involving only two groups. When required, Student-Newman-Keuls post-hoc test
was used for pair-wise comparisons among multiple groups. Significance was set
at p < 0.05 for all analyses.

Results

Characterization of Mitochondrial Preparations:
We initially characterized our mitochondrial isolation and purification
methodologies by analyzing the ultra-structure of mitochondria and probing for
mitochondrial markers. The electron-microscopy pictures indicate that the
preparations predominantly contain mitochondria (Figure 4.1A). Mitochondria
subjected to the rigorous percoll-purification maintained their structures, including
intact outer and inner mitochondrial membranes as well as cristae (Figure 4.1B &
4.1C). Mitochondrial marker proteins (VDAC and COX) were probed by western
blots in the various fractions obtained during the sequential purification steps
(Figure 4.2). We observed an enrichment of both outer (VDAC) and inner (COX)
membrane markers in the percoll purified fraction whereas they are markedly
lower in the synaptosomal fraction.
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Calcium and Mitochondrial Respiration:
To determine if calcium affects mitochondrial function, we measured
mitochondrial oxygen consumption using a Clark-type electrode and observed a
significant reduction of mitochondrial respiration (Figure 4.3). The reduction in
respiratory control ratio (RCR; State III/State IV) was calcium dose-dependent
(Figure 4.4). We then analyzed each of the substrate/inhibitor induced respiration
states. We observed that Complex I (pyruvate/malate as substrates) mediated
respiration was affected by calcium in a dose-dependent manner. We observed
higher oxygen consumption upon addition of calcium accompanied by a
reduction in State III respiration (in presence of ADP). However, State IV
respiration (in presence of Oligomycin- Complex V inhibitor) was not affected.
There was also a reduction in maximal oxygen consumption upon addition of the
uncoupler FCCP. There were no changes observed in the presence of Rotenone
(Complex I inhibitor) or Complex II mediated respiration (succinate as substrate)
(Figure 4.5). Lastly, we observed an incubation time-dependent effect of calcium
on the mitochondria in State III, State IV and State V respiration. Interestingly, we
again did not observe changes in succinate-driven respiration (Figure 4.6).

Mitochondria and NOS Protein:
To determine whether a nitric oxide Synthase (NOS) isoform was present
in the mitochondria, we probed for NOS using Western blots. We were able to
detect NOS protein in percoll-purified intact mitochondrial fraction using an
antibody directed against neuronal NOS (nNOS), while PSD-95 is present in the
synaptosomal but absent in the mitochondrial fraction (Figure 4.7). We were able
to detect increased intensity of NOS protein as a function of the antibody dilution
(Figure 4.8A). To rule out contamination by cytosolic NOS, we incubated
mitochondria with 2’,5’-ADP Sepharose beads, which binds to any extramitochondrial NOS, and were able to detect the protein in the mitochondrial
fraction (Figure 4.8B). Further, this protein band was detectable even after the
addition of Proteinase-K, which digests any protein bound to the outer
mitochondrial membrane, indicating that NOS has an intra-mitochondrial
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localization (Figure 4.9A). Lastly, Proteinase-K was able to digest Erk1/Erk2
(cytosolic marker) completely in presence of Triton-X, a detergent used to
permeabilize membranes (Figure 4.9B).

Mitochondria and NOS Activity:
Based on the data indicating the presence of NOS protein in the
mitochondria and to test the involvement of nitric oxide synthase (NOS) in
calcium-mediated

inhibition

of

mitochondrial

respiration,

we

conducted

experiments to determine NOS activity in mitochondria. We were able to
measure enzyme activity of NOS in percoll-purified intact mitochondria, as
detected by radiolabeled L-Arg to L-Cit conversion assay and observed an
increase in NOS activity dependent on the amount of mitochondrial protein
(Figure 4.10).

Calcium and Mitochondrial ROS/RNS Generation:
To determine if calcium could induce ROS/RNS generation in the
mitochondria, we used dihydro-dichlorofluorescin diacetate (H2DCF-DA) to
measure free radical generation. We observed a significant increase in the DCF
fluorescence of mitochondria in presence of calcium (200nmol/mg) compared to
those without calcium (Figure 4.11). To test if mitochondrial NOS might be
involved in such ROS/RNS increases, in another experiment, we used a NOS
inhibitor- NG-Nitro-L-arginine methyl ester, hydrochloride (L-NAME) and a
peroxynitrite scavenger - Tempol in presence of calcium (Figure 4.12). However,
neither L-NAME nor Tempol decreased the calcium induced ROS/RNS levels.

Calcium and Mitochondrial Oxidative Damage Markers:
Lastly, to assess the total extent of mitochondrial oxidative damage with
calcium, we utilized slot-blots to measure changes in markers of protein
oxidation, lipid peroxidation and protein nitration. We observed no differences
with calcium in levels of protein carbonyls, 4-hydroxynonenal (HNE) or in the
levels of 3-nitrotyrosine (3-NT). We observed slight increases in levels of protein
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carbonyls

(Figure

4.13)

at

lower

concentrations

compared

to

higher

concentrations of calcium. However, with 4-HNE (Figure 4.14) and 3-NT (Figure
4.15), no differences were observed at any concentrations of calcium used.
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Figure 4.1: Ultra-structure of mitochondria is maintained after percollpurification. Percoll-purified mitochondria were used to analyze their purity and
ultra-structure using electron microscopy (EM). The top panel (A) is a lowmagnification photograph of freshly isolated cortical mitochondria (Scale: 2cm =
2µm). The bottom panels (B) and (C) are high-magnification photographs of
individual mitochondria isolated from the same preparation. Intact outer and inner
mitochondrial membranes along with maintained cristae can be observed (Scale:
1cm = 0.1µm).
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Figure 4.1: Ultra-structure of mitochondria is maintained after
percoll-purification.
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Figure 4.2: Outer and inner mitochondrial membrane marker protein levels
are enriched with percoll-purification. Representative Western blots of
mitochondrial markers in the various fractions collected during the isolation and
purification procedure. The fractions were probed by a monoclonal antibody
against cytochrome c oxidase subunit IV (COX IV or COX) at 1:20,000 and a
polyclonal antibody against voltage dependent anion channel (VDAC) at
1:10,000 dilutions. The percoll-purified mitochondrial fractions demonstrate an
enrichment of VDAC (outer membrane marker) and COX (inner membrane
marker) protein levels compared to the brain homogenate and the crude
mitochondrial fractions.
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Figure 4.2: Outer and inner mitochondrial membrane marker protein levels
are enriched with percoll-purification.
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Figure 4.3: Representative traces of mitochondrial oxygen consumption
with calcium. Mitochondrial respiration was carried out at 37ºC by incubating
mitochondria in respiration buffer and oxygen consumption of mitochondria was
measured in response to addition of various substrates and inhibitors. Baseline
respiration is termed as State I containing 125mM KCl respiration buffer and
mitochondria (25-30ug). State II is initiated by addition of 5mM Pyruvate and
2.5mM Malate as substrates for Complex I of the electron transport chain (ETC).
Calcium was added to the mitochondria (0-1000nmol/mg) for 1min and State III is
initiated by activation of ATP Synthase (Complex V) with addition of ADP
(150µM). State IV occurs when ATP Synthase is inhibited by addition of
Oligomycin (2µM). FCCP (2µM) induces State V by uncoupling electron transport
from oxidative phosphorylation. Rotenone (1µM) is added followed by Succinate
(10mM) to verify electron transport through Complex II. All respiration
measurements were made in presence of 1mM L-Arg in KCl respiration buffer.
Calcium inhibited respiration in a dose-dependent manner.
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Figure 4.3: Representative traces of mitochondrial oxygen consumption
with calcium.
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Figure 4.4: Calcium decreases mitochondrial respiratory control ratio
(RCR). Increasing concentrations of calcium were used at the doses indicated
and the RCR, measured as State III (presence of ADP) over State IV (presence
of Oligomycin), of mitochondria in presence of calcium was significantly lowered
compared to the mitochondria with no calcium. No significant differences were
seen between 100 and 200nmoles/mg. Data represent group means ± SD; n = 3
per group. One-Way ANOVA; Student-Newman-Keuls post-hoc test; * p < 0.05
compared to 0nmol/mg Calcium; # p < 0.05 compared to 100nmol/mg.
Measurement

DF

F – value

P – value

Power

RCR

3

19.926

0.0005

1.000
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Figure 4.4: Calcium decreases mitochondrial respiratory control ratio
(RCR).
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Figure 4.5: Calcium decreases mitochondrial bioenergetics in a dosedependent manner. Increasing doses of calcium were added to the
mitochondria after the addition of the complex I substrates Pyruvate & Malate.
An increase in the nmol of oxygen consumed upon addition of calcium is
observed,

which

reaches

significance

at

500nmol/mg.

Decreases

in

bioenergetics was observed in State III (ADP) and State V (FCCP) as well.
However, calcium did not affect the complex II (Succinate) driven respiration.
Data represent group means ± SD; n = 3 per group. One-Way ANOVA; StudentNewman-Keuls post-hoc test; * p < 0.05 compared to 0nmol/mg Calcium; # p <
0.05 compared to 100nmol/mg Calcium; @ p < 0.05 compared to 200nmol/mg.
Measurement

DF

F – value

P – value

Power

Pyr/Mal

3

0.189

0.9009

0.072

Calcium

3

28.811

0.0001

1.000

ADP 1

3

8.318

0.0077

0.920

ADP 2

3

4.148

0.0478

0.632

Oligo

3

0.641

0.6100

0.131

FCCP

3

1.523

0.2815

0.261

Rot

3

0.647

0.6064

0.132

Succ

3

0.253

0.8568

0.080
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Figure 4.5: Calcium decreases mitochondrial bioenergetics in a
dose-dependent manner.
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Figure 4.6: Calcium decreases mitochondrial bioenergetics in a timedependent manner. Mitochondria were incubated with calcium after the addition
of the complex I substrates (pyruvate & malate) for increasing amounts of time.
An increase in the nmol of oxygen consumed upon addition of calcium was
observed while State III (ADP) driven respiration was inhibited with longer
incubations with calcium. When a higher concentration of calcium was added, the
inhibitory effect was more pronounced. However, as seen previously in Figure
4.3, calcium did not affect the complex II (Succinate) driven oxygen consumption.
n = 2 per group.
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Figure 4.6: Calcium decreases mitochondrial bioenergetics in a
time-dependent manner.
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Figure 4.7: NOS protein detected in brain mitochondria. Representative
Western blots indicating the purity of mitochondrial preparation. A polyclonal
antibody (1:250) against neuronal NOS (nNOS) shows immunoreactivity in the
percoll-purified

mitochondrial

fraction

suggesting

its

presence

in

brain

mitochondria. Post-snyaptic density 95 (PSD-95), probed by a monoclonal
antibody (1:20,000), is present in the synaptosomal fraction but absent from the
enriched mitochondrial fraction indicating that the mitochondrial preparation is
relatively pure.
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Figure 4.7: NOS protein detected in brain mitochondria.
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Figure 4.8: NOS protein is not an extra-mitochondrial contamination.
A) Representative Western blots showing that an intense ~155kD band was
detected in percoll-purified mitochondria (5 or 10ug protein) with decreasing
dilutions of a polyclonal antibody against neuronal NOS (nNOS). B) Percollpurified mitochondria (1mg/ml; 50-100ug) were subjected to affinity purification
by incubating them without (Total) or with 2’,5’-ADP Sepharose beads (50ug)
overnight with rocking at 4ºC to remove possible contamination by extramitochondrial NOS. They were then probed with antibodies against neuronal
NOS (nNOS; 1:250) and voltage-dependent anion channel (VDAC; 1:10,000)
using Western blots. Representative blots indicate the presence of NOS in the
mitochondria treated with beads suggesting that NOS detected in the
mitochondrial fraction is not an extra-mitochondrial contamination. Enrichment of
(VDAC) indicates that the effect of the beads is specific to proteins requiring
NADPH as a cofactor.
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Figure 4.8: NOS protein is not an extra-mitochondrial contamination.
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Figure 4.9: NOS protein is present in an intra-mitochondrial location.
A) Percoll-purified mitochondria (1mg/mg; 100ug) were incubated for 30min at
4ºC or 25ºC in absence or presence of a protease- Proteinase-K (50ug/ml) that
can digest proteins not protected by membranes. The reaction was stopped by
phenylmethylsulfonyl fluoride (PMSF; 1-2mM final) incubated for 10 min at 4°C or
25°C. The samples were centrifuged at 10,000 x g for 10 min and the pellets and
supernatants were collected and processed for Western blots. Antibody against
neuronal NOS (nNOS) at 1:250 shows that nNOS was retained in the
mitochondrial pellet fraction upon treatment with Proteinase-K, suggesting that it
is present inside the mitochondria. Antibody against voltage-dependent anion
channel (VDAC) at 1:10,000 indicates that VDAC was unaffected showing that it
is protected by mitochondrial membranes and therefore resistant to degradation.
Finally the effect of Proteinase-K degradation was not affected by the
temperature of incubation (4°C or 25°C). B) Brain homogenates were incubated
with Proteinase-K and/or a detergent- Triton-X (0.1%) and the reactions were
carried out for 30min at 37°C. The samples were then probed using Western
blots for Erk1/Erk2 (a cytosolic marker protein) using a polyclonal antibody at
1:1000. Representative blot shows that extracellular signal-regulated protein
kinase 1/2 (Erk1/Erk2) was degraded partially in presence of Proteinase-K
(200ug/ml) or Triton-X (0.1%) as it is not protected by membranes and
completely degraded when both Proteinase-K and Triton-X (0.1%) were added.
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Figure 4.9: NOS protein is present in an intra-mitochondrial location.
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Figure 4.10: NOS activity detected in brain mitochondria. Varying amounts of
percoll-purified mitochondria (0-200ug) were incubated for 15min at 25ºC in
presence of NOS substrates (radio-labeled L-Arginine), cofactors (NADPH, CaM
and BH4) and activator- calcium (100µM). The reaction was stopped by adding
excess of L-Citrulline and NOS activity was measured by the increase in radiolabeled Citrulline (dpm/min) produced compared to percent control (no
mitochondria). Insert indicates a bar graph of NOS activity measured as
nmol/min/mg of mitochondrial protein. Data represent group means ± SD; n = 4
per group; Student’s t-test.
Measurement

DF

t – value

P – value

NOS Activity

6

- 2.199

0.0702
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Figure 4.10: NOS activity detected in brain mitochondria.
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Figure 4.11: Calcium increased mitochondrial ROS/RNS levels. Mitochondria
(1mg/ml; 100ug) were incubated in 125mM KCl respiration buffer for 15min at
37ºC in presence of pyruvate and malate and 10µM H2DCF-DA (Ex: 485nm, Em:
530nm). ROS production was calculated as the rate of DCF fluorescence
expressed in arbitrary fluorescence units. A significant increase in the DCF
fluorescence was observed in mitochondria treated with calcium (200nmol/mg)
compared to those without calcium. Data represent group means ± SD; n = 4 per
group; Student’s t-test; * p < 0.05 compared to 0nmol/mg Calcium at 15min.
Measurement

DF

t – value

P – value

DCF Fluorescence

6

- 3.112

0.0208
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Figure 4.11: Calcium increased mitochondrial ROS/RNS levels.
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Figure 4.12: Tempol or L-NAME did not decrease calcium induced
ROS/RNS levels. Mitochondria (1mg/ml; 100ug) were incubated in 125mM KCl
respiration buffer for 30min at 37ºC in presence of pyruvate and malate and
10µM H2DCF-DA (Ex: 485nm, Em: 530nm). ROS production was calculated as
the percent increase in rate of DCF fluorescence compared to mitochondria with
no calcium and expressed in arbitrary fluorescence units. Calcium (200nmol/mg)
significantly increased ROS/RNS generation compared to mitochondria with no
calcium. 100µM NG-Nitro-L-arginine methyl ester, hydrochloride (L-NAME), a
NOS inhibitor or 5µM Tempol (a peroxynitrite scavenger) did not decrease
ROS/RNS levels in mitochondria treated with calcium. Data represent group
means ± SD; n = 5 per group; One-Way ANOVA; Student-Newman-Keuls posthoc test; * p < 0.05 compared to 0nmol/mg Calcium.
Measurement

DF

F – value

P – value

Power

DCF Fluorescence

3

8.606

0.0012

0.98
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Figure 4.12: Tempol or L-NAME did not decrease calcium induced
ROS/RNS levels.
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Figure 4.13: Calcium did not alter levels of protein carbonyls. Aliquots of
mitochondrial samples (200ng/ml) used for respiration studies were collected and
assessed for protein oxidation with an OxyBlot Protein Oxidation Detection Kit
using Slot-blots. Levels of protein carbonyls were measured by a polyclonal
antibody against the DNP moieties (1:1000) of oxidized proteins and expressed
as percent increase compared to their levels in mitochondria without calcium.
Protein carbonyls increased at lower concentrations of calcium (100nmol/mg)
than at higher concentrations (200 and 500nmol/mg). However, these changes
were not statistically significant compared to control (no calcium). Data represent
group means ± SD; n = 3 per group; One-Way ANOVA.
Measurement

DF

F – value

P – value

Power

Protein Carbonyls

3

1.610

0.2621

0.275
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Figure 4.13: Calcium did not alter levels of protein carbonyls.
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Figure 4.14: Calcium did not alter levels of 4-hydroxynonenal (4-HNE).
Aliquots of mitochondrial samples (200ng/ml) used for respiration studies were
collected and assessed for lipid peroxidation using Slot-blots. Levels of 4hydroxynonenal (4-HNE) were measured by a polyclonal antibody against 4-HNE
(1:10,000) and expressed as percent increase compared to their levels in
mitochondria without calcium. No changes in the levels of 4-HNE were observed
with any of the calcium concentrations used. Data represent group means ± SD;
n = 3 per group; One-Way ANOVA.
Measurement

DF

F – value

P – value

Power

4-Hydroxynonenal

3

2.048

0.1857

0.342
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Figure 4.14: Calcium did not alter levels of 4-hydroxynonenal (4-HNE).
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Figure 4.15: Calcium did not alter levels of 3-nitrotyrosine (3-NT). Aliquots of
mitochondrial samples (200ng/ml) used for respiration studies were collected and
assessed for protein nitration using Slot-blots. Levels of 3-nitrotyrosine (3-NT)
were measured by a monoclonal antibody against 3-NT (1:2,000) and expressed
as percent increase compared to their levels in mitochondria without calcium.
Levels of 3-NT did not change at any concentrations of calcium. Data represent
group means ± SD; n = 3 per group; One-Way ANOVA.
Measurement

DF

F – value

P – value

Power

3-Nitrotyrosine

3

0.051

0.9835

0.056
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Figure 4.15: Calcium did not alter levels of 3-nitrotyrosine (3-NT).
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Discussion
Our studies demonstrate that calcium inhibits mitochondrial respiration,
and increases free radical generation. We also confirm the presence of an active
NOS enzyme in the mitochondria, raising the possibility of its involvement in
mitochondrial dysfunction. However, we could not improve mitochondrial
bioenergetics or decrease ROS/RNS levels with NOS inhibitors or peroxynitrite
scavengers. Moreover, while we did observe increases in levels of protein
carbonyls (indicator of protein oxidation) and 4-Hydroxynonenal (4-HNE;
indicator of lipid peroxidation) we did not observe any changes in the levels of 3Nitrotyrosine (3-NT; indicator of protein nitration) in presence of calcium. All
these results suggest that though there is an active NOS in the mitochondria, it
may not be entirely responsible for the calcium induced mitochondrial
dysfunction.
Mitochondria isolated from the brain are most often contaminated by
synaptosomes, formed by the pinched off pre- and post-synaptic ends of
neurons, that can alter and complicate the interpretation of results obtained from
such mitochondria (Anderson and Sims 2000). Therefore, we employed a
method to release the synaptic mitochondria with nitrogen disruption which would
increase the total yield of mitochondria (Brown et al. 2004), avoiding the adverse
effects of digitonin (Brustovetsky et al. 2002). We further purified the total
mitochondria (synaptic and non-synaptic) by percoll discontinuous gradient
centrifugation. We checked for the purity of those mitochondrial preparations by
electron microscopy and found them to have mostly mitochondria with preserved
structures including intact cristae that lodge the ETC necessary for oxidative
phosphorylation (Figure 4.1). Moreover, mitochondrial marker proteins such as
VDAC for outer and COX for inner mitochondrial membranes are enriched in the
mitochondrial fraction with the sequential purification steps (Figure 4.2) while
minimizing contamination. Furthermore, we used only fresh mitochondria for the
studies described in this chapter, as cryopreserved mitochondria exhibit
decreases in mitochondrial bioenergetics (Nukala et al. 2006).
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Calcium (Ca2+) is taken up by the mitochondria through a uniporter, when
the cytoplasmic Ca2+ reaches around 1µM (Chalmers and Nicholls 2003; Nicholls
2005). Calicum is shown to regulate the citric acid cycle (TCA or Kreb’s cycle) by
activating

pyruvate

dehydrogenase

(PDHC),

NAD+-dependent

isocitrate

dehydrogenase and α-ketoglutarate dehydrogenase complex (KGDHC) resulting
in increases of NADH levels (Denton et al. 1988; Wan et al. 1989) as well as ATP
production by activating ATP synthase (Territo et al. 2000). These reactions
occur in the 0.1 to 1µM concentration range with fast kinetics on the order of milliseconds and provide for a physiological relevance to calcium inside the
mitochondria. At higher concentrations, calcium could inhibit respiration, cause
mitochondria to undergo MPT and release cytochrome c ultimately leading to cell
death (Gunter et al. 2004; Nicholls and Chalmers 2004; Jemmerson et al. 2005).
In our studies, we added patho-physiological doses (100 - 500nmol/mg
amounting to 10 - 50µM) of calcium to isolated mitochondria and examined its
effects on Complex I driven mitochondrial respiration in presence of L-Arg. We
observed that calcium induced mitochondrial dysfunction and the severity was
dose-dependent (Figure 4.3), similar to previous reports (Brustovetsky et al.
2003; Zhou et al. 2005). Of interest is the fact that mitochondria subjected to
density gradient centrifugation are more sensitive to Ca2+ effects than unpurified
CNS mitochondria (Brustovetsky and Dubinsky 2000). We observed significant
decreases in RCR (Figure 4.4) as well as decreases in individual states, most
noticeably in State III (coupled respiration in presence of ADP) and to a lesser
extent in State V (maximal respiration in presence of FCCP) (Figure 4.5).
Though the oxygen consumption increased initially upon addition of
calcium and returned to State II respiration rates, the response to ADP was
markedly affected, and this could be due to the transient depolarizing effect seen
with calcium (Figure 4.5). In one study, mitochondria exposed to a low Ca2+
concentration (4µM) resulted in a VDAC-mediated reversible cytochrome c
release, whereas at a higher Ca2+ concentration (100µM), there was
mitochondrial inhibition due to MPT induced irreversible cytochrome c release
(Schild et al. 2001). No changes could be observed in Complex II (succinate as

137

the substrate) driven oxygen consumption indicating that the inhibition of
mitochondrial respiration might be occurring at Complex I or upstream in the
Kreb’s cycle. Dubinsky’s group, upon addition of calcium, has shown that
cytochrome c released was accompanied by MPT and rupture of outer
mitochondrial membrane. However, the decline in mitochondrial respiration was
attributed to inhibition of Complex I rather than loss of cytochrome c
(Brustovetsky et al. 2002), supporting our data. Further, the inhibition of
mitochondrial respiration was exacerbated with longer exposures to calcium
(Figure 4.6), consistent with a previous study (Territo et al. 2000). This suggests
that deleterious effects of calcium are induced immediately and sustained over
time. However, it is not entirely clear how calcium inhibits mitochondrial
respiration and causes release of cytochrome c leaving room for the possibility of
a mitochondrial NOS-mediated pathway (Lores-Arnaiz et al. 2004; Boveris et al.
2006). In fact, an involvement of NOS for the effects of calcium on mitochondrial
respiration was shown in liver (Ghafourifar and Richter 1997; Giulivi 1998;
Traaseth et al. 2004; Schild and Reiser 2005), heart (Jekabsone et al. 2003;
Saavedra-Molina et al. 2003) and kidney (Boveris et al. 2006).
Therefore, in subsequent experiments we used two different NOS
inhibitors to assess if they can reverse the inhibition of mitochondrial respiration
induced by calcium (not shown). NG-nitro-L-arginine (L-NNA) and its NG-Nitro-Larginine methyl ester, hydrochloride (L-NAME) are both L-Arginine analogues. LNNA potently inhibits nNOS by binding tightly but non-covalently while L-NAME
is less specific being the precursor to L-NNA (Bryk and Wolff 1999). However, we
did not observe increases in State III respiration of mitochondria pre-incubated
(2-5min) with various concentrations of L-NNA or L-NAME with calcium (not
shown), similar to other studies in liver (Tay et al. 2004), heart (French et al.
2001) or brain (Schild et al. 2001) mitochondria. This could be due to the fact that
L-Arg was present throughout the reaction and could possibly be competing with
the inhibitor thereby rendering the inhibitors inefficient. We also omitted L-Arg
when the inhibitors were added and it did not change the outcome, raising the
possibility of the inhibitors not being sufficiently specific. Moreover, at higher
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concentrations, each of the inhibitors had a toxic affect on mitochondrial
bioenergetics. In another experiment, 5µM tempol, a scavenger of peroxynitrite
decomposition products and acting in a catalytic manner (Carroll et al. 2000),
was added to the mitochondria with calcium and tempol was unable to prevent
the inhibition of mitochondrial respiration (not shown). These data suggest that
the concentrations and kinetics of calcium may have an overwhelming effect on
mitochondrial respiration and/or may not directly involve mtNOS. It could also be
due to the differences in mitochondria from brain and other tissues from rat and
other species, mitochondrial isolation and purification procedures, buffer systems
and substrates and inhibitors used. Alternately, NO• or its derivatives observed
might diffuse into the mitochondria and lastly, a NOS-independent pathway for
generation of NO• (Zweier et al. 1999) might exist in the mitochondria.
One of the first reports for the existence of mtNOS enzyme in liver and in
brain non-synaptosomal mitochondria surfaced in 1995 and indicated that it is
similar to the eNOS isoform present bound to the inner mitochondrial membrane
facing the matrix (Bates et al. 1995). Since then, it was suggested the isoform in
liver mitochondria being similar to iNOS (Tatoyan and Giulivi 1998) while other
groups have followed up showing mitochondrial isoform to be iNOS in lung
mitochondria (Escames et al. 2003), eNOS (Lacza et al. 2001) and a nNOS
variant (Riobo et al. 2002; Lores-Arnaiz et al. 2004) in brain mitochondria. No
specific gene for mtNOS has been reported thus far and the targeting of mtNOS
could involve phosphorylation or a yet undiscovered mitochondrial localization
signal (Brookes 2004). Based on substrate-, cofactor- and activator-requirements
and availability, it is more plausible that the NOS isoform inside the mitochondria
is constitutive similar to eNOS or nNOS rather than the inducible NOS.
Therefore, to confirm the presence of NOS protein we used a polyclonal
antibody against nNOS. PSD-95, a synaptosomal marker and present in the
synaptosomal fraction, was absent in the mitochondrial fraction (Figure 4.7). We
were able to detect NOS protein in the percoll-purified mitochondrial fraction and
the intensity of the band was dependent on the antibody dilution (Figure 4.7 &
4.8A). However, the possibility of contamination of mitochondria by cytosolic
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NOS still exists (Brookes 2004). To check for such contamination, we obtained
percoll-purified mitochondria and subjected them to further affinity purification
(Lacza et al. 2003). We treated them with NADPH (NOS cofactor) immobilized to
2’,5’-ADP Sepharose beads, that will bind to any NADPH requiring enzyme
bound to the outer membrane, and were still able to detect NOS (Figure 4.8B).
The NOS band intensity was lower compared to untreated mitochondria while
VDAC showed a much intense band, leaving a possibility for contamination.
Therefore, we treated percoll-purified mitochondria with a protease (ProteinaseK), that will selectively digest proteins not protected by mitochondrial membranes
(Gao et al. 2004). Indeed, we used Proteinase-K with Erk-1/Erk-2, a cytosolic
marker, and it was degraded by Proteinase-K and completely digested in
presence of Triton-X (Figure 4.9B). We noticed NOS protein in Proteinase-K
treated mitochondria. VDAC, an outer mitochondrial membrane marker,
remained intact (Figure 4.9A) indicating that the Proteinase-K did not affect
mitochondrial integrity.
Giulivi’s group published a contradictory report where they purified and
characterized a protein from liver mitochondria and showed the isoform to be
nNOSα-like with two post-translational modifications – acylation by myristic acid
at the N-terminus and a phosphorylation site (Elfering et al. 2002) but do not see
similar results in the heart mitochondria (French et al. 2001). Similarly, Busija’s
group, in a comprehensive study, question the validity of their previous claim by
showing that mtNOS is not eNOS, nNOS or iNOS in liver (Lacza et al. 2003) or
heart mitochondria (Csordas et al. 2007). In lieu of the divergent and confounding
reports and due to non-availability of antibodies specific against mtNOS (Brookes
2004), although our data indicates a nNOS isoform present in the brain
mitochondria, it does not rule out the presence of an eNOS or iNOS isoform in
the mitochondria at this time.
Various groups have shown an active NOS in liver (Ghafourifar and
Richter 1997; Tatoyan and Giulivi 1998; Giulivi 2003), lung (Escames et al.
2003), heart (Kanai et al. 2001), kidney (Boveris et al. 2003), muscle (Boveris et
al. 2002) and brain mitochondria (Lacza et al. 2001; Riobo et al. 2002; Lores-
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Arnaiz et al. 2004) while it is disputed by other groups (French et al. 2001; Lacza
et al. 2003; Csordas et al. 2007). We tested if the mitochondrial nNOS detected
in our brain mitochondrial preparations is physiologically relevant by measuring
its activity in percoll-purified mitochondria. All the studies reporting NOS activity
indicate that it shows Ca2+-dependent activity and therefore we carried out all our
NOS activity measurements in presence of 100µM calcium (Miller 2002). Our
data shows that there is measurable nitric oxide (NO•) production (12.6 ± 0.67
nmol/min/mg) that increased with varying amounts of mitochondrial protein
(Figure 4.10), suggesting the presence of a physiologically relevant NOS enzyme
in brain mitochondria. The levels we detected were much higher than other
reports obtained from brain mitochondria (Lacza et al. 2001; Riobo et al. 2002;
Lores-Arnaiz et al. 2004). One of the reasons for this difference could be the
reaction incubation times, where a longer incubation could result in a feedback
inhibition of the enzyme by the NO• produced (Alderton et al. 2001). Secondly,
the concentrations of Ca2+ and L-Arg and cofactors could alter the amount of NO
generated and could explain the lack of effect of a nNOS antibody we used in
another experiment. We used varying dilutions of the antibody (Riobo et al.
2002), which was used to probe for NOS protein, to inhibit the enzymatic activity
but did not see any decreases in NO• production (not shown).
Mitochondria are the major sources of free radicals inside the cell formed
by the leakage of electrons from various sources of the ETC (Turrens 2003) and
calcium is shown to influence ROS/RNS generation in mitochondria by
processes not completely understood (Camello-Almaraz et al. 2006). This is
evident by the divergent reports on calcium increasing (Brustovetsky et al. 2003;
Sousa et al. 2003), decreasing (Starkov et al. 2002; Gyulkhandanyan and
Pennefather 2004), or causing no changes (Votyakova and Reynolds 2001;
Votyakova and Reynolds 2005; Tretter and Adam-Vizi 2006) in the ROS/RNS
levels of brain mitochondria. In general, from the above reports, succinate usually
in presence of ETC inhibitors tends to produce higher levels of ROS/RNS with
calcium compared to pyruvate/malate/glutamate as substrates.
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We examined if calcium (200nmol/mg) induces or increases ROS/RNS
generation within mitochondria that might be responsible for the inhibition of
mitochondrial respiration. We did observe a significant increase in ROS/RNS
levels with calcium (Figure 4.11) in presence of pyruvate/malate as substrates.
Furthermore, the ROS/RNS levels increased over time in both groups. In another
experimental protocol, we observed decreases in ROS/RNS levels with calcium
accompanied by partial loss of membrane potential (Appendix 1A and 1B),
supporting previous reports (Vergun and Reynolds 2005). This data is similar to
the transient depolarizing effect on mitochondria seen with higher doses of
calcium in our respiration studies. Our lab has previously shown that nonsynaptic mitochondria are able to buffer more calcium than synaptic mitochondria
before losing the membrane potential (∆ψ) and undergoing swelling but do not
exhibit differences in ROS/RNS levels (Brown et al. 2006). Those mitochondria
were able to sequester higher amounts of calcium compared to the doses we
used in the current set of experiments. One important difference is the use of
total mitochondria and the absence of ADP before the calcium challenge,
especially since the presence of ADP retains mitochondrial membrane potential
(∆ψ) and prevents MPT (Andreyev et al. 1998). Second, the continuous infusion
method of calcium was used previously whereas bolus additions were used in all
the experiments described in this chapter. Finally, we noticed that the opposite
effects of calcium are in fact due to the ‘effective’ protein and calcium
concentrations in the reaction buffers. To observe increases in ROS/RNS levels,
the reactions should be carried out at higher concentrations of both the
mitochondrial protein and calcium (Figure 4.11) while a reverse effect is seen
with lower concentrations (Appendix 1.A & 1.B). The results from our
experiments bring forth an important finding that could explain the discrepancies,
about calcium effects on ROS/RNS levels, observed with the previously
published literature.
It is well established that NO• at nanomolar concentrations competes with
oxygen and reversibly inhibits cytochrome c oxidase (COX), acting as a
physiological regulator of mitochondrial respiration (Brown 2001; Brookes et al.
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2002; Moncada and Erusalimsky 2002; Babior 2004). The source of NO• was
shown to be endogenous to the mitochondria (Giulivi et al. 1998) leading to
decreases in ATP generation (Giulivi 1998) and increases in ROS/RNS levels
(Sarkela et al. 2001), possibly due to a physical interaction between
mitochondrial NOS (mtNOS) and COX (Persichini et al. 2005). However,
prolonged exposure of COX to higher levels of NO• results in its irreversible
inhibition caused by peroxynitrite (ONOO-) (Brown and Borutaite 2002; Radi et al.
2002). Although, NO• can directly react with superoxide (O2•-) to form ONOO-,
NO• can react with ubiquinol (QH2), the reduced form of ubiquinone (Q), to yield
NO- and ubisemiquinone (QH•) radical. NO- can then react with molecular
oxygen (O2) to form ONOO- (Poderoso et al. 1999). Both NO• and ONOO- are
capable of diffusing across membranes and therefore into mitochondria (Radi et
al. 2002). One study showed the production of ONOO- following Ca2+ uptake and
activation of mtNOS and resulted in efflux of calcium from the mitochondria
(Bringold et al. 2000). Calcium is also shown to result in release of cytochrome c
(Andreyev and Fiskum 1999; Petrosillo et al. 2004) mediated through
peroxynitrite (Borutaite et al. 1999; Ghafourifar et al. 1999) but independent of
membrane permeability transition in brain mitochondria (Andreyev et al. 1998).
Based on those observations and our own data showing the presence of
an active NOS enzyme in brain mitochondria, it raises the possibility of the
involvement of ONOO- in calcium-induced free radical generation. Therefore we
used L-NAME and tempol to test if they would decrease the higher ROS/RNS
levels observed with calcium. We observed significant increases in ROS/RNS as
seen previously in all the groups tested compared to mitochondria without
calcium (Figure 4.12). Although tempol slightly decreased ROS/RNS levels
compared to mitochondria treated with calcium it was not significant, similar to a
previous study (Lacza et al. 2006). This is in contrast a previous report, where
calcium increased ROS/RNS levels and decreased in presence of tempol (Schild
and Reiser 2005). However, it was not verified if the high dose of tempol (10mM)
rescued mitochondrial respiration and the effect of tempol could have been due
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to its toxic effects on the mitochondria. This brings into question the role of nitric
oxide (NO•) and peroxynitrite in calcium induced free radical generation in the
mitochondria. Another plausible reason is that dichloro fluorescein (DCF)
measures a range of ROS/RNS including H2O2 and ONOO- which makes it
difficult to interpret the results. Moreover it is also susceptible to photo autooxidation (Possel et al. 1997; Ischiropoulos et al. 1999; Radi et al. 2001; Thomas
et al. 2002).
Finally, we tested if the increases in ROS/RNS levels observed with
calcium translates into oxidative damage in the mitochondria. We therefore
measured the levels of protein carbonyls (an indicator of protein oxidation), 4hydroxynonenal (4-HNE; indicator of lipid peroxidation). We observed differences
in protein carbonyls (Figure 4.13) and 4-HNE (Figure 4.14) at lower
concentrations of calcium but they were not significant. Moreover, a wide variety
of nitrated proteins have been found in the mitochondria indicating involvement of
peroxynitrite (Riobo et al. 2001; Elfering et al. 2004) and we therefore measured
the levels of 3-nitrotyrosine (3-NT; indicator for protein nitration). However, we
did not observe any changes in levels of 3-NT at any of the calcium doses tested
(Figure 4.15). An absence of measurable or significant changes in oxidative
damage markers does not necessarily mean the lack of RNS involvement. The
methodology used measures the extent of total oxidative damage and not the
individual modified proteins (Kohen and Nyska 2002; Tarpey et al. 2004). In fact,
oxidative damage to certain key mitochondrial proteins including those involved
in Kreb’s cycle or Electron Transport Chain (ETC) has been observed. While
Complexes I and II of ETC, creatine kinase are oxidatively inactivated by
peroxynitrite, ATP synthase, aconitase, VDAC and Mn-SOD are inactivated by
nitration of tyrosine residues through the peroxynitrite decomposition products
(Radi et al. 2002). The inactivation or inhibition of these proteins might be
sufficient to inhibit mitochondrial respiration (ex: ATP Synthase) or amplify the
free radical generation (ex: Mn-SOD) and thereby contribute to mitochondrial
dysfunction ultimately resulting in cell death.
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Based on the collective evidence, although the brain mitochondria contain
a nNOS-like functional enzyme it may not play a major role in calcium mediated
dysfunction in brain mitochondria. This is based on the lack of effect of NOS
inhibitors and/or peroxynitrite scavengers on calcium induced a) inhibition of
mitochondrial respiration and b) increases in ROS/RNS levels. Moreover, no
alterations were detected in levels of markers for oxidative damage. The short
exposure time (less than 30min) of mitochondria to calcium might be insufficient
to elicit detectable changes in ROS/RNS levels and/or oxidative damage
markers.
Mitochondrial dysfunction, as measured by mitochondrial respiration,
ROS/RNS levels and oxidative damage markers, is more prominent in
pathologies following traumatic injuries, stroke and neurodegenerative conditions
such as Alzheimer’s disease (AD). This implies that calcium induced
mitochondrial dysfunction may be only one of the many mechanisms responsible
for the global cellular oxidative stress. One such mechanism is the cytosolic
calcium induced activation of phospholipase A2 (PLA2) that mediates the rapid
release of arachidonic acid (AA) and lysophospholipids.

Some of the AA is

converted to pro-inflammatory mediators such as prostaglandins, leukotrienes
and thromboxanes, collectively known as eicosanoids. Arachidonic acid (AA)
cascade can lead to generation of free radicals resulting in lipid peroxidation
thereby altering plasma membrane as well as mitochondrial membrane
composition, fluidity and permeability. The mitochondrial proteins can be oxidized
from such cytosolic sources of free radicals and nitrated by cytosolic NOS
mediated NO• and ONOO- generation. Lastly, calcium activated cytosolic
calpains can also degrade mitochondrial proteins thereby causing mitochondrial
dysfunction.
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Chapter Five

Summary and Future Directions
Nature has equipped its various life forms with programmed development
filled with redundancies to ensure survival and growth. There are however other
stochastic events occurring in nature that modulate an organism’s adaptability
and thereby determine its lifespan. Free radicals are one such entity that when
left unchecked can cause oxidative stress and reversible or irreversible damage
to the organism. Oxidative stress at the cellular level has been implicated to have
a causal role in the gradual deterioration of tissue and organ function observed
with aging and age-related neurodegeneration (reviewed in Chapter One).
Typically, freshly isolated mitochondria are preferred for the study of their
structure and function because such mitochondria are structurally intact as well
as tightly coupled that is necessary for their respiratory function. However, in
cases of a large sample size or valuable post-mortem samples or those requiring
transport of samples, mitochondria isolated out of their cellular milieu undergo
significant deterioration in their structure and function. This prevents conducting
studies on mitochondrial bioenergetics thus limiting their usage. To overcome
this obstacle, we optimized a method utilizing a well-characterized cryoprotectant
such as dimethyl sulfoxide (DMSO).
Freshly isolated mitochondria were cryopreserved in the presence of
DMSO and stored for the intended duration (upto 6 months). Such cryopreserved
mitochondria show similar structure and function compared to freshly isolated
mitochondria as observed by the ultra-structure, mitochondrial marker (COX and
VDAC) levels and mitochondrial respiration. There was a partial decrease in
mitochondrial bioenergetics that could be attributed to the loss of cytochrome c
from cryopreserved mitochondria. They however were functionally viable
compared to mitochondria frozen in the absence of DMSO. We also observed
that mitochondria can be cryopreserved in their crude or purified form. This
makes it feasible to considerably expand the time-frame and the range of
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biochemical, molecular and metabolic studies that can performed without the
constraints of mitochondrial longevity ex vivo (Contents of Chapter 2).
Alzheimer’s disease (AD) is one of the most prevalent neurodegenerative
conditions in aged people resulting in a progressive deterioration of cognition and
memory. While anatomic and metabolic deficiencies were observed with AD, the
underlying mechanisms are yet unclear. Oxidative stress at the level of
mitochondria and their dysfunction is one of the mechanisms gaining credibility.
However, such studies are limited by the availability of suitable post-mortem
brain tissues. We established a collaborative study with the Alzheimer’s Disease
Research Center (ADRC) Rapid Autopsy Unit of the Sander’s Brown Center on
Aging at University of Kentucky (Contents of Chapter 3).
We successfully employed the cryopreservation method to store
mitochondria from post-mortem brains of AD and control subjects that were
longitudinally assessed for neuropsychological symptoms. Synaptic and nonsynaptic mitochondria were isolated from the middle-temporal (MT), frontal (F)
and sensory (S) regions. The synaptic mitochondria from AD patients showed
decreased respiration measured by their respiratory control ratio (RCR) and
maximal complex I-driven respiration compared to control mitochondria in all the
regions measured. We did not observe any changes in ROS/RNS levels.
However, we observed higher oxidative damage (measured by protein carbonyls)
in all the regions of AD compared to control subjects. Moreover, non-synaptic
mitochondria had higher protein carbonyl content compared to synaptic
mitochondria in each of the regions assessed. These data do indicate a role for
mitochondrial oxidative stress and dysfunction.
Mitochondria, owing to their origin, structure and function, occupy a unique
and intriguing position in the cell. They primarily provide the energy critical for
metabolism, apart from calcium buffering and other vital functions. The price
mitochondria pay for their semi-autonomous existence is oxidative stress. This
led to a newer and significant role being ascribed to mitochondria- their
involvement in cell death. Though mitochondria are established as a major
source of oxidative stress inside the cell, the underlying mechanisms require
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further elucidation. This dissertation attempts to offer a mechanistic explanation
to the sources and the interplay of free radicals and calcium in mitochondrial
dysfunction (Contents of Chapter Four).
One of the mechanisms postulated is the presence of a new isoform of
nitric oxide synthase (mtNOS) that has been isolated and localized to
mitochondria; though its existence and physiological role is debated. NOS, when
activated by calcium, produces nitric oxide (NO•) which normally acts as a
second messenger molecule in diverse cellular processes such as vasodilation
and neurotransmission. NO• can also interact with ROS producing various
reactive nitrogen species (RNS) such as nitrite, nitrogen dioxide radicals and
peroxynitrite (ONOO-). These highly reactive radical species can damage DNA,
proteins and lipids. This ultimately results in cell death via apoptosis or necrosis.
We investigated if a) calcium causes oxidative damage and mitochondrial
dysfunction and b) if mitochondrial function can be rescued. We generated doseand time-response curves for the effect of calcium on mitochondrial
bioenergetics. We observed a significant reduction in mitochondrial respiratory
control ratio (RCR) and rate of oxygen consumption of brain mitochondria in a
dose- and time-dependent manner. This was accompanied by a transient
‘depolarizing’ effect on oxygen consumption with addition of calcium. This
calcium effect was primarily Complex I (pyruvate and malate) driven respiration
that was not observed with succinate (Complex II) driven respiration.
We then tested NOS (L-NNA & L-NAME) inhibitors in presence of calcium
and measured the rescue/recovery of mitochondrial bioenergetics. We observed
no recovery of State III (in presence of ADP) respiration with any of the inhibitors.
At higher concentrations, each of the inhibitors had a toxic affect on
mitochondrial bioenergetics. We also tested tempol, a free-radical scavenger,
and observed no recovery of mitochondrial function. From these data, we
conclude that calcium alters mitochondrial bioenergetics significantly and
irreversibly as shown by the lack of effect of NOS inhibitors and free-radical
scavengers. This could be due to lack of specificity of NOS inhibitors or more
plausibly an overwhelming effect of calcium.
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Furthermore, we conducted experiments to a) measure NOS activity and
b) detect NOS protein in purified brain mitochondria. NOS protein could be
detected in the percoll-purified mitochondria while PSD-95 was enriched in the
synaptosomal fraction but visibly absent in the mitochondrial fraction. To remove
possible contamination of cytosolic NOS protein in brain mitochondria, we treated
purified mitochondria with cytosolic protein removal or digestion treatments. The
data indicates that NOS is present inside the mitochondria though the precise
intra-mitochondrial location is yet to be determined. However, it must be noted
that our studies do not completely rule out contamination of mitochondrial
preparations.
We measured NOS activity in isolated ultra-pure brain mitochondria and
observed a mitochondrial protein-dependent increase in nitric oxide production in
intact mitochondria. This suggests the presence of a NOS isoform localized to
mitochondria, the exact nature of which is yet to be determined. This enzyme
might be in part responsible for regulation of mitochondrial bioenergetics.
However, the gene transcription, type of isoform, its transport, physiological
function and regulation of protein levels and enzyme activity are all questions that
need further investigation.
Experiments were then conducted to study if calcium altered ROS/RNS
levels and we did observe significant increases in ROS/RNS levels over time in
presence of calcium. We then tested if L-NAME or tempol would alter the
ROS/RNS levels. We observed no changes in the ROS/RNS levels with either of
the treatments. In a slightly different experimental paradigm, we measured
ROS/RNS levels in parallel with changes in membrane potential. We did not
observe any increases in ROS/RNS levels with calcium. On the contrary,
ROS/RNS levels decreased significantly in presence of higher concentrations of
calcium. This was accompanied by a detectable loss of membrane potential with
the addition of calcium. These data suggest that the loss in membrane potential
in presence of calcium might be responsible for the decrease in the observed
free-radical generation. One plausible explanation could be that loss of
mitochondrial membrane potential might lead to inhibition of the electron
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transport chain. Studies remain to be performed if loss of membrane potential
leads to membrane permeability transition (MPT) and possibly release of
cytochrome c. The differences in ROS/RNS levels with calcium under various
experimental paradigms could be attributed to the effective concentration of
calcium and mitochondrial protein in the respiration medium. This could explain
the contradictory results of various groups reporting that calcium increased or
decreased or caused no change in ROS/RNS levels.
We addressed the question if changes in ROS/RNS levels with calcium
led to changes in mitochondrial membrane and protein components. We tested
this by measuring levels of protein carbonyls, 3-nitrotyrosine (3-NT) and 4hydroxynonenal (4-HNE), as markers for protein oxidation, protein nitration and
lipid peroxidation respectively, in presence of calcium. We observed differences
in the levels of protein carbonyls with calcium but were not significant. We did not
observe any changes in the levels of and 4-HNE and 3-NT, raising the question
of the consequences of changes in ROS/RNS levels, the time-frame required to
alter mitochondrial components and their role in mitochondrial dysfunction
through oxidative damage per se.
During the course of this dissertation, one of the recurring and
confounding reasons is the experimental conditions used by the various groups
to determine the effects of calcium on mitochondrial respiration, presence of
mtNOS and its regulation and consequences of calcium induced free radical
generation. More careful studies are required to address plausible alternate
mechanisms, other than acute effects of mtNOS mediated oxidative stress,
underlying mitochondrial dysfunction observed with calcium.
One such mechanism is a role for nitric oxide (NO•) in mitochondrial
biogenesis (Nisoli and Carruba 2006). NO• through the cyclic GMP (cGMP)
pathway causes increased mitochondrial proliferation resulting in mitochondria
that are functionally active. It is also shown to upregulate Hsp70, a mitochondrial
chaperone involved in protein import and folding. NO• is upregulated with caloric
restriction that also activates mitochondrial biogenesis implicating its role in
extending lifespan. Therefore, the role of mtNOS in aging requires further
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investigation. It should be kept in mind that nitric oxide (NO•) can also act as an
anti-oxidant based on its local concentrations and the surrounding environment.
Lastly, NO• is also involved in upregulation of uncoupling proteins (UCPs)
possibly due to cross-talk between mtNOS and UCPs at the level of
mitochondria.
The presence of UCPs in mitochondria adds another dimension in the
regulation of mitochondrial bioenergetics (Mattiasson and Sullivan 2006). They
are present in the mitochondrial inner membrane and help in translocation of
protons from the inter-membrane space back into the matrix. This results in
uncoupling of electron transport and oxidation from ADP phosphorylation of the
ETC leading to lowering of membrane potential (∆ψ) and instead of ATP
generation the energy is dissipated in the form of heat. Apart from their classic
role in thermogenesis, UCPs are also shown to be involved in mitochondrial
proliferation and thereby increase ATP levels. Because UCPs lower the
membrane potential, they could alter mitochondrial calcium uptake and/or
overload thereby preventing induction of cell death through membrane
permeability transition. In addition, ketone bodies are shown to provide more
NADH, substrate for Complex I driven respiration, and also lower ROS by
altering the redox state of ubiquinone. Therefore, mild uncoupling through UCPs,
whereby ROS generation is lowered while preserving mitochondrial function,
presents a novel therapeutic opportunity in a variety of disease settings and such
mechanisms are currently being investigated in the laboratory.
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Appendix A
Figure A.1: Calcium decreases mitochondrial ROS/RNS levels. Mitochondria
(100ug) were added to a constantly stirred cuvette in a total volume of 2mls of
125mM KCl buffer at 37ºC containing 1mM L-Arg, 10µM H2DCF-DA (Ex: 485nm,
Em: 530nm). Each run was performed with a baseline reading of buffer.
Mitochondria, calcium and the substrates/inhibitors were added as indicated. The
slope of DCF fluorescence was quantified for the respective conditions including
baseline and expressed in arbitrary units. A significant decrease in DCF
fluorescence, as a measure of free radical generation was observed in
mitochondria treated with calcium compared to those without calcium. The
decrease was calcium dose-dependent and was observed with additions of
calcium, ADP, Oligomycin, FCCP and Rotenone but not Succinate. Data
represent group means ± SD; n = 3 per group. One-Way ANOVA; StudentNewman-Keuls post-hoc test; * p < 0.05 compared to 0nmol/mg Calcium; @ p <
0.05 compared to 200nmol/mg.
Measurement

DF

F – value

P – value

Power

Mito

2

0.000

-

0.05

Pyr/Mal

2

0.574

0.5964

0.102

Calcium

2

20.738

0.0038

0.987

ADP

2

11.936

0.0125

0.889

Oligo

2

5.773

0.0502

0.594

FCCP

2

5.815

0.0496

0.597

Rot

2

3.851

0.0972

0.429

Succ

2

0.080

0.9241

0.057
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Figure A.1: Calcium decreases mitochondrial ROS/RNS levels.

153

Figure

A.2:

Calcium

decreases

mitochondrial

membrane

potential.

Mitochondria (100ug) were added to a constantly stirred cuvette in a total volume
of 2mls of 125mM KCl buffer at 37ºC containing 1mM L-Arg, 150nM TMRE (Ex:
550nm, Em: 575nm). Each run was performed with a baseline reading of buffer.
Mitochondria, calcium and the substrates/inhibitors were added as indicated. An
increase in TMRE fluorescence, as a measure of loss of mitochondrial
membrane potential (∆ψ), was observed in mitochondria treated with calcium
compared to those with no calcium. This increase was calcium dose-dependent
and was sustained in presence of ADP (see calcium 200-500nmol/mg). n = 3 per
group.
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Figure A.2: Calcium decreases mitochondrial membrane potential.
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Appendix B
adenosine triphosphate (ATP), electron transport chain (ETC), calcium (Ca2+),
reactive oxygen species (ROS), de-oxy ribo nucleic acid (DNA), mitofusins (Mfn),
dynamin-related proteins (Drp), peroxisome proliferator-activated receptor-γ
coactivator (PGC), nuclear respiratory factor (NRF), outer mitochondrial
membrane (OMM), inner mitochondrial membrane (IMM), inter-membrane space
(IMS), mitochondrial DNA (mtDNA), ribonucleic acid (RNA), ribosomal RNA
(rRNA), transfer RNA (tRNA), translocase of the outer membrane (TOM), sorting
and assembly machinery (SAM), translocase of the inner membrane (TIM),
nicotanamide adenine dinucleotide (NADH), flavin adenine dinucleotides
(FADH2), adenosine diphosphate (ADP), inorganic phosphate (Pi), NADHubiquinone oxidoreductase (Complex I), coenzyme Q (ubiquinone), succinateubiquinone oxidoreductase (Complex II), nitroproprionic acid (3-NP), Ubiquinonecytochrome c oxidoreductase (Complex III), cytochrome c oxidase (COX or
Complex IV), water (H2O), F0-F1-ATPase or ATP synthase (Complex V), adenine
nucleotide translocase (ANT), magnesium (Mg2+), voltage-operated channels
(VOC), receptor-operated channels (ROC), N-methyl-D-aspartate (NMDA), storeoperated channels (SOC), receptor tyrosine kinases (TyrK), Phospholipase C
(PLC), endoplasmic reticulum (ER), inositol 1,4,5-trisphosphate receptors
(InsP3R), ryanodine receptors (RyR), protein kinase C (PKC), protein kinase A
(PKA), protein phophatases 1 and 2a (PP1 and PP2a), calmodulin (CaM),
troponin C (TnC), nuclear factor-kappa B (NF-κB), nuclear factor of activated T
cells (NF-AT), cyclic adenosine monophosphate (cAMP), cyclic-AMP response
element binding protein (CREB), NF-kappaB inhibitory protein (IκB), calmodulin
kinase II (CaMKII), sarco(endo)plasmic reticulum Ca2+-ATPases (SERCA),
secretory-pathway Ca2+-ATPases (SPCA), mitochondrial calcium uniporter
(MCU), sodium (Na+), Na+/ Ca2+ exchangers (NCX), plasma membrane (PM),
plasma membrane Ca2+-ATPases (PMCA), proton (H+), permeability transition
pore (PTP), nitric oxide or nitrogen monoxide (NO•), endothelium-dependent
relaxation factor (EDRF), superoxide (O2•-), cyclic guanosine monophosphate
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(cGMP), nitric oxide synthase (NOS), neuronal NOS (nNOS or NOS-1), inducible
NOS (iNOS or NOS-2), endothelial NOS (eNOS or NOS3), calmodulin (CaM),
(6R)-5,6,7,8-tetrahydro-L-biopterin (BH4), nicotinamide adenine dinucleotide
phosphate (NADPH), flavin adenine dinucleotide (Fadeel and Orrenius 2005),
flavin mononucleotide (FMN), PSD-95 discs large/ZO-1 homology (PDZ), postsynaptic density protein 95 (PSD-95), heat-shock protein 90 (Hsp90), protein
inhibitor of NOS (PIN), inositol 1,4,5-trisphosphate (IP3), diacylglycerol (Arrigoni,
Benzi et al. 1984), phosphatidylinositol 4,5-bisphosphate (PIP2), protein kinase B
(Akt), eNOS-interacting protein (NOSIP), eNOS traffic inducer
(NOSTRIN), interferon-γ (IFN-γ), janus kinase (JAK),

protein

signal transducers and

activators of transcription (STAT), IFN-γ regulatory factor 1 (IRF-1), NOSassociated protein 110 (NAP-110), iron-sulphur (Fe-S), heme-oxygenase 1 (HO1), cytochrome c oxidase (COX-IV), soluble guanylyl cyclase (sGC), hypoxiainducible factor 1 (HIF-1), iron-regulatory protein (IRP), iron-responsive elements
(IREs), aryl-hydrocarbon receptor nuclear translocator (ARNT), vascular
endothelial growth factor (VEGF), insulin-like growth factor II (IGF-II), cGMPdependent protein kinase (PKG), cyclic nucleotide-gated channels (CNG), central
nervous system (CNS), peripheral nervous system (PNS), long-term potentiation
(LTP), lipopolysaccharide (LPS), reactive nitrogen species (RNS), nitroxyl
radicals (NO-), peroxynitrite (ONOO-), hydroxyl radical (•OH), hydrogen peroxide
(H2O2), copper,zinc-associated superoxide dismutase (Cu,Zn-SOD), free radical
theory of aging (FRTA), mitochondrial theory of aging (MTA), ozone (O3), ultraviolet radiation (UV), peroxyl radicals

(ROO•), alkoxyl radicals (RO•),

hypochlorous acid (HOCl), manganese-superoxide dismutase (Mn-SOD),
glutathione peroxidase (GPx), nitrosoperoxo carbonate (ONOOCO2-), nitrogen
dioxide (•NO2), carbonate (CO3•-), peroxynitrous acid (ONOOH), interleukin-8
(IL-8), interleukin-1β (IL-1β), epidermal growth factor (EGF), insulin receptor
kinase (IRK), mitogen-activated protein kinases (MAPK), extracellular signalregulated protein kinase (ERK), c-Jun NH2-terminal kinase (JNK), activator
protein 1 (AP-1), low-molecular-weight antioxidants (LMWA), ascorbate (Vitamin
C), tocopherols (Vitamin E), glutathione (GSH), lipid radical (L•), lipid peroxyl
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radical (LOO•), malonyldialdehyde (MDA), 4-hydroxynonenal (4-HNE), cysteine
(Cys), methionine (Met), iron (Fe2+), copper (Cu+), lysine (Lys), histidine (His), 3nitro tyrosine (3-NT), arginine (Arg), proline (Pro), threonine (Thr), tryptophan
(Trp), 8-hydroxy-2-deoxyguanosine (8-OHdG), manganese (Mn2+), phosphatidyl
serine (PS), caspase recruitment domain (CARD), death effector domain (DED),
Fas ligand (FasL), tumor necrosis factor-α (TNFα), tumor necrosis factor-α
receptor 1 (TNFR1), death-inducing signaling complex (DISC), mitochondrial
membrane permeability transition pore (MPTP), benzodiazepine receptor (PBR),
hexokinase (HK), creatine kinase (CK), second mitocondria-derived activator of
caspases/ direct IAP-binding protein with low pI (Smac/Diablo), apoptotic
protease-activating

factor

1

(Apaf-1),

apoptosis-inducing

factor

(AIF),

Endonuclease G (Endo G), high temperature requirement protein A2
(HtrA2/Omi), inhibitors of apoptosis proteins (IAP), voltage-dependent anion
channel (VDAC), cyclophilin D (CypD), µ-calpain (calpain I), m-calpain (calpain
II), Alzheimer’s disease (AD), Parkinson’s disease (PD), average life expectancy
(ALE), maximum lifespan (MLS), mild cognitive impairment (MCI), respiratory
control ratio (RCR), cryoprotective additives (CPA), dimethyl sulfoxide (DMSO),
bovine serum albumin (BSA), potassium phosphate monobasic anhydrous
(KH2PO4),

ethylene

glycol-bis(2-aminoethylether)-N,N,N',N'-tetraacetic

acid

(EGTA), hydroxyethyl piperazine-1-ethanesulfonic acid potassium salt (HEPES),
magnesium

chloride

(MgCl2),

carbonyl

cyanide

4-(trifluoromethoxy)

phenylhydrazone (FCCP), bicinchoninic acid (BCA), potassium chloride (KCl),
enzyme-linked immunosorbent Assay (ELISA), tris-buffered saline (TBS),
horseradish peroxidase (HRP), analysis of variance (ANOVA), standard
deviations (SD), β-Amyloid (Aβ), positron emission tomography (PET), functional
magnetic resonance imaging (fMRI), ayloid precursor protein (APP), post-mortem
interval (PMI), potassium hydroxide (KOH), dihydro dichlorofluorescin diacetate
(H2DCF-DA), Alzheimer’s disease research center (ADRC), frontal (F), middletemporal (MT), sensory (S), dichloro fluorescein (DCF), arbitrary units (AU), 2,4dinitrophenyl hydrazone (DNP), nuclear DNA (nDNA), pyruvate dehydrogenase
complex

(PDHC),

α-ketoglutarate

dehydrogenase

158

complex

(KGDHC),

mitochondrial NOS (mtNOS), calcium chloride (CaCl2), L-arginine (L-Arg), Lcitrulline (L-Cit), tetramethylrhodamine ethyl ester (TMRE), NG-Nitro-L-arginine
(L-NNA) and NG-Nitro-L-arginine methyl ester, hydrochloride (L-NAME), sodium
chloride (NaCl), phosphate (PO-4), phenylmethylsulfonyl fluoride (PMSF),
phosphate buffer saline (PBS), ubiquinol (QH2), ubiquinone (Q), ubisemiquinone
(QH•), phospholipase A2 (PLA2), arachidonic acid (AA)
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